Proteome comparison of helicobacter pylori isolates associated with four disease groups by McWilliams, Tracy
 
 
School of Biomedical Sciences 
 
 
 
 
 
Proteome Comparison of Helicobacter pylori Isolates 
Associated with Four Disease Groups 
 
 
 
 
 
 
Tracy McWilliams 
 
 
 
 
 
 
 
This thesis is presented for the Degree of 
Doctor of Philosophy 
of 
Curtin University of Technology 
 
 
 
 
December 2006 
 
i 
 
Declaration 
 
 
To the best of my knowledge and belief this thesis contains no material previously 
published by any other person except where due acknowledgement has been made. 
 
This thesis contains no material which has been accepted for the award of any other 
degree or diploma in any university. 
 
 
 
Signed…………………………………………. 
                                                             
 
 
Date ………………....... 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ii 
 
ACKNOWLEDGEMENTS 
 
Firstly, I wish to thank my supervisors Robert Lock and Warren Grubb.  Their support 
and encouragement made this thesis possible. 
 
Next, I would like to thank John Pearman, Jeff Coombs, Geoffrey Forbes and the staff of 
the Royal Perth Hospital for their assistance in the H. pylori experiments and in 
obtaining isolates for this study. 
 
Finally, I would like to thank my family for their advice and encouragement throughout 
my PhD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
INDEX 
 
Contents          Page 
 
Declaration.................................................................................................................... i 
Acknowledgements...................................................................................................... ii 
Index ........................................................................................................................... iii 
Index of figures ........................................................................................................... vi 
Index of tables........................................................................................................... viii 
Abbreviations.............................................................................................................. ix 
Enzyme Commission Numbers................................................................................... xi 
Definitions.................................................................................................................. xii 
Abstract ..................................................................................................................... xix 
1.1  INTRODUCTION ................................................................................................ 1 
1.1  HELICOBACTER PYLORI................................................................................. 1 
1.1.1  The Discovery of H. pylori ........................................................................ 1 
1.1.2  Phenotypic Characteristics......................................................................... 3 
1.1.3  Geographical Epidemiology of H. pylori................................................... 6 
1.1.4  Association of H. pylori with Illness ......................................................... 8 
1.1.5  The H. pylori Genome ............................................................................. 13 
1.2 PROTEOMICS .................................................................................................... 15 
1.2.1  Genomics, Transcriptomics and Proteomics............................................ 15 
1.2.2  Post-translational modifications............................................................... 18 
1.2.3  Proteomic Technologies........................................................................... 19 
1.2.4  Proteomic Challenges .............................................................................. 22 
1.3  2-DE PROTEOME ANALYSIS TECHNIQUES .............................................. 23 
1.3.1   Protein Preparation.................................................................................. 25 
1.3.2  Cell Disruption......................................................................................... 25 
1.3.3   Protection Against Proteolysis................................................................ 25 
1.3.4   Removal of Contaminants....................................................................... 26 
1.3.5   Protein Solubilisation.............................................................................. 28 
1.3.6   First dimension........................................................................................ 31 
1.3.7   Second dimension ................................................................................... 35 
1.3.8   Visualisation of spots.............................................................................. 39 
1.3.9   Computer Analysis.................................................................................. 45 
1.3.10 Types of Analyses................................................................................... 46 
1.3.11  Protein identification methods in proteomics ........................................ 48 
1.3.12  Bioinformatics........................................................................................ 51 
1.4  Previous Studies versus the Present Study.......................................................... 53 
1.4.1  Jungblut’s study of H. pylori ................................................................... 53 
1.4.2  Enroth’s study of H. pylori ...................................................................... 53 
1.4.3  Current study of H. pylori........................................................................ 55 
1.4.4  Comparisons between H. pylori isolates.................................................. 56 
1.5  Aims of the Investigation.................................................................................... 58
 
 
iv 
Contents          Page 
 
 
1.1  MATERIALS AND METHODS........................................................................ 59 
2.1  Materials ............................................................................................................. 59 
2.2  List of Solutions.................................................................................................. 63 
2.3  Bacterial isolates ................................................................................................. 68 
2.4  Culture conditions............................................................................................... 68 
2.5  Sample preparation ............................................................................................. 69 
2.6  Wash-up .............................................................................................................. 69 
2.7  First dimension electrophoresis (isoelectric focusing) ....................................... 70 
2.8  Second dimension electrophoresis (SDS-PAGE) ............................................... 71 
2.8.1  Gradient Gels ........................................................................................... 71 
2.8.2   Preparation of Homogeneous (Single-Concentration) Gels ................... 71 
2.8.3  Tris-glycine buffer system ....................................................................... 73 
2.8.4  Tris-tricine buffer system......................................................................... 74 
2.8.5  Second Dimension Electrophoresis ......................................................... 75 
2.8.6  After 2D-PAGE ....................................................................................... 75 
2.9  Mr and pI ............................................................................................................. 75 
2.10  2-DE Gel Staining............................................................................................. 78 
2.11  Gel Drying ........................................................................................................ 79 
2.12  Image Analysis.................................................................................................. 79 
2.12.1  Scanning................................................................................................. 80 
2.12.2  Automated spot detection ...................................................................... 80 
2.12.3 Spot editing ............................................................................................. 81 
2.12.4 Matchsets ................................................................................................ 82 
2.12.5 Entering Mr and pI Data.......................................................................... 87 
2.12.6  Normalisation......................................................................................... 87 
2.12.7 Analyses.................................................................................................. 87 
2.12.8  Exporting Matchset Data ....................................................................... 90 
2.12.9  Excel merging of overlapping pI and Mr ranges.................................... 90 
2.13  Cluster analysis ................................................................................................. 91 
2.14  Peptide mass fingerprinting .............................................................................. 93 
2.14.1  Spot Excision ......................................................................................... 93 
2.14.2 The Australian Proteomics Facility (Lock et al, 2001) Procedure.......... 96 
2.14.3  The Proteomics International Procedure................................................ 97 
2.15  Protein identification......................................................................................... 98 
3.0  RESULTS ......................................................................................................... 100 
3.1  First dimension protein separation (isoelectric focusing)................................. 100 
3.2  Separation of proteins in the second dimension (SDS-PAGE)......................... 100 
3.2.1   Gradient gels ......................................................................................... 100 
3.2.2   Crosslinkers........................................................................................... 101 
3.2.3   Running Conditions .............................................................................. 102 
3.2.4   Tris-glycine electrode buffer gels ......................................................... 102 
3.2.5   Tris-tricine electrode buffer gel ............................................................ 103 
  
  
v 
Contents          Page 
 
 
3.3  Image analysis................................................................................................... 105 
3.3.1  Spot detection......................................................................................... 106 
3.3.2  Matchset strategies................................................................................. 106 
3.3.3  Proteome reproducibility within replicate groups.................................. 107 
3.3.4  Gel pattern comparisons between and  within groups ........................... 109 
3.3.5  Pattern expression comparisons............................................................. 111 
3.4  Cluster analysis of protein patterns................................................................... 114 
3.5 Protein Identification ......................................................................................... 114 
3.6  Comparison of theoretical and observed data................................................... 117 
1.1  DISCUSSION................................................................................................... 156 
4.1  Proteome Analysis of Microorganisms............................................................. 156 
4.2   Comparisons between the H. pylori studies..................................................... 156 
4.2.1  Isolates included in the study................................................................. 156 
4.2.2  Spot resolution ....................................................................................... 157 
4.2.3  Staining technique.................................................................................. 158 
4.3  The H. pylori proteome..................................................................................... 158 
4.4  Basic proteins of H. pylori ................................................................................ 159 
4.5  Separation of Low Molecular Mass Proteins.................................................... 162 
4.6  Theoretical versus observed proteome.............................................................. 164 
4.6.1  Posttranslational modifications.............................................................. 165 
4.6.2  Observed Mr versus Theoretical Mr....................................................... 165 
4.6.3  Protein Modal Distribution .................................................................... 167 
4.6.4  In vitro and in vivo................................................................................. 168 
4.7  Cluster Analysis of H. pylori ............................................................................ 169 
4.8  Variability among H. pylori isolates................................................................. 170 
4.8.1  Post translational modifications............................................................. 171 
4.8.2  Variation in gene expression.................................................................. 171 
4.8.3  Plasmids as a source of proteomic diversity .......................................... 173 
4.9  Conserved proteins............................................................................................ 174 
4.10   Proteomic Differences between Disease Groups........................................... 175 
4.10.1  GU Unique and Absent Proteins.......................................................... 176 
4.10.2  Unique and Absent Proteins in DU Isolates ........................................ 181 
4.10.3  Unique and Absent Proteins in NUD Isolates...................................... 186 
4.10.4  Unique and Absent proteins in GI Isolates .......................................... 191 
4.10.5  GU Differentially Regulated Proteins.................................................. 192 
4.10.6  DU Differentially Regulated Proteins.................................................. 194 
4.10.7  DU and NUD Differentially Regulated Proteins ................................. 198 
4.10.8  NUD Differentially Regulated Proteins............................................... 203 
4.10.9  Unidentified Proteins ........................................................................... 203 
4.10.10  Stress response, cell division, cell membrane and other proteins...... 203 
4.11  Conclusions..................................................................................................... 212 
4.12  Future Directions ............................................................................................ 215 
5.0  APPENDIX....................................................................................................... 217 
6.0  REFERENCES ................................................................................................. 242  
vi 
 
INDEX OF FIGURES 
 
Contents          Page 
 
Figure 1.1  Helicobacter pylori.................................................................................... 4 
Figure 1.2 H. pylori coccoidal form............................................................................. 5 
Figure 1.3  Worldwide frequency rates........................................................................ 7 
Figure 1.4  2-DE proteome analysis techniques ........................................................ 24 
Figure 2.1  Second dimension protocols.................................................................... 72 
Figure 2.2  Construction of Matchsets....................................................................... 83 
Figure 2.3 Example of Analysis sets.......................................................................... 89 
Figure 3.1  Separation of Proteins by Gradient Gels. .............................................. 118 
Figure 3.2  Comparison of Low Molecular Mass Separation Techniques. ............. 119 
Figure 3.3  Tris-glycine and Tris-tricine gels .......................................................... 120 
Figure 3.4   Silver and Coomassie stained gels ....................................................... 121 
Figure 3.5  Cluster analysis dendrograms................................................................ 122 
Figure 3.6  Positional and quantitatively conserved proteins 46-150 kDa .............. 123 
Figure 3.7 Positional and quantitatively conserved proteins 7-46 kDa ................... 124 
Figure 3.8  Unique (GU) and Absent (DU) spots .................................................... 125 
Figure 3.9  Unique (DU) and Absent (GU) spots .................................................... 126 
Figure 3.10  Unique (GI) and Absent (NUD) spots................................................. 127 
Figure 3.11  Unique (NUD) and absent GI spots..................................................... 128 
Figure 3.12  Proteins that are differentially expressed ............................................ 129 
Figure 3.13 Proteins with pI positional shifts .......................................................... 130 
Figure 3.14 Scatter diagrams ................................................................................... 132 
Figure 3.15  pI Distribution of H. pylori proteins.................................................... 133 
Figure A.1 H. pylori GU1 pH 4-7............................................................................ 217 
Figure A.2  H. pylori GU2 pH 4-7........................................................................... 218 
Figure A.3  H. pylori GU3 pH 4-7........................................................................... 219 
Figure A.4  H. pylori NUD1 pH 4-7........................................................................ 220 
Figure A.5  H. pylori NUD2 pH 4-7........................................................................ 221 
Figure A.6  H. pylori NUD3 pH 4-7........................................................................ 222 
Figure A.7  H. pylori DU1 pH 4-7........................................................................... 223 
Figure A.8  H. pylori DU2 pH 4-7........................................................................... 224 
Figure A.9  H. pylori DU3 pH 4-7........................................................................... 225 
Figure A.10  H. pylori GI1 pH 4-7 .......................................................................... 226 
Figure A.11  H. pylori GI2 pH 4-7 .......................................................................... 227 
Figure A.12  H. pylori GU1 pH 6-11....................................................................... 228 
Figure A.13  H. pylori GU2 pH 6-11....................................................................... 229 
Figure A.14  H. pylori GU3 pH 6-11....................................................................... 230 
Figure A.15  H. pylori NUD1 pH 6-11.................................................................... 231 
Figure A.16  H. pylori NUD2 pH 6-11.................................................................... 232 
Figure A.17  H. pylori NUD3 pH 6-11.................................................................... 233 
  
 
vii 
 
Contents          Page 
 
 
Figure A.18  H. pylori DU1 pH 6-11....................................................................... 234 
Figure A.19  H. pylori DU2 pH 6-11....................................................................... 235 
Figure A.20  H. pylori DU3 pH 6-11....................................................................... 236
Figure A.21  H. pylori GI1 pH 6-11 ........................................................................ 237 
Figure A.22  H. pylori GI2 pH 6-11 ........................................................................ 238 
Figure A.23  NUD3 Identified Flagellin Spots........................................................ 239 
Figure A.24  NUD1 Identified Flagellin Spots........................................................ 240 
Figure A.25  GI2 Identified Flagellin Spots ............................................................ 241 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
viii 
 
 
INDEX OF TABLES 
 
 
Contents          Page 
 
Table 1.1  Acrylamide Gel Concentration Guide ...................................................... 38 
Table 2.1  Isolates included in this study................................................................... 67 
Table 2.2  Proteins excised. ....................................................................................... 94 
Table 3.1 Valid spots ............................................................................................... 134 
Table 3.2 Summary of the %T%C and buffer systems............................................ 135 
Table 3.3 Spot matches between disease groups ..................................................... 136 
Table 3.4  Spot matches between isolates................................................................ 137 
Table 3.5  Three isolate comparisons ...................................................................... 138 
Table 3.6 Two isolate comparisons ......................................................................... 140 
Table 3.7  Protein summary..................................................................................... 141 
Table 3.8  Eight and nine isolate comparisons ........................................................ 142 
Table 3.9  Absent spots for two isolate subsets ....................................................... 143 
Table 3.10 Strain cluster membership ..................................................................... 144 
Table 3.11 List of Tables and Figures ..................................................................... 145 
Table 3.12  Positional and quantitatively conserved spots ...................................... 146 
Table 3.13 Specifically unique spots ....................................................................... 150 
Table 3.14 Specifically absent spots........................................................................ 151 
Table 3.15 Differentially expressed proteins ........................................................... 152 
Table 3.16 Positional 2-DE protein differences for 11 H. pylori isolates................ 153 
Table 3.17  Potential post-translational modifications ............................................ 154 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ix 
 
 
ABBREVIATIONS 
 
2D    Two dimensional 
2-DE    Two dimensional electrophoresis 
2D-PAGE   Second dimension polyacrylamide gel electrophoresis 
ACTH    Adrenocorticotropic hormone 
APAF    Australian Proteome Analysis Facility 
APS    Ammonium persulphate 
BPB    Bromophenol blue 
Bis    N,N’-Methylene-bis-acrylamide 
C    Crosslinker 
CBB G250   Coomassie Brilliant Blue G250 
CDM    Chemically defined medium 
CHAPS   (3-[(3-Chloramidopropyl)dimethylammonio]- 
    1-propanesulfonate 
DTT    Dithiothreitol 
DU    Duodenal ulceration 
ESI-MS   Electrospray ionization mass spectrometry 
GI    Gastritis 
GU    Gastric ulceration 
HCCA    Alpha-cyano-4-hydroxycinnamic acid 
HCl    Hydrochloric acid 
HDH    Homoserine dehydrogenase 
x 
IEF    Isoelectric focusing 
IPG    Immobilised pH gradient  
MALDI-TOF Matrix assisted laser desorption/ionization-mass 
spectrometry time of flight 
MSS    Multiple surfactant solution 
Mr    Relative molecular mass 
NUD    Non-ulcer dyspepsia 
pI    Isoelectric point 
PDA    Piperazine diacrylamide 
PEG    Polyethylene glycol     
Q4    H. pylori strain NCTC11637 
RPH    Royal Perth Hospital 
SB3-10   N-Decyl-N,N-dimethyl-3-ammonio-1- 
    propanesulfonate 
SDS    Sodium dodecyl sulphate 
T    Total polyacrylamide concentration 
TBP    Tributyl phosphine 
TEMED   N,N,N’,N’-Tetra-methyl-ethylenediamine 
TFB    Trifluoroacetic acid 
Tris    Tris(hydroxymethyl)- aminoethane 
TSB    Tryptic soy broth 
UCSF  University of California at San Francisco 
 
 
 
xi 
 
Enzyme Commission Numbers 
 
 
 
1.1.1.3 Homoserine dehydrogenase 
1.1.1.41 Isocitrate dehydrogenase 
2.7.4.3 Adenylate kinase 
4.1.1.71 Subunit of 2-oxoglutarate oxidoreductase 
4.1.2.13 Fructose bisphosphate aldolase 
4.2.1.51 Prephenate dehydrogenase 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xii 
DEFINITIONS 
 
Agglomerative hierarchical cluster analysis A method for creating clusters in which 
each case starts out as a cluster. In the present instance, a case is equivalent to a H. 
pylori strain and a variable is equivalent to a spot.  At every step, clusters are combined 
until all cases are members of a single cluster.  Once a cluster is formed it cannot be 
split, it can only be combined with other clusters (Everitt B S 1993). 
 
Agglomeration schedule The results of the cluster analysis are summarised in a listing 
of the cluster numbers (assigned ID number = cluster number) being combined at each 
stage in the cluster analysis (SPSS version Manual). 
 
Arbitrary analysis sets are composed of any group of spots selected by the analysis 
program user (PDQUEST Manual). 
 
Auto-matching is the process by which the PDQUEST program automatically matches 
spots in a number of gel images to those on the Standard Image. The program’s 
algorithm matches spots between images by warping them to a common standard by 
reference to landmarks. 
 
Between-groups clustering  The distance between two clusters is defined as the 
average of the distances between all pairs of individuals that are made up of one 
individual from each group (Everitt B S 1993) 
 
A Boolean Analysis Set is formed by combining two previously defined Analysis Sets 
(A and B) using Boolean operators.  The Boolean Sets created might include 1) the 
intersection of A and B; 2) the union of A and B; 3) spots that are unique to set A plus 
spots that are unique to set B; 4) Spots that are only found in B; 5) spots that are only 
found in A. 
 
xiii 
Distance Measure allows a specific distance or similarity measure to be used in 
clustering.  SPSS does not plot actual distances but re-scales them to numbers between 0 
and 25.  Lines, which are the measure of relatedness on a diagram, join the cases 
indicate a clustering. Distance can be calculated in two different forms Interval and 
Binary.  Interval measures compare the quantitative values for variables (i.e. the 
volumes for spots) between cases (i.e. isolates) and binary measures compare the 
qualitative values for the variables (i.e. presence/absence only) (SPSS version 11 
manual). 
 
Euclidean distance (interval measure) is a dissimilarity measure for continuous data. 
The distance between two items is the square root of the sum of the squared differences 
in values for each variable (SPSS version 11 Manual).  
 
Gaussian Spot  PDQUEST uses Gaussian modelling to create “idealised” spot 
boundaries.  A Gaussian spot is a precise three-dimensional representation of a scanned 
spot.  Gaussian curves are fitted to the scanned spot in the X, Y and Z dimensions, 
where X and Y represent co-ordinates on the 2-D gel and the Z axis represents spot 
volume.  Additional modelling is then performed to create the final Gaussian spot 
(PDQUEST Manual). 
 
A Gel Image File is a fully processed image file of a gel.  This file is a duplicate of the 
original scan and is utilised in the matchset so it can be edited without losing any of the 
information contained in the original scan image (PDQUEST Manual). 
 
Gel Spot File contains a synthetic image with Gaussian representation of the spots in the 
Gel Image File (PDQUEST Manual). At least 6 successive Gaussian spot 
approximations are required to generate the Gel Spot File. 
 
In a hierarchical classification, the data are not partitioned into a particular number of 
classes or clusters at a single step.  Instead the classification consists of a series of 
partitions, which may run from a single cluster containing all individuals, to n clusters 
xiv 
each containing a single individual.  Hierarchical clustering techniques may be 
subdivided into agglomerative methods that proceed by a series of successive fusion of 
the n individuals into groups, and divisive methods, which separate the n individuals 
successively into finer groupings (Everitt B S 1993). 
 
Image Warping is a function that deforms images; all positions in one image plane are 
mapped to positions in another plane.  It is used to bring two or more images into 
alignment (Gustafsson et al 2002). 
 
K-means Clustering attempts to identify relatively homogeneous groups of cases based 
on selected characteristics, using an algorithm that can handle large numbers of cases. 
However, the algorithm requires the number of clusters to be specified.  The number of 
clusters can only be specified if this information is known (SPSS Manual).  
 
Landmark spots set reference positions used to compensate for slight positional 
differences of corresponding spots on different images due to gel distortion. These 
landmark spots are used by the program to align and position matchset gel images for 
matching.  Spots may be selected as landmark spots if they are well resolved and present 
in all members of the matchset in corresponding locations.  They are particularly 
valuable if selected at the edges of the image, if isolated from other spots or if located in 
or near regions of high spot concentrations. A minimum of 20 landmarks were 
distributed throughout each Standard image.  
 
Manual matching is used if a legitimate spot is present in corresponding positions on 
one or more member images but is not matched to the Standard Image by automatic 
matching.  The spot is selected in the Standard Image and its corresponding position is 
highlighted in all the image members of the matchset.  If this spot is also located in other 
images, it may then be selected there and matched.  
 
Matching is the process by which the analytical software program identifies spots in one 
or more gel images that are found in identical locations to some of those on the Standard 
xv 
image.  This identification may be performed by auto-matching or manual matching of 
the protein spots. 
 
A Matchset is a set of gel images that has been grouped together for the purpose of 
qualitative and quantitative comparison.  Spots on one image can be compared to spots 
on every other image in the matchset. 
 
There are two types of matchsets 1) level one matchset (see Figure 2.2A) and 2) level 
two matchset (see Figure 2.2B).  A level one matchset is created directly from gel 
image files.  It may contain some or all of the gel images of a given experiment.  A level 
two matchset is created from the Standard images of a number of level one matchsets. 
 
MS/MS Sequencing data Product ion MS/MS sequence data from one or more peptide 
– MS/MS mode (Westermeier R and Naven T 2002). 
 
Normalisation Before gels are compared for protein spot differences, the spot volumes 
of the different gel image files included in the matchset have to be adjusted by 
normalisation. Normalisation corrects for systematic differences due to variable protein 
loads and staining effectiveness. 
 
Pattern difference (binary measure) is a dissimilarity measure for binary data that 
ranges from 0 to 1. Computed from a fourfold table as bc/(n2), where b and c represent 
the diagonal cells corresponding to cases present on one item but absent on the other and 
n is the total number of observations (SPSS version 11 Manual). 
 
Peptide mass fingerprinting (PMF) is a technique for searching protein databases for 
protein identity.  The subject protein is cleaved, and the masses of the resultant peptide 
are used for a database search (Westermeier R and Naven T 2002).   
 
Peptide mass fingerprint and composition information.  The molecular mass of each 
of the peptides derived from the enzyme digestion or chemical cleavage of the protein 
xvi 
can be used alongside some composition information relating to one or more of the 
peptides (Westermeier R and Naven T 2002). 
 
Peptide mass fingerprint and sequence information.  The molecular mass of each 
peptide derived from enzyme digestion or chemical cleavage of the protein can be used 
along side some direct sequence information relating to more of the peptides 
(Westermeier R and Naven T 2002). 
 
Positionally Conserved refers to protein spots that are found in corresponding positions 
for all isolates included in the study. Positionally conserved spots consists of two subsets 
1) spots which vary by less than a factor of three or more (quantitatively conserved) and 
2) spots which vary in volume by a factor of three or more. 
 
Protocol For the purposes of the present study the word “protocol” refers a set of 
specific electrophoresis conditions that were used to separate proteins in a particular Mr 
and pI range. 
 
A Quantitative Analysis Set contains spots from two different images or replicate 
groups that are present in both images or replicate groups but differ in concentration to a 
predetermined degree (usually by a factor of 3 or more) i.e. it includes spots whose 
volume has significantly increased or decreased. 
 
A Qualitative Analysis Set contains spots from two different images or replicate groups 
that were detected in one image or replicate group, but not in the other.  Such a set might 
contain, for example, proteins that were expressed under experimental conditions but not 
expressed under control conditions, or visa versa. 
 
A Reference image for a matchset is the gel image chosen as the best representative of 
all the images in that matchset, i.e. it contains the greatest number of well-resolved 
spots.  
 
xvii 
Replicate Groups  A replicate group is a set of gels that is prepared from the same 
protein sample using the same protocol where a protocol refers to the specific 
electrophoresis conditions that were used to separate proteins in a particular Mr and pI 
range.   
 
There are two reasons for the formation of replicate groups.  The first is to determine the 
validity of spots.  In order to be accepted as valid, this study required that, a particular 
spot must be observable in at least three out four gel images for each replicate group. In 
addition, slight variations in quantitation values need to adjusted, due to variables such 
as loading and staining.  The volume of a given spot is best estimated by averaging 
results from several gel images. 
 
Serial charge trains are protein isoforms that appear as a train of spots, usually 
horizontal, that differ in pI and/or Mr.  These may indicate post-translational 
modifications such as glycosylation or phosphorylation. 
 
Simple matching (binary measure) is the ratio of matches to the total number of 
values. Equal mass is given to matches and non-matches (SPSS version 11 Manual). 
 
Single cluster solution Displays cluster membership for a single cluster solution with a 
specified number of clusters. 
 
Spot Volume is a measure of protein quantity related to staining intensity.  The spot 
volume is determined from the average spot intensity (mean density of pixels in the 
spot) by the spot area (number of pixels in a spot). 
 
Squared Euclidean distance (binary measure) The binary squared Euclidean 
dissimilarity measure.  Computed from a fourfold table as SQRT(b+c), where b and c 
represent cases present on one item but absent on the other its minimum value is 0 
(absent spots), and it has no upper limit (present spots) (SPSS version 11 Manual).  
 
xviii 
Squared Euclidean distance (interval measure) A measure of distance between pairs 
of cases. The distance between two cases is the sum of the squared differences between 
the variables of the cases. This dissimilarity measure is used for continuous data (SPSS 
version 11 Manual).  
 
 SPOT NUMBER 1 SPOT NUMBER 2 
GU1 100 90 
NUD1 280 150 
 
 In the above example [values are normalised spot volume (units determined by 
computer algorithm)] the squared Euclidean distance is (280-100)2 + (150-90)2 which 
equals 1802 + 602 which equals 36000.  A disadvantage with this measure is that when 
variables are measured on different scales variables that are measured in larger numbers 
will contribute more to the computed distance than variables measured in smaller 
numbers. 
 
A Standard image is a composite image that contains all the spots present in all the gel 
images in a particular matchset.  The starting point for generating a Standard image is to 
enter all the spots detected into the Reference image. 
 
A Statistical User Set is composed of spots from replicate groups whose volumes are 
found to be significant according to a specified statistical test (e.g. Student T-Test, or 
Mann-Witney Test). 
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Abstract 
The Gram-negative bacterium Helicobacter pylori is found in human gastric mucosa.  H. 
pylori, one of the most common chronic bacterial infections of humans, is present in 
almost half of the world population.  It is associated with chronic gastritis, non-ulcer 
dyspepsia, gastric and duodenal ulcers, and malignant neoplasms.   The aim of this study 
was to detect microbial candidate protein markers whose presence might be correlated 
with the development of four different clinical consequences of H. pylori infection, 
gastric ulceration [GU], duodenal ulceration [DU], non-ulcer dyspepsia [NUD] and 
gastritis [GI].  Eleven H. pylori isolates associated with these outcomes were analysed. 
The total complement of protein from these H. pylori isolates were resolved by two-
dimensional polyacrylamide gel electrophoresis (2D-PAGE) and compared using 
PDQUEST pattern analysis software.  Relationships between the isolates associated with 
specific disease outcomes were determined by cluster analysis.   Fifty six disease 
specific proteins were then characterised by tryptic peptide-mass fingerprinting using 
matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-
TOF MS).  Up to 1165 protein species were resolved from each H. pylori strain.  
Proteome analysis revealed that only 470 (40%) of the proteins detected were common 
to all eleven isolates.  Twenty six of the 56 disease specific proteins that were selected 
for identification consisted of spots whose expression is altered in response to stress 
conditions or those that can affect H. pylori cell division and the cell membrane.  The 
remaining 30 proteins had no known function.  This study has provided further 
confirmation of the extensive variation that the bacterium H. pylori exhibits at the 
proteome level.   Most significantly this study has found, through the application of 
cluster analysis and protein matching, that isolates do form disease groups.   
Comparative proteome analysis is a useful method for highlighting the extensive strain 
variation that H. pylori exhibits and to determine if any disease specific proteins exist.  
 
  1 
 
    
 
1.1  HELICOBACTER PYLORI 
1.1.1  The Discovery of H. pylori 
In 1979 Robin Warren, a pathologist in Perth, Western Australia, noticed that curved 
bacteria were often present in gastric biopsy specimens submitted for histological 
examination from patients with antral gastritis (Warren, 1983).  However, because 
these organisms were not present within the gastric mucosa but were present in the 
mucous layer overlying the tissue, they were thought to be irrelevant.  Warren found 
that similar organisms had been described by European pathologists in the late 19th 
century but, because attempts to culture them had failed, they had been ignored and 
forgotten by generations of scientists (Fung, 1995). 
 
In 1981, Barry Marshall, a medical registrar working in gastroenterology 
collaborated with Warren.  They reviewed the patients in whom large numbers of 
gastric spiral bacteria had been seen.  One of these patients had been treated with 
tetracycline; his symptoms resolved and the subsequent endoscopic biopsy showed 
that the antral gastritis had also resolved (Marshall and Warren, 1984).  In addition, 
they were finally able to visualise organisms in gastric biopsies from high-
magnification electron micrographs. 
 
Since the organisms had the appearance of curved, Gram-negative rods, the 
investigators used methods for the isolation of Campylobacter species, which 
involved inoculating the biopsy specimens onto blood agar and incubating the 
cultures under microaerobic conditions. The project to culture bacteria from gastric 
biopsy specimens began in March 1982, with the microbiologist John Pearman 
supervising (Goodwin and Worsley, 1993a).  Gastric specimens from 100 
consecutive patients being gastroscoped were examined by direct microscopy and 
cultured.  Among the first 34 cultures, spiral bacteria were seen in six.  However, in 
spite of frequent variations in media and incubation temperatures, they could not be 
cultured. Since most campylobacters grow within 48 hours under such conditions, 
plates without visible growth were normally discarded within 3 days (Goodwin and 
Worsley, 1993a).  However, when the 35th culture, by chance, was incubated for 5 
days over an Easter holiday, colonies were seen.  The date was the 14th April 1982 
(Marshall and Warren, 1984).  Following this discovery, and taking into account the 
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length of time required to culture this organism, it was isolated from 11 patients; it 
was then characterised and called Campylobacter pyloridis (later revised to 
Campylobacter pylori) (Marshall and Warren, 1984; Goodwin and Worsley, 1993b; 
Goodwin, 1994; Anonymous, 1989).  The two earliest isolates are now designated 
NCTC11637 and NCTC11638. 
 
However, based on DNA hybridisation and base composition, ultrastructural studies, 
and analyses of cellular fatty acids, respiratory quinones, enzyme profiles and growth 
requirements, the bacterium was transferred in 1989 to a new genus Helicobacter and 
renamed Helicobacter pylori.  The Helicobacter genus now consists of more than 20 
species including non-gastric Helicobacter species such as H. pullorum (Stanley et 
al, 1994). 
 
Following publication of a report in the Lancet in 1984 (Marshall and Warren, 1984), 
investigators all over the world rapidly confirmed the presence of these organisms in 
the gastric mucus (Jones et al, 1984; McNulty and Watson, 1984).  By 1984, it was 
becoming clear that H. pylori infection was a major culprit in many gastrointestinal 
disorders, although this conclusion would still generate controversy for some years 
(Blaser, 1990).   
 
In 1985 Marshall et al postulated “that Campylobacter pyloridis could colonise 
histologically normal mucosa and induce gastritis”.  It was shown that “ingested 
Campylobacter pyloridis was able to colonise normal gastric mucosa.  That this 
“colonisation is associated with acute inflammatory changes; polymorphonuclear 
neutrophil leucocytes infiltration and exudation from the mucosa; mucus depletion; 
and reversible epithelial cell damage.  These changes may now be referred to as 
being characteristic of acute Campylobacter pyloridis gastritis” (Marshall et al, 
1985).  Marshall also demonstrated how in individuals who are unable to clear the 
infection chronic gastritis may result. 
 
Prior to the isolation of H. pylori the accepted paradigm was “no acid, no ulcers”.  
The discovery that H. pylori was the culprit in many gastrointestinal disorders has 
revolutionised the view on the diseases associated with the gastric environment 
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(Goodwin and Worsley, 1993a).  This major breakthrough has completely changed 
how some important gastrointestinal disorders are treated.  
 
1.1.2  Phenotypic Characteristics 
H. pylori is a spiral, Gram-negative bacterium that has blunt rounded ends in gastric 
biopsy specimens (Goodwin and Worsley, 1993b).  However, when the bacteria are 
cultured on solid media, they assume a rod-like shape. H. pylori organisms are 2.5 to 
5.0 m long and 0.5 to 1.0 m wide (Goodwin and Armstrong, 1990; Goodwin and 
Worsley, 1993b).  H. pylori is motile and usually possess 4-6 unipolar-sheathed 
flagella that are essential for motility.  Each flagellum is approximately 30 m long 
and approximately 2.5 nm thick (Geis et al, 1993; Goodwin and Armstrong, 1990) 
(Figure 1.1). After prolonged culture (4-5 days) on solid or in liquid medium, the 
bacteria may form spheroid or coccoid bodies.  A coccoid microorganism is shaped 
like or resembles a sphere.  The coccoid forms initially appear as U-shaped bacilli 
with the ends of two arms joined by a membranous structure (Worku et al, 1999) 
(Figure 1.2).   The coccoidal form is metabolically active but is non-culturable (Bode 
et al, 1993).   
 
Over the period of its evolution, H. pylori has become well suited to its 
environmental niche, the human stomach and duodenum.  Currently, no other host is 
known except for primates such as macaque and baboon (Goodwin and Worsley, 
1993b).  H. pylori is found in gastric juice and under the mucous layer at the surface 
of gastric epithelial cells. In order to survive in the highly acidic environment of the 
stomach, the Helicobacter genus has evolved a distinctive adaptation, the high 
expression of the enzyme urease (Goodwin and Worsley, 1993a and 1993b).  Urea 
diffuses freely from plasma into gastric juice.  H. pylori produces large amounts of 
nickel-containing urease which degrades each molecule of urea to produce one 
carbon dioxide and two ammonia molecules, leading to the net production of alkali 
to neutralise stomach acid in the H. pylori’s local environment (Hu and Mobley, 
1993).  Without urea, H. pylori is intolerant of acid, but in its presence the bacterium 
prefers mildly acidic conditions and can withstand a pH as low as 1.5 (Marshall et al, 
1990). 
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Figure 1.1  Helicobacter pylori 
A transmission electron micrograph (negative staining) of a H. pylori bacterium. 
Note the characteristic bundle of sheathed flagellae attached to one pole of the cell. 
Scale bar, 0.5 m. (Suerbaum and Josenhans, 1999) 
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Figure 1.2 H. pylori coccoidal form 
Electron micrographs of negatively-stained preparations of H. pylori, illustrating 
early (top left) and late (top right) decline phase of growth in the transformation to 
coccoidal form (bottom).  Precoccoidal forms (top left, top right) typically have 
flagellae which are absent in coccoidal forms.  Bars 500 nm (Worku et al, 1999) 
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H. pylori is microaerophilic and possesses a respiratory type of metabolism.  It is a 
fastidious microorganism that requires nutrient-rich media, an atmosphere enriched 
in CO2 (5-12%), and high humidity (96-100 %) and prefers a pH near 7.0 (Velazquez 
and Feirtag, 1999).  It is slow growing, requiring a minimum of 3-5 days incubation 
time. Culture media are usually supplemented with blood as a reducing agent rather 
than as a nutrient (Cohen, 1995) and shaking is needed in liquid systems to provide 
good dispersion of gases throughout the liquid (Sjostrom and Larsson, 1996).  Cells 
grow at 30 and 37oC but not at 25oC and the growth at 42oC is variable (Goodwin 
and Armstrong, 1990).  Atmospheric hydrogen (as much as 5-10%) is either required 
or stimulates the growth of these organisms.  H. pylori grows poorly, if at all, in 
routine aerobic or anaerobic atmospheres (Tominaga et al, 1999). 
 
 
1.1.3  Geographical Epidemiology of H. pylori 
H. pylori is probably the most common chronic bacterial infection of humans, 
present in more than half of the world population (Figure 1.3). The pattern of H. 
pylori infection in developing countries is different from that seen in developed 
countries.    
 
Developing Countries   
A high level of seroprevalence in the general population has been reported in large 
studies of developing nations (most percentage figures are available from studies 
performed prior to 2000).  For example the levels in Africa are: 85% in Nigeria 
(Holcombe et al, 1991; Holcombe et al, 1992), 79% in Zaire (Glupczynski et al, 
1992), 79% in Algeria and 71% on the Ivory coast (Teh et al, 1994);  In the Far East 
countries: 75% in Vietnam (Megraud et al, 1989) and in Thailand (Perez-Perez et al, 
1990).  
 
Acquisition occurs in about 10% of children every year between the ages of two and 
eight, with most people infected by their teens (Bardhan, 1997).   Increased 
prevalence in developing countries is believed to be due to overcrowding, poor 
hygiene and inadequate sanitation.  In developing countries, most adults are infected 
(Calam, 1996).  
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Figure 1.3  Worldwide frequency rates 
Average frequency rates for H. pylori worldwide in the year 2000 (figure obtained 
from The Helicobacter Foundation website http://www.helico.com/) 
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Developed Countries   
In the majority of Western countries, the prevalence is lower.  For example, 
Australia, 20%, USA 40%, UK, 30%, Spain, 53% (Martin-de-Argila et al, 1996), 
Germany, 37% (Ito et al, 2002) and Greece, 49.2% (Apostolopoulos et al, 2002).  
The exception is Singapore, 70% (Ito et al, 2002).    
 
The prevalence of H. pylori infection increases with the age of the host.  In the 
Western world, the percentage of the population that is infected rises gradually from 
infancy to an age of about 60 years.  Infection is uncommon in young children, but 
present in about 20% of persons under the age of 40 years and about 50% of those 
over the age of 60 years (Graham et al, 1991a).  In Western countries, H. pylori 
infection is associated with low socioeconomic status (Fiedorek et al, 1991; Graham 
et al, 1991b).  Ethnic minority groups such African-Americans and Hispanics, and 
immigrants from developing countries are believed to be responsible for isolated 
areas of high prevalence in some Western countries (Replogle et al, 1995).   There is 
no significant difference in H. pylori prevalence in relation to gender. 
 
A wide body of evidence now also indicates that once acquired, H. pylori usually 
persists for life, unless eradicated by antimicrobial therapy (Blaser, 1996; Blaser 
1997) 
 
1.1.4  Association of H. pylori with Illness 
Severe pathological consequences of H. pylori infection develop in approximately 
10% of those infected, and infection is associated with a variety of disease outcomes 
(Dunn et al, 1997).  These  outcomes include gastritis, non-ulcer dyspepsia, iron 
deficiency anaemia, gastric and duodenal ulcer disease, the development of gastric 
mucosal atrophy (presumed to be a precancerous condition), gastric carcinoma, 
malignant tumours of the mucosa-associated lymphoid tissue (MALT lymphoma), 
and an increased susceptibility to other infectious diseases (Dunn et al, 1997).  H. 
pylori infections are associated with very high morbidity and mortality, and they 
impose a major burden upon health care systems worldwide (Correa, 2003; Ofman et 
al, 1997).  
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Gastritis (GI)  
Gastritis is defined as an inflammatory reaction in the gastric mucosa and can be 
associated with glandular atrophy and alterations in the differentiation and function 
of the epithelial cells (Goodwin and Worsley, 1993a).  All H. pylori infected patients 
develop chronic gastric inflammation but perhaps surprisingly, this condition is 
usually asymptomatic (Calam, 1996).  This condition is nevertheless important 
because individuals with it are quite strongly predisposed to more serious disease 
outcomes (ulcers, adenocarcinoma or lymphoma). 
 
Gastritis in patients who are H. pylori negative is rare and it is typically antral-
sparing or Type A gastritis associated with an autoimmune disease known as 
Addisonian pernicious anaemia. 
 
Gastritis frequently progresses from simple inflammation to atrophy (atrophic 
gastritis) which indicates a loss of normal gastric glands (Sitas et al, 1993; Asaka et 
al, 1992).  This is followed by a growth of new metaplastic (i.e. cells transformed to 
an abnormal state with evidence of DNA damage) epithelium and glands, which are 
less differentiated than normal.  Chronic gastritis follows a stepwise, slow 
progression over many years from simple inflammation to more severe and extensive 
atrophy and metaplasia.  Without treatment, gastritis is a long-standing and probably 
life-long condition (Goodwin and Worsley, 1993a).   
 
Although many patients with H. pylori infection develop gastritis, not all patients 
have the same disease outcome; therefore, it is believed that environmental and 
microbial or host genetic factors may play a role in the development of disease 
(Goodwin, 1994). 
 
Duodenitis (DU) 
Duodenitis is characterised by changes in the architecture and villous structures of 
the duodenal mucosa, and alterations in morphology and differentiation of the 
duodenal epithelium (Goodwin and Worsley, 1993a).  In duodenal ulcer disease, 
duodenitis is limited nearly entirely to the duodenal bulb and is usually very patchy.  
Inflammatory duodenitis develops in connection with H. pylori gastritis.  The 
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progress of acid-induced metaplasia to inflammation is probably the result of the 
extension of the H. pylori infection from the stomach into the bulb (Goodwin and 
Worsley, 1993a). 
 
Inflammation in the duodenal bulb occurs in other diseases that include Zollinger-
Ellinson syndrome, duodenal Crohn’s disease, ulcerative jejunitis and pancreatic 
disorders (Goodwin and Worsley, 1993b). 
 
Non-ulcer dyspepsia (NUD)  
Non-ulcer dyspepsia is a broad diagnostic term referring to a complex of symptoms 
that includes epigastric pain or discomfort which may or may not be related to food 
intake.  Four different syndromes are generally recognised (Thompson and Heaton, 
1980):   
 
 ulcer-like dyspepsia  which involves classical ulcer-like symptoms, but no ulcer; 
 dysmotility-like dyspepsia which involves dyspeptic symptoms which suggest 
gastric stasis or dysmotility of the small bowel; 
 reflux-like dyspepsia which involves symptoms suggestive of gastro-oesophageal 
reflux; and 
 unspecified dyspepsia which is a category reserved for dyspeptics who do not fall 
into any of the above groups (Calam, 1996). 
 
Symptoms of NUD may be chronic, recurrent, or new in onset and can usually be 
distinguished from typical gastroesophageal reflux, the irritable bowel syndrome, or 
biliary disease. This epigastric discomfort may initially be attributed to an ulcer, 
which is subsequently found not to be present (Goodwin, 1994).  
 
 Non-ulcer dyspepsia occurs in 25-40% of the population worldwide.  H. pylori has 
been found in 40-60% of patients with non-ulcer dyspepsia (Pantoflickova and Blum, 
2001).  Although the link between H. pylori and peptic ulcer disease and gastric 
cancer has been accepted for a number of years, there continues to be controversy 
about the role of this organism in NUD (Pantoflickova and Blum, 2001; McColl, 
2000).   
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Recent studies have indicated that improvement of NUD symptoms following 
eradication of H. pylori (57% recovery rate) is not as significant as the recovery rates 
of other disease outcomes (Azuma et al, 2001; Talley et al, 1999).  It is believed that 
other unknown factors may be responsible for the symptoms of NUD.  
 
Iron deficiency anaemia   
In one study of 30 patients it was found that 91.7% of the patients cured of H. pylori 
subsequently recovered from anaemia and had increased serum ferritin levels 
(Barabino, 2002).     Iron is crucial for H. pylori growth.  The precise pathological 
mechanism of the H. pylori induced anaemia is still lacking but one possible 
explanation is that iron is diverted to the H. pylori-infected antrum of the stomach.  It 
is not known why iron deficiency anaemia does not develop in all infected 
individuals (Barabino, 2002). 
 
Gastric and duodenal ulcers (GU and DU respectively).  
Ulcers are defined as breaches in the epithelium, which are associated with acute and 
chronic inflammation. The prevalence of H. pylori infection in patients with gastric 
ulcer disease is reported to be nearly 80% (Labenz and Borsch, 1994) and the rate is 
nearly 100% (Park et al, 1993) in patients with chronic duodenal ulcer disease. 
Patients with gastric ulcers typically have atrophic gastritis and corpus-predominant 
gastritis.  Patients with duodenal ulcers have few atrophic changes and have antrum 
predominant gastritis (Goodwin, 1994).   
 
Eradication of H. pylori drastically reduces recurrence of duodenal and gastric ulcers.   
Duodenal ulcers in adults with no evidence of H. pylori infection are generally due to 
Zollinger-Ellison syndrome, Crohn’s disease, or cancer (McColl, 2000).   About 20% 
of gastric ulcers are not caused by H. pylori, but are due to the corrosive effect of 
non-steroidal anti-inflammatory medications often taken for arthritis (Dixon, 2000). 
 
Gastric cancers 
Gastric adenocarcinomas are often associated with H. pylori infection. This is 
probably related to the observation that H. pylori acquisition leads to chronic 
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gastritis, which may result in atrophy of the gastric epithelium (atrophic gastritis) 
(Calam, 1996). The clinical importance of atrophic gastritis is related to the fact that 
it significantly increases the risk of gastric cancer development (Nomura et al, 1991).  
Most gastric cancers occur in mucosa with atrophic changes, and patients with 
atrophic gastritis are estimated to have a five- to nine-fold increased risk for 
developing gastric cancer (Parsonnet et al, 1991).  
 
It has been found that gastric cancers often develop in patients with non-ulcer 
dyspepsia, active gastric ulcers, and hyperplastic gastric polyps, but gastric cancers 
rarely develop during the follow-up in patients with active duodenal ulcers (Uemura 
et al, 2001).  The significance of the negative association with duodenal ulcers is not 
yet known. 
 
Gastric cancer develops in five percent of H. pylori-positive persons over a 10 year 
period. Incidence of gastric cancer is higher in developing countries (Uemura et al, 
2001).  However, in the developed countries, gastric cancer is receding, probably 
because of the decreasing prevalence of H. pylori (Calam, 1996).  It is entirely 
possible that if H. pylori could be eliminated from the developing countries, through 
the application of antibiotics and improvements in hygiene and sanitation, that the 
incidence of gastric cancer would approximate that seen in the developed countries. 
 
Mucosa-associated lymphoid tissue (MALT) lymphoma   
Lymphoma is defined as any neoplasm (tumour) of the lymphoid tissue, whether 
benign or malignant.  Lymphoid tissue is reticular connective tissue that houses 
macrophages and a continuously changing population of lymphocytes (Marieb, 
1995).   
 
Several studies have found that the most common aetiology of MALT lymphomas in 
the stomach is H. pylori and chronic gastritis, i.e. in approximately 90% of cases 
(Wotherspoon et al, 1993; Hussell et al, 1993).  It is believed that H. pylori may 
provide the antigenic stimulus for sustaining the growth of lymphoma in the 
stomach.  However, the exact mechanism of the transition from H. pylori infection to 
low-grade lymphoma is still unclear.  
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Following the initial study by Wotherspoon et al (1993), several groups have shown 
that eradication of H. pylori with antibiotics results in regression of low-grade gastric 
MALT lymphoma in 75% of cases (Wotherspoon et al, 1993; Hussell et al, 1993).   
However, the elimination of H. pylori does not lead to the eradication of high-grade 
MALT lymphomas (Wotherspoon et al, 1993). This discovery was a major 
breakthrough in the treatment of low-grade MALT lymphomas. 
 
1.1.5  The H. pylori Genome 
Studies of H. pylori DNA by polymerase chain reaction (PCR), pulsed-field gel 
electrophoresis and random amplification of polymorphic DNA (RAPD) have 
suggested that the species is extremely genetically diverse (Jiang et al, 1996).  The 
use of RAPD-PCR and DNA fingerprinting showed that strains from unrelated 
infected patients had unique fingerprints whereas strains isolated from family 
members had very similar, although not identical patterns (van der Ende et al, 1996).  
These results implied that differences observed between the strains infecting 
individual family members occurred after the primary infection and suggested that H. 
pylori evolution is rapid, resulting in a genome so highly fluid that it produces highly 
diverse strains (Jiang et al, 1996). 
 
The recent availability of the genomic sequence for two unrelated H. pylori isolates, 
J99 and 26695 (see www.tigr.org.), has enabled a detailed analysis of the overall 
level of genetic diversity that had been previously suggested for this organism. H. 
pylori is the first bacterial species for which two complete genome sequences from 
two unrelated strains was completed. 
 
The complete genome sequence of H. pylori strain 26695 was first published in 
Nature in August 1997 (Tomb et al, 1997).   This strain has a circular chromosome of 
1,667,867 base pairs and 1,590 predicted coding sequences.  H. pylori strain 26695 
was originally isolated in the early 1980’s in the United Kingdom from a patient with 
gastritis of ‘unknown severity’ (Tomb et al, 1997). This strain had been passaged 
extensively in the laboratory prior to its sequence being completed in 1997 (Alm et 
al, 1999). 
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The complete genome sequence of strain J99 was released in 1999 (Alm et al, 1999).  
J99 has a circular chromosome of 1,643,831 base pairs, which is 24,036 base pairs 
smaller than the 26695 chromosome and has 1,490 predicted coding sequences.   H. 
pylori J99 was originally isolated in the United States in 1994 from a patient 
diagnosed with a duodenal ulcer and had been subjected to minimal passage in the 
laboratory before genomic sequencing began in 1996 (Alm et al, 1999).  
 
The availability of the two completed genome sequences from two unrelated strains 
has allowed a precise analysis of their genetic differences.  Although the two 
chromosomes are organised differently in a limited number of discrete regions, the 
genome size and gene order of these two H. pylori isolates was found to be very 
similar (Alm and Trust, 1999).  The regions of organisational differences are 
associated with insertion sequences, DNA restriction/modification genes, repeat 
sequences, or a combination of the above.  Genes that were unique to only one of the 
strains comprised between 6% and 7% of the total coding capability of each strain 
(Alm et al, 1999; Alm and Trust, 1999).  Half of the genes unique to each strain were 
contained within a single hypervariable region of the chromosome called the 
plasticity zone.  A significant level of variation at the nucleotide level was seen 
across the genome.  Alm et al (1999) suggests that this provides an explanation for 
why the nucleotide-based typing techniques seem to indicate a high degree of 
apparent genetic diversity among independent H. pylori isolates. This nucleotide 
variation together with the organisational rearrangements is believed to have 
provided an over-estimation of the gene diversity of H. pylori as assessed by pulsed-
field gel electrophoresis (Alm and Trust, 1999).  As with other bacterial genomes 
sequenced to date, only approximately 60% of the genes identified encoded a product 
that can presently be assigned a function (Alm et al, 1999). One-half of the 
remaining gene products, which have an unknown function, have homologues in 
other bacteria, and the remainder appear to be H. pylori-specific. 
 
Approximately 40% of H. pylori isolates contain plasmids, ranging in size from 1.5 
to 23.3 kb, but they do not contain recognised virulence factors (Kleanthous et al, 
1991; Minnis et al, 1995). 
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The aim of this study was to detect microbial candidate protein markers whose 
presence might be correlated with the development of four different clinical 
consequences of H. pylori infection GU, DU, NUD and GI.  This was examined by 
the means of proteome analysis.  The proteome of an organism may be defined ‘as 
the total protein complement expressed by an organism or tissue under a given set of 
conditions’.   
 
 
1.2 PROTEOMICS 
1.2.1  Genomics, Transcriptomics and Proteomics 
Comparative molecular biology analyses can be performed at three levels, the 
genome, the transcriptome and the proteome.   
 
Genome  
The genome has been defined as the sum total of all the genetic material in the 
chromosomes of a particular organism; its size is generally given as its total number 
of base pairs (Yeatman, 2003).  Genomics (the study of DNA or the genes of a cell) 
begins with the gene and makes inferences about the protein products of that gene 
(Wilkins et al, 1997).  A gene has been defined as a specific segment of DNA that 
controls a specific cellular function. 
 
Genomics is based primarily on sequencing of DNA. However, while the genomic 
methods have proved to be very successful these methods are unable to identify the 
relative concentrations of the proteins, to define when or if the protein is produced or 
the extent of post-translational modifications (Humphrey-Smith et al 1997; Pardanani 
et al, 2002).   
 
The environment influences gene expression and modifies gene products in ways that 
may stimulate, accelerate, or inhibit biochemical processes. This does not change the 
genome, but inevitably changes the complement of transcribed genes (the 
transcriptome) and the composition of proteins translated from them (the proteome) 
in affected tissues (Wilkins et al, 1997).  
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Transcriptome  
Cell biology can also be studied at the level of messenger RNA (transcriptome) (Su, 
2002).   The transcriptome has been defined as the complete profile of transcribed 
messenger RNA expressed in a given tissue, cell or biological system at a given time 
under specific conditions.  Analysis of the transcriptome in a given sample yields a 
measurement of the relative level of each mRNA in the mRNA pool (Yeatman, 
2003).   
 
Regulation of the pool of mRNA in a cell or organism is the result of a series of 
complex mechanisms. The concentration of a particular mRNA is dependent on its 
rates of synthesis, transcription, transport from the nucleus (in eukaryotes) and its 
rate of decay (Kettman et al, 2001).  The half-lives of mRNAs may change in 
response to hormones, nutrient levels, cell growth rates, viral infection, exposure to 
toxins or carcinogens and temperature shifts in ways that are not completely 
understood.  In addition, the half-lives of most mRNAs are probably determined by 
other factors, including their affinity for proteins (Humphrey-Smith et al, 1997; 
Wilkins et al 1997).    
 
A protein cannot be synthesised without its mRNA being present, and conversely 
there may be abundant amounts of specific mRNA but no translation of message into 
protein.  For example, studies have shown that there may be a poor correlation 
between the total mRNA abundance and the amount of a particular protein expressed 
in a cell at a given time.  Anderson and Seilhamer (1997) showed that human liver 
mRNAs were enriched for secreted proteins, whilst mRNAs for cellular proteins 
were under-represented.  Clements and Foster (1998) showed that Staphylococcus 
aureus produced long-lived mRNAs for starvation recovery proteins, which quickly 
synthesised growth and replication proteins after the stimulus, indicating that the 
starvation event was over.  Studies such as these show that in order to obtain an 
accurate estimate of the protein profile produced by an organism or cell under given 
conditions the proteome needs to be examined directly. 
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Proteome  
Cell biology can also be studied at the level of the proteome.  The term proteome was 
used for the first time in 1995 to describe the total protein complement of the genome 
(Wasinger et al, 1995).  The proteome has been defined as the complete profile of 
proteins expressed in a given tissue, cell or biological system at a given time under 
specific conditions (Wilkins et al, 1997). 
   
The proteome differs substantially in concept from the genome.  The genome may be 
analysed in its entirety, from beginning to end and is fixed for each individual. The 
proteome is not a fixed feature of an organism.  Instead, it changes with the stage of 
development, the tissue and the environmental conditions under which an organism 
finds itself (Wilkins et al, 1997). In addition, some body fluids such as serum or 
urine have no DNA or mRNA, which makes these samples incompatible for these 
types of analysis. 
 
The transcription of DNA into mRNA is only the first step in a long series of events 
resulting in the production of a protein.  For example, in eukaryotes, mRNA is 
subjected to post-transcriptional control in the form of splicing, polyadenylation and 
editing prior to translation (Strachan and Read, 2000).  The coding into many 
different protein forms can be generated at this step.   Proteins are also subject to 
post-translational modifications (e.g. phosphorylation, glycosylation or proteolysis) 
(Kirschner, 1999) and compartmentalisation (Colledge and Scott, 1999).  These 
events cannot be determined from a DNA sequence or from mRNA expression 
levels; therefore, studies of the expressed proteins are required.   
 
Proteome research endeavours to examine the total protein complement expressed by 
a particular genome and to address biological problems that cannot be answered by 
examination of nucleic acid sequences alone (Westermeier and Naven, 2002).   The 
growth of proteomics is a direct result of advances in large-scale nucleotide 
sequencing of genomic DNA.  Without this information, protein identification would 
be a very difficult process.  Protein identification relies on the presence of some form 
of database for the given organism (Pandey and Lewitter, 1999: Shevchenko et al, 
2000).  The majority of DNA and protein sequence information has accumulated 
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within the last 11 years with the completion of many prokaryotic and eukaryotic 
genome sequences (Broder and Venter, 2000).   
 
1.2.2  Post-translational modifications  
In the 1940s Beadle and Tatum proposed that one gene encoded only one protein 
(Singer and Berg, 2004).  It is now known that this is not true since multiple proteins 
may be expressed from a single gene depending on how the gene is transcribed, how 
the mRNA is processed and translated, and how the protein is post-translationally 
modified.  
 
Post-translational modifications are critical to our understanding of physiological 
protein function.  However, while DNA data and mRNA data infer that sequence 
motifs exist that may be modified they do not indicate which sequence motif will 
actually be post-translationally modified (Wilkins et al, 1997).  It is estimated that up 
to 200 different types of post-translational modification exist (Krishna and Wold, 
1993).   The average number of protein isoforms per gene has been predicted to be 
one or two in bacteria, three in yeast, and three or more in humans (Wilkins et al, 
1997).  Therefore, it is clear that the tenet of “one gene, one protein” is an 
oversimplification.   
 
Post-translational modifications of proteins occur after coding and translation; 
common examples include phosphorylation and glycosylation (Strachan and Read, 
1997).  Many proteins have multiple potential modifications states.  For example, if a 
protein can be potentially glycosylated and phosphorylated each modification motif 
present would represent a potential protein form.  Each additional state would add a 
large amount of additional diversity to the expression profile of that protein (e.g. 64 
potential forms for just six modifications) (Wilkins et al 1997).  All modified forms 
from one protein can also vary in abundance, activity or location inside a cell, which 
cannot be predicted from the genome or transcriptome. 
 
Proteins are known to be modified post-translationally in response to a variety of 
intracellular and extracellular signals (Hunter, 1995).  For example, protein 
phosphorylation is an important signalling mechanism and incorrect regulation of 
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protein kinases or phosphatases can result in oncogenesis (Hunter, 1995).  By using 
proteomics, changes in the modifications of many proteins expressed by a cell or 
organism can be analysed simultaneously. 
 
For example, glycosylation is believed to be an important biochemical alteration 
often associated with malignant transformation (Gorelik et al, 2001).  By comparing 
the changes in protein glycosylation and total protein expression of normal tissue and 
carcinoma tissue, protein markers may be identified that differ in their glycosylation 
modification patterns and protein expression levels (Schulenberg et al, 2003; Dwek 
et al, 2001). 
 
1.2.3  Proteomic Technologies 
Thirty years ago when two-dimensional gel electrophoresis (2-DE) was introduced, 
very few tools existed for proteomics.  Since that time, new technologies have 
emerged and old ones have been improved in areas from protein separation to protein 
identification.  Currently there are three technological approaches dominating the 
field of proteomics.  These are 2-DE, liquid chromatography and protein microarrays 
(Kersten et al, 2002).  These three approaches are often used in conjunction with 
mass spectrometry.  These techniques can be used either separately or jointly with 
one or more of the other methods.   
 
Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) proteome 
analysis  
2D-PAGE, first described by O’Farrell (1975) and Klose (1975), was the first 
approach used to study the simultaneous expression of multiple proteins in a 
complex mixture.  A number of advances since 1975 have improved this established 
technique for protein separation and it remains a key method for the examination of 
differential protein expression.   The 2D-PAGE approach permits the separation and 
detection of proteins from a wide variety of sources without the need for any prior 
knowledge of their function (Kersten et al, 2002; Wilkens et al, 1997).  
 
Until recently, the separation of complex protein samples has been dominated by the 
techniques of 2D-PAGE, followed by mass spectrometric analysis of protein spots of 
interest.  Proteins are separated according to two independent properties: in the first 
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dimension according to their isoelectric point and in the second dimension according 
to their molecular mass.  The protein spots are then visualised by staining (e.g. 
Coomassie Brilliant Blue or silver nitrate).  Spot intensity staining may be used to 
compare relative abundance between the specific proteins of two samples.  A number 
of automated gel-scanning software programs are available to quantify spot intensity 
and facilitate gel comparisons (Marengo et al, 2005).  The identity of a protein spot is 
established by excising the spot from the gel, performing protease digestion on the 
gel piece, extracting the resulting peptides, and obtaining peptide mass data or 
peptide sequence data via mass spectrometry (Thiede et al, 2005).  The peptide mass 
fingerprint or sequence data is used to interrogate protein databases for protein 
identification. 
 
Liquid Chromatography-Mass Spectrometry (LC-MS) based approaches    
An alternative proteomics approach to the 2-DE method is LC-MS.    In such cases, 
the protein mixture is digested and the resultant peptides eluted directly from a 
reverse phase high performance liquid chromatography (RP-HPLC) column into the 
mass spectrometer, where multiple peptide product ion MS/MS spectra are acquired 
(LC-MS) (Westermeier and Naven, 2002).  Unfortunately, proteins are not generally 
amenable to high quality, robust separation of increasingly complex mixtures by RP-
HPLC.  If the sample is a complex mixture of proteins there is an increased 
likelihood that the digested peptides will co-elute which results in the MS being 
unable to select all the peptides for fragmentation.  This has been circumvented by a 
two-dimensional LC/MS (2DLC/MS) approach.  In the first dimension, the proteins 
are first digested typically, by trypsin, then acidified and subjected to cation-
exchange chromatography (Westermeier and Naven, 2002).  In the second 
dimension, the bound peptides are eluted with increasing ionic strength onto a RP-
HPLC column.  The peptides are bound due to their hydrophobic properties and 
subsequently eluted into the mass spectrometer (Wahsburn et al, 2001).   
 
A further development of the RP-HPLC approach that is now being used is MudPIT 
(Multidimensional protein identification technology), (Wahsburn et al, 2001).   The 
protein mixture is fractionated into a soluble fraction and an insoluble fraction 
(containing membrane proteins).  The former fraction is digested with trypsin and 
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subjected to the RP-HPLC approach and the insoluble fraction is cleaved firstly with 
cyanogen bromide and secondly with trypsin before 2DLC/MS (Wahsburn et al, 
2001).    
 
To date the LC-MS approach has been used successfully to characterise relatively 
simple protein mixtures (Link et al, 1999; Washburn et al, 2001) and to look 
specifically at protein-protein interactions (Muller et al, 2001).  2-DE-based 
proteome analysis provides information about protein abundance at the gel level by 
comparing staining intensities. However, when peptide mixtures are analysed 
directly by LC/MS/MS techniques, much of the original quantitative information is 
lost (Peng and Gygi, 2001).  Its application to expression proteomics is still at an 
early stage in its development and time will result in a better understanding of its true 
potential for the quantitative study of protein expression. 
 
Protein Microarrays  
The third technological approach that has been developed to screen complex protein 
samples rapidly involves the production of microarrays of antibodies, peptides or 
synthetic mimetic compounds.  Similar to DNA microarrays protein microarrays 
consist of thousands of probes (proteins, peptides, or synthetic compounds) 
immobilised on a solid support, which may be a glass slide, chip or microtitre wells 
(Lopez and Pluskal, 2003).  Recognition molecules utilised must be capable of 
binding the individual target proteins or a range of target proteins with a certain 
degree of affinity and specificity (Lopez and Pluskal, 2003).  The array or 
recognition particles (e.g. recombinant proteins) may be protein/antibodies but do not 
need to be.  The protein arrays are immobilised on a solid support (glass or 
membrane substrate) such that their ability to bind target protein(s) is not 
compromised.  The target protein mixtures are applied and bind to their appropriate 
array that are then quantitatively detected (Kusnezow and Hoheisel, 2003).  Common 
detection methods are radiography and fluorescent tags.  
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1.2.4  Proteomic Challenges 
Automation  
The study of proteins presents a number of unique challenges such as automation.   
Although the technology for the analysis of proteins is rapidly progressing, it is still 
not feasible to study proteins with the high throughput that can be achieved in the 
study of nucleic acids.  Proteomic techniques rely on methods such 2D-PAGE which 
are not high throughput methods.  Even the performance of mass spectrometry can 
generate stacks of data that may require considerable time in either data acquisition 
or analysis (Lopez, 2000).  Although hundreds of proteins can be analysed quickly, 
and in an automated fashion, by the different types of mass spectrometers some 
proteins still cannot be identified.  This may be due to poor digestion or the protein in 
question not being located in any of the protein databases. 
 
Low abundance proteins   
Proteomics is still limited in the study of low abundance proteins.  In some 
eukaryotic cells, the amounts of the most abundant proteins can be 106-fold greater 
than those of the low-abundance proteins (Wilkens et al, 1997).  Many important 
classes of proteins (that may be important drug targets) such as transcription factors, 
protein kinases, and regulatory proteins are low copy proteins.  These low-copy 
proteins (1-10 copies per cell) will not be observed in the cell lysate without 
additional purification steps (Wilkens et al, 1997).   
 
There is no equivalent of the PCR for proteins, so the analysis of low-abundance 
proteins remains a major challenge.  In DNA studies the amplification of DNA is 
possible with PCR.  In addition, in protein interaction studies native conformation of 
proteins must be maintained to obtain meaningful results (Wilkens et al, 1997).   
 
Basic proteins   
The visualisation of extremely basic proteins in 2-DE proteome analysis is still an 
area that requires improvement.  Extremely basic proteins require sample 
pretreatement to enrich for basic proteins followed by separation on specialised 
immobilised pH gradient (IPG) strips (see page 34) with pH ranges extended beyond 
pH 11 (Bae et al, 2003).  Strongly alkaline proteins such as ribosomal and nuclear 
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proteins with pIs between 10.5 and 11.8 have been separated using narrow IPGs pH 
10-12 and 9-12 (strips created in a particular laboratory) (Gőrg et al, 1997).  
However, 2-DE quantitative analysis of alkaline proteins with pIs between 11-12 is 
still not possible in most laboratories.   
 
In spite of the above limitations proteomics has enormous potential to provide insight 
into those questions that DNA and mRNA studies cannot answer.  The ability to 
study the protein expression of organisms will provide new insights into post-
translational modifications, differential expression of proteins, protein-protein 
interactions, protein localisation, the effects of environment factors on organisms, 
and disease/control studies. 
 
 
1.3  2-DE PROTEOME ANALYSIS TECHNIQUES 
2-DE Proteome Analysis has developed from, and continues to be dependent upon, 
the core technology of two-dimensional electrophoresis (2-DE) which is currently 
one of the major methods available capable of simultaneously separating thousands 
of proteins.  2-DE separation of proteins in the first dimension is based upon a 
surface charge fractionation by isoelectric focusing. This is followed by a mass-
driven separation in the second dimension, by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE). 
 
The techniques utilised in 2-DE proteome analysis are as follows (see Figure 1.4): 
 protein preparation, e.g. cell disruption, inhibition of proteolysis, removal of 
contaminants and solubilisation of proteins; 
 first dimension Separation – isoelectric focusing; 
 second dimension Separation – SDS PAGE on polyacrylamide slab gels; 
 visualisation – staining of gels; 
 image analysis – determination of differences between 2-DE gels;  
 excision of protein spots of interest; 
 digestion of isolated proteins and mass spectrometry –  e.g. Matrix Assisted 
Laser Desorption Ionisation (MALDI); and 
 bioinformatics. 
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Figure 1.4  2-DE proteome analysis techniques 
An example of the techniques that might be utilised in a Proteome analysis project 
using a combination of 2D gel electrophoresis and MALDI-TOF-MS. 
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1.3.1   Protein Preparation 
Adequate sample preparation is one of the most important prerequisites for a 
successful 2-D experiment.  The sample preparation procedure may include cell 
disruption, inhibition of proteolysis, removal of contaminants such as salts, RNA, 
DNA and lipids, and solubilisation of all proteins.  In some samples cell disruption 
may not be required as proteins are already in solution e.g. blood, tears, and milk. 
Ideally, to avoid protein losses, complete sample preparation should be accomplished 
in a single step in order to eliminate unnecessary handling.  However, this is often 
not possible.  There is no universal protocol for sample preparation. 
 
1.3.2  Cell Disruption 
To fully analyse all proteins contained in cells or tissues, the sample must be 
effectively disrupted. The choice of disruption method is dependent upon the type of 
sample and if the analysis is targeting all of the material or just a particular 
subcellular fraction.   There are a number of cellular disruption techniques that may 
consist of gentle (typically mammalian) or more vigorous lysis methods (microbial 
and plant cells) (Gőrg et al, 2004).  Cell disruption techniques include osmotic lysis, 
freeze thaw cycling, detergent lysis, enzymatic lysis of the cell wall, sonication, 
grinding with (or without) liquid nitrogen, high pressure (e.g. French press), 
homogenization with glass beads and a bead beater, nitrogen cavitation, or a rotating 
blade homogenizer.  These techniques may be used on their own or in combination 
(Wilkens et al, 1997; Westermeir and Naven, 2002).     
 
1.3.3   Protection Against Proteolysis 
When cells are lysed, proteases are often liberated or activated.  There are a number 
of methods to prevent the action of these proteases.  Most are inactive at low 
temperatures and at pH above 9 (Olivieri et al, 2001).  Therefore proteases can often 
be inhibited by Tris base, sodium carbonate, or a basic carrier ampholyte mixture, 
although the use of an alkaline environment (pH 9 or greater) may result in the loss 
of some basic proteins (Westermeier and Naven, 2002). Strong denaturants such as 8 
M urea, 10% TCA or 2% SDS also inhibit proteases (Wu and Wang, 1984).   
 
  26 
 
    
 
These approaches alone are sometimes insufficient to prevent proteolysis.  For this 
reason a cocktail of protease inhibitors may be utilised.  Such cocktails include a 
number of compounds designed to inhibit different classes of proteases (e.g. EDTA 
to inhibit metalloproteases by chelating the metal ions they require for activity). 
 
1.3.4   Removal of Contaminants 
A crude extract may be contaminated with non-protein impurities such as salt ions, 
phospholipids, nucleic acids, nonionic detergents, polysaccharides, phenolic 
compounds and insoluble material, which interfere with separation and resolution of 
proteins during 2-DE.   However, steps undertaken to remove impurities have the 
potential to cause losses of proteins that will alter the subsequent protein profile 
(Westermeier and Naven, 2002; Gőrg et al, 2004).  Therefore such steps should only 
be used where these impurities will significantly decrease the resolution of the 
proteins. 
 
Salts 
Salts, residual buffers, and other charged small molecules disturb the isoelectric 
focusing (IEF) process and must be limited to as low a concentration as possible  
(preferably less than 10 mM).  In an electric field salt contaminants start to migrate 
towards the electrodes.  Due to their size these contaminants will migrate at a faster 
rate than the proteins in the applied sample (Westermeir and Naven, 2002; Gőrg et 
al, 2004).  During the first dimension separation contaminants are forming ion fronts 
between the region with low ion concentration and regions with high ion 
concentrations, which are moving towards the electrodes (Gőrg et al, 2004).  These 
differences in conductivity generate heat.   If the voltage applied is too high during 
the migration of these contaminants it will generate regions of high heat that will 
burn the strips where the ion front is located (Westermeir and Naven, 2002).   
  
Desalting can be performed by tube dialysis, mini-desalting columns, spin dialysis, 
gel filtration or protein precipitation/resuspension using organic solvents such as 
methanol or acetone (Westermeier and Naven, 2002; Oh-Ishi and Maeda, 2002).   In 
some instances, proteins cannot be desalted prior to electrophoresis in the first 
dimension.  For example, proteins in halobacteria lysates will not be soluble if the 
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salt is removed (Bandyopadhyay and Sonawat, 2000).  In such cases, the sample can 
be electrophoreticaly desalted during the first IEF phase by extended application of a 
low voltage.   
 
Phospholipids  
Many proteins, especially membrane proteins, form complexes with lipids.  This 
reduces their solubility and can affect both their apparent pI and Mr.  Strongly 
denaturing conditions and detergents minimise lipid-protein interactions. Lipids can 
often be removed with detergent or by precipitation with acetone (Westermeir and 
Naven, 2002).   
 
Nucleic acids  
Nucleic acids can increase sample viscosity which causes background smearing in 
first dimension electrophoresis.  Nucleic acids can also bind to proteins through 
electrostatic interactions and inhibit isoelectric focusing or cause protein 
precipitation (Link, 1999; Gőrg et al, 2004).  Nucleic acids are visualised with silver 
staining as horizontal streaks in the acidic part of the gel.  Ultracentrifugation can be 
used to remove large DNA.  However, this technique may also result in loss of very 
high molecular mass (Mr) proteins from the sample (Westermeier and Naven, 2002).  
Nucleic acids can also be removed by treatment with endonuclease, or with 
sonication, that breaks them into small fragments.  Protein precipitation with 
methanol or acetone also removes nucleic acids, which remain in the supernatant. 
 
Ionic detergent  
Ionic detergents (usually SDS) are often used during protein extraction; however, 
this can strongly interfere with protein migration in the first dimension.  SDS forms 
complexes with proteins, and the resulting negatively charged molecules will not 
properly focus (Ames and Nikaido, 1976).  SDS can partially be removed by acetone 
precipitation.  The protein is precipitated by the acetone and the SDS remains in 
solution.  Protein precipitation will be more complete if conducted at –20oC (Guy et 
al, 1994). 
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Polysaccharides  
Polysaccharides can clog gel pores in the first dimension, causing protein 
precipitation and extended focusing times, which result in horizontal streaking (Gőrg 
et al, 2004).  Some polysaccharides contain negative charges and can complex with 
proteins by electrostatic interactions.  Polysaccharides can be removed by 
precipitating the sample in TCA, ammonium sulphate or phenol/ammonium acetate.  
Ultracentrifugation will also remove high Mr polysaccharides.   However, loss of 
very high Mr proteins may occur. 
 
Phenolic compounds  
Phenolic compounds are present in many plant tissues and can modify proteins 
through an enzyme-catalysed oxidative reaction (Gőrg et al, 2004).  They may be 
treated by a variety of methods:  
 
1. prevention of phenolic oxidation by the use of reductants during extraction;  
2. rapid removal of phenolics by precipitation;  
3. use of oxidative inhibitors such as diethyldithiocarbamic acid or thiourea; and  
4. removal by adsorption to polyvinylpyrolidone (PVP) and/or 
polyvinylpolypyrolidone (PVPP) (Flengsrud and Kobro, 1989; Cremer and 
van de Walle, 1985). 
 
Insoluble material (cell debris)  
Insoluble material in the sample can clog gel pores in the first dimension and result 
in poor focusing.  Samples should always be centrifuged prior to application in the 
first dimension (Westermeier and Naven, 2002). 
 
1.3.5   Protein Solubilisation 
The sample solution (IPG rehydration solution) must contain certain components to 
ensure complete solubilisation and denaturation of proteins prior to their separation 
in the first dimension.  A particular challenge in proteomics is the solubilisation and 
separation of proteins such as membrane and membrane-associated proteins and 
proteins from insoluble samples such as hair and skin (Wilkins et al, 1997).  
Enhanced protein solubility has largely been achieved by including appropriate 
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reagents, which can be divided into three groups - chaotropes, surfactants and 
reducing agents. 
 
Chaotropic agents  
Chaotropic agents such as urea enable proteins to unfold and thus expose their 
hydrophobic cores.  This is achieved by changing the hydrogen bond structure in the 
solution, thus decreasing the energy penalty for contact of the hydrophobic residues 
with the solution (Herbert, 1999).  However, this can increase the potential for 
hydrophobic interactions, especially when lipids are present in the sample (Rabilloud 
1996; Rabilloud, 2000).  In practice, with urea denaturation it is normal to have 
surfactants such as 3-(3-cholamidoproyl) dimethylammonio-1-propane sulfonate 
(CHAPS) present to aid in protein solubilisation (Herbert, 1999).   
 
Thiourea  
Thiourea is used in combination with urea to increase the solubility of proteins.  
Thiourea is an efficient chaotrope, although it is poorly soluble in water and requires 
high concentrations of urea for solubility, the optimal conditions being solutions of 2 
M thiourea in 5-7 M urea (Herbert, 1999; Link, 1999).  Although the use of urea and 
thiourea improve solubilisation of hydrophobic proteins, it is only in combination 
with surfactants such as CHAPS and sulfobetaine 3-10 that improved sample 
solutions for 2-DE may be achieved (Herbert, 1999). 
 
Surfactants  
It is normal to have at least one surfactant present in the first dimension sample 
solution to solubilise the hydrophobic regions that are exposed because of 
denaturation in chaotropes.   Detergents act on hydrophobic interactions by providing 
a stable dispersion of hydrophobic proteins in the aqueous medium, in the form of 
micelles (Link, 1999).  
 
Surfactants that are suitable for use in the IEF buffer are restricted to nonionic 
(Triton X-100, Nonidet P-40) or zwiterionic surfactants (CHAPS) however, the use 
of nonionic or zwiterionic detergents in the presence of urea presents some problems.  
In concentrated urea solutions, urea can bind linear alkyl chains to form inclusion 
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compounds (Link, 1999).  These complexes are much less soluble than free solute, 
and may precipitate (Link, 1999).  This precipitation is stronger with increasing alkyl 
chain length and higher urea concentrations.  Therefore, many nonionic or 
zwiterionic detergents with linear hydrophobic tails cannot be used in the presence of 
high concentrations of urea (Link, 1999). 
 
This limits the choice of surfactants mainly to those with non-linear alkyl tails (e.g. 
Triton X-100, Nonidet P-40, CHAPS) or with short alkyl tails (e.g. octyl glucoside).  
Commonly used surfactants such as Triton X-100, Nonidet P-40 and the sulfobetaine 
CHAPS are soluble in high concentrations of urea (Wilkins et al 1997; Herbert, 
1999).  However, they are not efficient at quenching hydrophobic interactions in high 
concentrations of chaotropes and their solubilising power is further reduced in the 
presence of the highly chaotropic thiourea (Gőrg et al, 2004).  In contrast, 
sulfobetaines with long linear alkyl tails such as N-decyl-N, N-dimethyl-3-ammonio-
1-propane sulfonate are more efficient at protein solubilisation but suffer from poor 
solubility in high concentrations of urea (Herbert, 1999). In order to achieve 
maximum efficiency for those proteins that require strong surfactants, low 
concentrations of the chaotropes may have to be used (Herbert, 1999; Link, 1999).  
For example, SB3-10 may only be used with urea concentrations ≤ 5 M.   
 
Reduction and alkylation  
Proteins contain a number of cysteine residues that are often linked in pairs to form 
disulphide bridges.   In order to allow complete unfolding of many proteins it is 
necessary to reduce disulphide bonds.  Protocols to do this have been utilised in 
proteome analysis since its early beginnings.   
 
Reduction of protein disulphide bridges is usually achieved with a free-thiol-
containing reducing agent such a 2-mercaptoethanol or dithiothreitol (DTT).  
However, free-thiol-containing reagents such as these are charged, especially at 
alkaline pH, and migrate out of the pH gradient during the IEF (Galvanni et al 2001; 
Gőrg et al, 2004).  This results in reformation of disulphide bonds and a consequent 
loss of solubility for some proteins, especially those that are prone to interaction by 
disulphide bonding (Wilkins et al, 1997; Herbert et al, 1998). 
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As reduced polypeptide chains migrate to their isoelectric point (pI), they sometimes 
leave behind the reducing agent allowing either the reformation of disulphide bridges 
or a variable degree of cysteine-alkylation by residual acrylamide monomers in the 
gel (Herbert, 1999).  The regeneration of disulphide bridges could occur between 
unlike polypeptide chains (i.e. not only within but also between polypeptide chains).  
If this were to occur, artifactual spots could be generated in the 2-DE gel.  
  
In peptide mass spectrometric analysis, the identity of cysteine-containing peptides is 
difficult to establish if different mass values are generated from cysteine oxidation 
products and acrylamide adjuncts (Yan et al, 1998).  This results in a range of 
possible masses being obtained which may generate a number of possible protein 
identities during protein database searches. Therefore, it is advantageous for 
proteomic applications to modify cysteine to completion by reduction with tributyl 
phosphine (TBP) or dithiothreitol (DTT) followed by alkylation, prior to separation 
in the first dimension (Yan et al, 1998).   
 
However, free-thiol-containing reagents, such as DTT, react with acrylamide or other 
alkylating agents (iodoacetamide, N-ethylmaleimide) in preference to the cysteine-
thiol.  This may lead to incomplete alkylation of cysteine residues.  Herbert et al 
(1998) replaced DTT with an uncharged reducing agent, TBP.  Because phosphines 
do not contain a thiol, they cannot be alkylated by acrylamide.  This leads to a 
simplified IPG strip re-equilibration protocol incorporating reduction and alkylation 
in a single step and cysteine modification proceeds to completion (Herbert, 1999).  
This greatly enhances protein solubility during the IEF, which increases the transfer 
of protein to the second dimension with a range of samples. 
  
1.3.6   First dimension 
Proteins are amphoteric molecules with both acidic and basic buffering groups that 
become protonated or deprotonated depending on the pH environment.  In a basic 
environment, the acidic groups become negatively charged, while in the acidic 
environment the basic groups become positively charged.  The net charge of a 
protein is the sum of all negative and positive charges of the amino acid side chains 
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and amino- and carboxy-termini. The isoelectric point (pI) is the specific pH at 
which the protein has no net charge and therefore stops migrating in an electric field 
(Righetti, 1983; Berkelman et al, 1998).  Proteins are positively charged at pHs 
below their pI and negatively charged at pHs above their pI.  
 
Isoelectric focusing   
Isoelectric focusing is performed in a pH gradient.  When a protein is placed at a 
certain pH on the gradient and an electric current is applied, the protein will start to 
migrate towards the electrode of the opposite sign to its net charge (Righetti, 1983).  
Because it migrates inside a gradient, it will eventually arrive at a pH value 
equivalent to its isoelectric point where it will stop (Berkelman et al, 1998).  Should 
it diffuse away from this point it will become charged again and migrate back to its 
pI.  The effect is the focusing of each protein to a tight band centred on its pI.  The 
efficiency of focusing is improved by increased voltage.  Isoelectric focusing can 
produce high-resolution separation of complex mixtures of proteins. 
 
There are two kinds of pH gradient gels (Righetti, 1983; Westermeier and Naven, 
2002): 
 those which are formed in a gel by the effect of an electric field upon amphoteric 
buffers (carrier ampholytes), which are free in solution; and 
 immobilised pH gradients (IPG) in which the buffering groups are attached to the 
gel matrix. 
 
Carrier ampholyte-generated pH gradients   
Carrier ampholytes are small, soluble, amphoteric molecules that have a high 
buffering capacity near their pI.   They have good and regular electric conductivity 
and an absence of biological effects (Righetti, 1983; Westermeier and Naven, 2002). 
Almost all the carrier ampholytes are charged; those with the higher pI positively, 
those with the lower pI negatively. 
 
Carrier ampholyte-generated pH gradients were the first to be developed for 
isoelectric focusing (O'Farrell, 1975; Klose, 1975). IEF was performed using 
polyacrylamide rod gels with pH gradients generated using carrier ampholytes (Link, 
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1999). In this technique, the pH gradient is established by the electric field.  At the 
beginning, the gel with carrier ampholyte has a uniform average pH value.  When an 
electric field is applied however, the negatively-charged carrier ampholytes migrate 
towards the anode, the positively-charged ones to the cathode, with velocities 
depending on their net charges (Berkelman et al, 1998).  The carrier ampholytes then 
align themselves in between the two electrodes according to their pI, forming a pH 
gradient.    
 
To maintain a gradient that is as stable as possible, electrode solutions (anode and 
cathode buffers) are used between the gel and the electrodes.  An acid is used at the 
anode and a base at the cathode (Righetti, 1983).  Should an acidic carrier ampholyte 
reach the anode, its basic buffering group would acquire a positive charge from the 
acidic solution there and it would be attracted back to the cathode (Berkelman et al, 
1998; Link, 1999).  Similarly, basic carrier ampholytes would acquire a negative 
charge from the basic solution and be attracted back to the anode.  Although 
theoretically the carrier ampholytes should have functioned as previously mentioned 
in fact, given enough time, they eventually suffer from gradient drift (Berkelman et 
al, 1998). 
 
Isoelectric focusing is a relatively slow separation method because, close to their 
isoelectric points, proteins have only a low net charge and therefore low mobility.  
Also high resolution requires long separation distances, which results in extended 
migration times (Link, 1999).  Long runs present difficulties in reproducibility for 
carrier ampholyte-generated pH gradients because of gradient drift. Because the 
carrier ampholytes are in free solution, the gradient is unstable during an extended 
IEF run and they usually drift towards the cathode (Link, 1999). This gradient drift 
causes a flattening of the pH gradient at both ends of the gel.  This effect is 
particularly noticeable above pH 9 and most of the basic proteins eventually drift out 
of the gel together with the basic part of the gradient (Berkelman et al, 1998).  
Because of this, the protein pattern is time dependent.   
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Another problem is that the proteins of the sample behave like additional carrier 
ampholytes and modify the pH profile of the gradient.  This means that the gradient 
is sample dependent (Link, 1999; Westermeier and Naven, 2002). 
 
The pH gradients generated by such procedures in the first dimension are inherently 
variable, which makes it difficult to obtain reproducible 2-D gel runs in large 
numbers (Gőrg et al, 2004; Berkelman et al, 1998). The subsequent results are 
therefore highly dependent on the skill of the operator. 
 
Immobilised pH gradients (IPG)   
Due to the limitations of the carrier ampholyte method, an alternative technique for 
pH gradient formation was developed, IPG (Bjellqvist et al, 1982). An IPG strip is 
created by covalently incorporating a gradient of acidic and basic buffering groups 
into a polyacrylamide gel at the time it is cast.  The buffers, called acrylamido 
buffers (e.g. Amersham Biotech Immobilines), are a set of well-characterised 
molecules, each with a single acidic or basic buffering group covalently linked to an 
acrylamide monomer (Link, 1999; Westermeier and Naven, 2002).  The pH gradient 
is generated by casting a gradient gel using a continuously varying mixture of 
acrylamido buffers with the desired pH extremes. The main advantage of the IPG 
system is that during polymerisation the buffering groups forming the pH gradient 
are immobilised via vinyl bonds to the polyacrylamide backbone of the strip (Link, 
1999; Westermeier and Naven, 2002).  This results in pH gradients that are 
effectively stable, thus eliminating the effects of pH gradient drift (cathodic drift) 
encountered in conventional IEF using free ampholytes (Link, 1999; Westermeier 
and Naven, 2002).  After the advent of immobilised pH gradients stabilised on a stiff 
plastic support strips, the practicality of utilising 2-DE gels to resolve complex 
protein mixtures in a quick and reproducible manner became apparent. 
 
Advantages of immobilised pH gradients  
There are a number of advantages of IPG strips compared to gels with pH gradients 
generated from carrier ampholytes.  These are (Westermeier and Naven, 2002; 
Berkelman et al, 1998): 
 standardised reproducibility; 
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 the chemistry of the buffering acrylamide derivatives is better controllable; 
 the film-supported gel strips are easy to handle; 
 the fixed gradients are not modified by the sample composition, and they do 
not drift with IEF time; 
 stable basic pH gradients allow reproducible separation and display of basic 
proteins; 
 higher protein loads are achievable; 
 less protein is lost during equilibration in SDS buffer, because the fixed 
charged groups of the gradient retain the proteins like a weak ion exchanger; 
and 
 reproducible protein patterns can be prepared on gradients engineered 
according to special needs.  They are commercially available in a variety of 
pH ranges (wide range, pH 3-10 and narrow range, pH 4.5-5.5). 
 
Carrier ampholytes continue to have an important function in IPG strip sample 
application as they improve the solubility of proteins considerably.   The addition of 
carrier ampholytes in the sample solution enhances protein solubility by reducing 
protein aggregation due to charge-charge interactions (Berkelman et al, 1998).  In a 
solution, they are charged but they do not disturb isoelectric focusing like ionic 
buffers, because they migrate to their pIs, where they become uncharged.  Therefore, 
small quantities of free ampholyte are included in the rehydration solution 
(Berkelman et al, 1998).    
 
1.3.7   Second dimension 
Sodium dodecyl sulphate (SDS) electrophoresis   
With SDS-PAGE the polypeptides are separated on gels in the presence of SDS 
according to their apparent molecular masses.  
 
Polyacrylamide composition   
A polyacrylamide gel is formed from the polymerisation of acrylamide monomers 
into long chains and the cross-linking of these chains by bifunctional compounds 
such as N, N-methylenebisacrylamide (Link, 1999).  Different cross-linkers (e.g. 
piperazine diacrylamide and bis-acrylamide) impart different characteristics to 
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polyacrylamide gels (e.g. susceptibility to swelling, tensile strength and background 
staining characteristics). Polymerisation of acrylamide is initiated by the addition of 
either ammonium persulphate or riboflavin.  N,N,N’,N’-Tetramethylethylenediamine 
(TEMED) may be added to accelerate the polymerisation process by catalysing the 
formation of free radicals from persulphate (Link, 1999).  These in turn initiate 
polymerisation.  Oxygen inhibits polymerisation and thus gel mixtures are usually 
deoxygenated by reduced air pressure before gels are poured.   
 
The pore size can be exactly and reproducibly determined from the total acrylamide 
concentration T and the degree of cross-linking C. 
 
T = (a + b) x 100 [%],        C = b x 100 [%] 
               V                                       a + b 
Where a is the mass of acrylamide in g 
b the mass of crosslinker in g 
V the volume in ml 
 
When C remains constant and T increases, the pore size decreases.  When T remains 
constant and C increases, the pore size follows a parabolic function.  At high and low 
values of C, the pores are large (Westermeier and Naven, 2002).   
 
SDS and TBP   
SDS binds to proteins to form complexes with a necklace-like structure composed of 
protein-decorated micelles connected by short flexible polypeptide segments (Ibel et 
al, 1990)   As a result, large amounts of SDS are incorporated in the SDS-protein 
complex in a ratio of approximately 1.4g SDS/g protein (Berkelman et al, 1998).  
Because SDS masks the native charge of the proteins, the SDS-protein complexes 
have essentially a constant net negative charge per unit mass.   SDS solubilises 
proteins by blocking hydrogen bonding and inhibiting hydrophobic interactions, and 
largely unfolds the protein molecules, eliminating the secondary and tertiary 
structures (Link, 1999). 
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Usually a reducing agent such as TBP is added to the sample to reduce the disulphide 
bridges between cysteines (Herbert et al, 1998). Following separation in the first 
dimension, in order to allow complete unfolding of many proteins, it is necessary to 
reduce disulphide bonds.   In addition, cysteine residues need to be completely 
alkylated prior to second dimension separation to prevent difficulties associated with 
incomplete alkylation of proteins by free monomers of acrylamide in the gel (see 
Reduction and Alkylation page 30).   
 
Essentially, the electrophoretic mobility of proteins treated with SDS and TBP 
depends only on the molecular mass of the protein.  
 
Homogeneous versus gradient gels   
Slab gels may be prepared with either a single concentration of acrylamide or 
gradient-polyacrylamide forms that can be optimised to separate proteins over a 
specific Mr range.   
 
Large format single percentage (homogeneous) gels offer good resolution within a 
specific Mr range but poor resolution outside of this Mr range (see Table 1.1).  For 
example, a 7.5% acrylamide gel might efficiently resolve proteins with Mr between 
24-200 kDa (this is partially dependent upon the pore size of the gel and the 
complexity of the sample) (Berkelman et al, 1998).  A commonly used second-
dimension gel for 2-DE is a homogeneous gel containing 12.5% T and 3% C.  
 
Gradient gels have an increasing concentration of acrylamide from top to bottom.  
For example, in a 10-20% gradient gel there is 10% polyacrylamide concentration at 
the top that increases to 20% at the bottom of the gel.  When a gradient gel is used, 
the overall separation interval is wider and the linear separation interval is larger 
(Berkelman et al, 1998).  The entire Mr range may be displayed on one gradient gel 
where two or more homogeneous gels would be required to obtain good resolution of 
the same Mr range.  In addition, bands are sharper on gradient gels because the 
decreasing pore size functions to minimise diffusion. However, a gradient gel 
requires more skill to cast, so unless precast commercial gels are utilised they may 
present problems with reproducibility (Link, 1999). Another disadvantage of gradient  
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% Acrylamide in Separation Size Range 
resolving gel (Mr x 103) 
Single Percentage  
5% 36-200 
7.5% 24-200 
10% 15-200 
12.5% 7-100 
15% 0-60 
 
Gradient   
5-15% 14-200 
5-20% 10-200 
10-20% 0-150 
 
Table 1.1  Acrylamide Gel Concentration Guide 
An approximate guide to the acrylamide concentrations suitable for protein 
separation by Mr (Berkelman et al, 1998). 
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gels is that they compress the protein pattern that leads to spatial resolution 
difficulties, especially for high Mr proteins. 
 
1.3.8   Visualisation of spots 
There are many techniques employed for the detection of protein on 2-D gels.  The 
four most commonly used methods are staining with either coomassie brilliant blue, 
silver nitrate, or fluorescent dyes and autoradiography.  
 
In choosing the chemical entity to bind to the proteins the key issues which must be 
considered are, sensitivity (detection threshold), linearity of response, homogeneity 
(i.e. consistency of dye biding by different proteins), and reproducibility (Berkelman 
et al, 1998; Westermeier and Naven, 2002).  Homogeneity and reproducibility are 
generally less important for 1-D electrophoresis, in which different samples are 
loaded in parallel lanes of the slab gels. The situation is quite different in 2-D slab 
gels, in which there is usually only one sample per gel (exception is fluorescent dual 
labelling of proteins [Bernhardt et al, 1999]), because the abundance of different 
protein spots separated on one gel have to be compared to those on other gels. 
 
There is a list of desirable properties for the spot detection techniques in 2-DE gels 
for proteomics (Westermeier and Naven, 2002) they are: 
 
1. be sensitive enough for low copy number proteins; 
2. allow quantitative analysis; 
3. have a wide linearity of range; 
4. have a wide dynamic range; 
5. be compatible with mass spectrometry; 
6. be non toxic; 
7. be environmentally friendly; 
8. have ease of handling (time, complexity of procedure); 
9. be reproducible; and 
10. be inexpensive 
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Unfortunately, no staining method has all of these features.  The choice of staining 
technique for any particular project will often be dependent on the amount of the 
protein sample available. For example, in the study of human tissue biopsies it may 
be difficult to obtain large quantities of protein.  However, when studying bacterial 
proteomes, it is often easy to acquire large protein quantities.  Low protein amounts 
will require dyes with higher sensitivities and this will determine the staining 
technique utilised. 
 
Coomassie Stains   
There are a number of Coomassie Brilliant Blue (CBB) dyes including R250, R350 
and G250, all of which belong to the triphenylmethane family. CBB forms 
complexes with basic amino acids such as arginine, tyrosine, lysine and histidine.  
CBB staining requires an acidic medium for electrostatic attraction to be exerted 
between the dye molecules and the amino groups of the proteins (Link, 1999).  This 
ionic attraction, together with the van der Waals’ forces, binds the dye-protein 
complex together. The binding however, is fully reversible under the appropriate 
conditions. 
 
Coomassie R250.  The Coomassie R250 dye was the first of the triphenylmethane 
dyes to be introduced. This dye has a detection limit of 30-100 ng of protein per spot 
(Patton, 2002).  The classical approach involves the use of a regressive staining 
approach where gels are saturated with CBB R250 that has been dissolved in an 
aqueous solution containing methanol and acetic acid, followed by destaining in a 
similar solution devoid of the dye (Patton, 2002).  The proteins have a higher affinity 
for the dye molecules than the gel matrix and therefore a point is reached where the 
background staining is minimal but the protein spots are well defined (Patton, 2002).   
However, the classical CBB R250 staining procedure is often not appropriate for 2D 
gel electrophoresis.  Gel-to-gel reproducibility in staining is difficult to control 
because during gel destaining, with solutions containing alcohol, the protein spots are 
partly destained to varying extents along with the gel background.  Some proteins 
such as collagens may even destain before the gel itself (Westermeier and Naven, 
2002).  Because no steady state of staining is reached, quantification is not reliable 
and not reproducible. 
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Coomassie G250.   In 1985, a new colloidal technique for the staining of 2-DE gels 
was developed (Neuhoff et al, 1988). Coomassie G250 solution utilises 3% 
phosphoric acid.  In the presence of a strong acid CBB G250 has diminished 
solubility in methanol permitting its use as a colloidal dispersion.  Colloidal CBB 
G250 stain also contains alcohol, but in the presence of ammonium sulphate.  
Ammonium sulphate increases the strength of the hydrophobic interactions between 
proteins and dye (Neuhoff et al, 1988).  Initially trichloracetic acid (TCA) was 
utilised instead of phosphoric acid, but it was found that this led to irreversible, acid-
catalysed esterification of glutamic and aspartic acid side chain carboxyl groups, an 
effect that can complicate interpretation of peptide mapping data from mass 
spectrometry due to variable esterification of proteins.  The use of phosphoric acid 
with methanol prevented this problem (Peisker, 1988; Mitra et al, 1994).  
 
During staining, equilibrium is achieved between colloidal particles and freely 
dispersed dye in solution.  The low concentration of free dye penetrates the gel 
matrix and preferentially stains the proteins, but colloidal dye particles are excluded 
from the gel, thus preventing matrix staining (Neuhoff et al 1988; Patton, 2002).   
This permits rapid staining of proteins without an undesired background.   Because 
of this, the G250 procedure has the advantage of not requiring the gel alcohol-
destaining step.  The limit of protein detection for colloidal CBB stain is 
approximately 8-10 ng of protein and, since the destaining step is unnecessary, 
quantitation is more reliable (Patton, 2002).  However, the linear dynamic range of 
the dye is relatively small. 
 
CBB colloidal stained gels are compatible with mass spectrometry because the dye 
can be completely removed from the proteins prior to analysis.  It is important to use 
a dye of high quality in order to avoid interference due to contaminants.  The CBB 
G250 colloidal stain has 5 of the 10 desirable staining properties listed on page 39.   
These are that it allows quantitative analysis, has a wide dynamic range, is 
compatible with mass spectrometry, is highly reproducible and is the most affordable 
of the four detection methods. 
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This technique is an improvement on previous Coomassie staining methods although 
it still has a lower sensitivity than silver. 
 
Silver Stains   
The silver ion (Ag+) complexes with lysine residues of proteins.  The basic 
mechanism underlying all silver staining involves reduction of ionic silver to its 
metallic form (Switzer et al, 1979; Oakley et al, 1980).  Detection of proteins in the 
gel requires a difference in the oxidation-reduction potential between sites occupied 
by proteins and adjacent sites of the gel.  If the protein site has a higher reducing 
potential than the surrounding gel or matrix, then the protein will be positively 
stained (Westermeier and Naven, 2002).  Conversely, if the protein site has a lower 
reducing potential than the surrounding gel, the protein will appear to be negatively 
stained.  Negatively stained protein spots give the appearance of a lighter stained 
centre surrounded by a darker stained border.  The detection limit for silver nitrate 
stains is about 0.5 – 1.5 ng per spot (Patton, 2002). 
 
Silver staining methods are quite complex, multi-step procedures that must be 
stopped at some arbitrary time point in order to avoid over-development.  Therefore, 
gel-to-gel reproducibility can be difficult to achieve, one study found that there are 
variations of 20% in spot intensities on duplicate gels (Quadroni and James, 1999).  
The addition of a specific quantity of a known protein can be used as a reference 
point for normalisation of gel spot intensity. 
 
This means that silver staining is one of the most sensitive non-radioactive methods 
for detecting proteins separated by gel electrophoresis.  It is 20-fold more sensitive 
than Coomassie staining for most proteins and equivalent to that provided by 
fluorescent stains such as SYPRO Ruby (White et al, 2004).  However, small traces 
of contaminants may cause a loss of sensitivity and result in staining artefacts.  
Therefore, care is required in selecting reagents and during handling of gels in order 
to obtain high sensitivity and good images.   
 
Silver stains can be modified for compatibility with mass spectrometry by omitting 
glutaraldehyde from the sensitising solution (Shevchenko et al, 1996; Scheler et al, 
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1998). The detection sensitivity then decreases to about one fifth that of the 
unmodified procedure.  
 
Silver staining has 3 of the 10 desirable properties listed on page 39, these being that 
it is sensitive enough for low copy number proteins, has a wide linearity of range, 
and is a medium-cost staining technique (more expensive than CBB G250 but less 
expensive than SYPRO or autoradiography detection methods).   
 
SYPRO fluorescent dyes   
Certain d-block and lanthanide transition metal complexes such as those containing 
ruthenium, rhenium, osmium, platinum, europium, or terbium are intensely 
luminescent.  Early SYPRO fluorescent dyes such as SYPRO Red and Orange bind 
protein through noncovalent interactions with the SDS-shell complex on SDS-protein 
complexes (Steinberg et al, 1996a; Steinberg et al, 1996b).  However, the staining 
techniques of these dyes are not compatible with electroblotting or electroeluting and 
they are less sensitive than the more recent SYPRO stain SYPRO Ruby (Patton, 
2002).  SYPRO Ruby is a ruthenium-based metal chelate that binds avidly to 
proteins by a CBB-type mechanism primarily involving lysine, arginine, and 
histidine residues (Patton, et al 1999).  The SYPRO Ruby stain is more sensitive than 
CBB and exhibits a broader linear dynamic range. 
 
The SYPRO Ruby staining method is rapid, requiring approximately 4 hours in 
comparison to the 24 hours required by the colloidal CBB stain.  Like colloidal CBB 
G250, but unlike silver nitrate, SYPRO Ruby is a staining procedure that approaches 
a fixed end-point (Patton et al, 1999).  Thus, staining times are not critical and the 
procedure can be performed for extended periods without gels overdeveloping.  
Proteins that stain poorly with silver are often readily detected by SYPRO Ruby 
(Nishihara and Champion, 2002).  However, a disadvantage of SYPRO Ruby is that 
it is expensive in comparison to colloidal CBB and silver nitrate stains.  The SYPRO 
Ruby method has 6 of the 10 desirable staining properties listed on page 39, these 
being that it is sensitive enough for low copy number proteins, allows quantitative 
analysis, has a wide linearity of range, has a wide dynamic range, is compatible with 
mass spectrometry, and is highly reproducible.  However, due to the cost of this 
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staining technique large-scale proteome analysis studies may become too expensive.  
Fluorescent dyes are not visible to the naked eye, which makes it difficult to 
ascertain if a particular experiment has been successful until the gel is scanned by a 
fluorescence imager.   
 
Radiolabelling   
Radiolabelling is commonly accomplished by incorporating 3H, 14C, 35S, 32P, or 125I 
into proteins (Link, 1999; Springer, 1996). After electrophoresis, signal detection 
may be accomplished using film, direct autoradiography (for the -emitting isotopes) 
or by fluorography (for the -emitting isotopes).  Autoradiography has the ability to 
detect proteins below the pg range.  Therefore, this is one of the most sensitive 
detection techniques.  Fluorography employs fluorescent enhancers impregnated into 
the gel matrix to improve detection of the radioactive emissions through the 
generation of light.  Intensifying screens may be used to enhance the signal of high-
energy isotopes such as 32P or 125I (Link, 1999).  These screens absorb the 
radioactive emissions that pass through the film, fluoresce and generate light that 
exposes the film.  Over the past decade, fluorescent imagers and microchannel plate 
analysers have begun to replace autoradiography film for detecting radiolabelled 
proteins (Link, 1999).  The new technologies offer a wider dynamic range and better 
detection sensitivity than film. 
 
Although sensitive detection is achieved, radiolabelling is both hazardous and 
expensive.  Expenditures involved include disposal of the radioactive waste, 
inventory control, training laboratory personnel and monitoring their exposure.  
Reducing reliance on radioactivity in biomedical research had become a high priority 
in many laboratories over the past several years as it makes economic good sense and 
provides a safer work environment.  Autoradiography has 3 of the 10 desirable 
staining properties listed on page 39, these being that it has a wide linearity of range, 
has a wide dynamic range and is potentially the most sensitive technique available 
for the detection of low copy number proteins. 
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1.3.9   Computer Analysis 
Scanning 
 2-DE-gels can be used to resolve thousands of proteins from one cell type or 
organism.  This mass of information makes it difficult, if not impossible to discern 
all the differences between samples with the unaided eye, particularly when low 
abundance proteins may barely be visible and the eye is poor at quantitating. 
Therefore, a scanning densitometer or digital camera must be used to prepare 
quantitative, digitised gel images to be analysed with a computer.  The best results 
may be achieved by acquiring the gel images as a grey-scale TIFF file with adequate 
resolution and intensity measured preferably using a 16 bit scale providing 216 levels 
of intensity ( i.e. over 65,000) (Westermeier and Naven 2002).  The ability to utilise 
a 16-bit intensity scale is conditional on the ability of the analytical software to 
access this format.  However, the use of a 16-bit scale results in large files (typically 
14 Mb for 18.5 x 18.5 cm gel).  This may make it difficult to analyse a large number 
of image files, and therefore it may be more advisable to use an 8-bit scale, which 
produces much smaller files (typically 1.4 Mb for 18.5 x 18.5 cm gel).  In addition 
increases in dots per inch or bit scale may not necessarily improve the degree of 
information obtained from the gel images to be analysed.  
 
Image Analysis   
Analysis of complex 2-DE patterns has been facilitated by the development and 
utilisation of sophisticated image analysis software.  In this manner, one can detect 
and quantify even faint spots, quantitatively compare 2-DE gel images and identify 
protein expression changes across sets of 2-DE gel images (Link, 1999).   
 
There are three types of 2-DE imaging software available (some programs may fall 
into more than one category): 
 
 public domain tools for basic image analysis e.g. Flicker http://www-
lecb.ncifcrf.gov/flicker/ 
 professional programs which evaluate with high reproducibility and offer 
many valuable functions for image analysis, statistical evaluation and data 
reporting e.g. PDQUEST and Melanie.   
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 fully automated software solutions integrated with robotic hardware for high-
throughput hands-free analysis involving a large number of gels e.g. 
Progenesis, PDQUEST (Westermeier and Naven 2002). 
 
The development of software for 2-DE gel image analysis is a continuously evolving 
process.  The functions become more reliable, reproducible and automated from year 
to year.  With the latest programs, it is already possible to compare gels of different 
sizes, shapes, and even damaged gels.  However, if the protein spots on the gels are 
not reproducible, even the most advanced software cannot fix the problem.     
Currently the most advanced software packages still require a certain degree of 
manual correction of protein matches.  The day of fully automated software analysis 
is approaching, but it is not here yet. 
 
1.3.10 Types of Analyses  
PDQUEST Analysis   
An important part of databasing is the ability to compare data between experiments.  
The spots in the PDQUEST program consist of Quantitative, Qualitative, Boolean, 
Arbitrary and Statistic.  This enables Analysis sets to be created which contain 
statistically and biologically related spots. 
 
Arbitrary analysis sets are composed of any group of spots selected by the program 
user (PDQUEST manual 6.2.1). 
 
A Boolean analysis set is formed by combining two previously defined Analysis Sets 
(A and B) using Boolean operators.  The Boolean Sets created might include: 1) the 
intersection of A and B; 2) the union of A and B; 3) spots that are unique to set A 
plus spots that are unique to set B; 4) Spots that are only found in B;  and 5) spots 
that are only found in A (PDQUEST manual 6.2.1). 
 
A quantitative analysis set contains spots from two different images or replicate 
groups that are present in both images or replicate groups that differ in concentration 
to a predetermined degree (usually by a factor of 3 or more) i.e. it includes spots 
whose volume has significantly increased or decreased (PDQUEST manual 6.2.1). 
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A qualitative analysis set contains spots from two different images or replicate 
groups that were detected in one image or replicate group, but not in the other.  Such 
a set might contain, for example, proteins that were expressed under experimental 
conditions but not expressed under control conditions, or vice versa (PDQUEST 
manual 6.2.1). 
 
A statistical user set is composed of spots from replicate groups whose volumes are 
found to be significant according to a specified statistical test (e.g. Student T-Test, or 
Mann-Witney Test) (PDQUEST manual 6.2.1). 
 
Cluster analysis  
The aim of classification is to group together a number of objects based on their 
attributes or variables so that the object is more similar to other objects in its group 
than objects in the other groups (Everitt, 1972; Everitt, 2004).   Two methods that 
may be used to classify objects are discriminant analysis and cluster analysis.  
Discriminant analysis requires that the parameters used to define group membership 
are known for the cases used to derive the classification rule. However, in cluster 
analysis the parameters used to define group membership for all cases is unknown.  
In fact, even the number of groups is often unknown.  The goal of cluster analysis is 
to identify homogeneous groups or clusters. 
 
In biology, cluster analysis is often used to classify animals and plants.  This is called 
numerical taxonomy.  In medicine, cluster analysis is often used to identify diseases 
and their stages.  For example, by examining patients who are diagnosed as 
depressed, it might be found that there are several distinct subgroups of patients with 
different types of depression (Everitt, 1972; Everitt, 2004).  Two of the most 
commonly used types of cluster analysis are k-means and hierarchical clustering 
techniques (Everitt, 1972; Everitt, 2004).   
 
K-means Clustering attempts to identify relatively homogeneous groups of cases 
based on selected characteristics, using an algorithm that can handle large numbers 
of cases. However, the algorithm requires the number of clusters to be specified.  The 
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number of clusters can only be specified if this information is known (SPSS Manual 
Version 11).  
 
In a hierarchical classification, the data are not partitioned into a particular number 
of classes or clusters at a single step.  Instead the classification consists of a series of 
partitions, which may run from a single cluster containing all individuals, to n 
clusters each containing a single individual.  Hierarchical clustering techniques may 
be subdivided into agglomerative methods that proceed by a series of successive 
fusion of the n individuals into groups, and divisive methods, which separate the n 
individuals successively into finer groupings (SPSS Manual Version 11). 
 
Agglomerative hierarchical cluster analysis A method for creating clusters in 
which each case starts out as a cluster. In the present instance, a case is equivalent to 
a H. pylori strain and a variable is equivalent to a spot.  At every step, clusters are 
combined until all cases are members of a single cluster.  Once a cluster is formed it 
cannot be split, it can only be combined with other clusters (SPSS Manual Version 
11). 
 
The application of most methods of cluster analysis depends on the availability of 
suitable computer software.  There is a large range of cluster analysis software 
packages available, these include SPSS, SAS, SYSTAT, CLUSTAR and CLUSTAN.  
These programs differ in the types of statistical analysis that can be performed 
ranging from a wide range of applications (SPSS and SAS) to programs that are 
specially designed for cluster analysis (SYSTAT, CLUSTAR, CLUSTAN).    
 
1.3.11  Protein identification methods in proteomics 
Spot Volume is a measure of protein quantity related to staining intensity.  The spot 
volume is determined from the average spot intensity (mean density of pixels in the 
spot) by the spot area (number of pixels in a spot) (PDQUEST Manual). 
 
A protein cannot be identified based on its position in a gel alone.  Identification is 
only possible by further analysis of the protein, for instance using mass spectrometry.  
Furthermore it is incorrect to conclude that a protein is up or down regulated on the 
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basis of an increased or decreased spot volume because the protein may have 
changed its pI due to post-translational modification and may now be co-migrating 
with another protein.  Therefore, proteins of interest have to be analysed further.  
This is done mainly by mass spectrometry (MS).  Generally, MS data can be used in 
four approaches for protein identification. These approaches are peptide mass 
fingerprinting, peptide mass fingerprinting and composition information, peptide 
mass fingerprint and sequence information, and MS/MS sequencing data. 
 
Other methods, such as Edman degradation, were the principal methods of protein 
sequencing in the eighties but have largely been superseded by mass spectrometry 
sequencing.  
 
Peptide mass fingerprinting (PMF) is a technique for searching protein databases for 
protein identity.  The subject protein is cleaved, and the masses of the resultant 
peptides are used for a database search (James et al, 1993; Westermeier and Naven, 
2002).   
 
PMF and composition information is a technique where each peptide’s molecular 
mass combined with its composition information can be used for a database search 
(Westermeier and Naven, 2002). 
 
PMF and sequence information for each peptide can be used along side some of the 
direct amino acid sequence information to search a peptide sequence database 
(Westermeier and Naven, 2002). 
 
The product ion MS/MS sequence data from one or more peptide – MS/MS mode 
(Isobe et al 1990; Westermeier and Naven, 2002). 
 
Spot Cutting.   The gel plugs containing the proteins of interest are excised from the 
gel after image analysis.  Cutting spots from a gel manually is a very tedious job.  
The spots of interest, marked on the gel image printout for further analysis, have to 
be matched to the actual gel and transferred to the correct tube or a microtitre plate.  
Additionally, contamination with exogenous proteins such as skin keratins must be 
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avoided. Robot spot pickers not only increase the speed of the excision process but 
also minimise contact with the gel and consequent keratin contamination from hair, 
skin and dust particles (Lopez, 2000).  
 
Protein Cleavage, proteolysis. In this approach the proteins have been purified, in 
many cases, by 2-D gel electrophoresis and are either enzymatically or chemically 
cleaved.  An aliquot of the peptide mixture is then analysed by mass spectrometry.  
The proteins are digested either in-gel or after transfer to membranes (PVDF or 
nitrocellulose) with an enzyme or chemical reagent which specifically cleaves at 
certain amino acid residues.  The exact masses of the peptides that result from this 
cleavage are then measured in a mass spectrometer. A commonly used enzyme is 
trypsin that cleaves only at the C-terminal side of arginine or lysine (Wilkins et al, 
1997; Link, 1999).  However, there may be occasions where digestion with an 
alternative enzyme will be advantageous, specifically in the case of post-translational 
modifications, and small proteins, which may have few trypsin cleavage sites 
(Fountoulakis et al, 1997).   
 
Chemical methods of protein cleavage are not commonly used.  When these methods 
are applied, it is often for specific applications where no suitable enzyme is available 
or enzymatic cleavage is not appropriate.  An example is cyanogen bromide cleavage 
of insoluble or membrane proteins.  Cyanogen bromide cleaves specifically at 
methionine residues, often yielding relatively large peptides (Westermeier and 
Naven, 2002). 
 
Mass Spectrometry.  Mass spectrometry is an analytical technique that measures the 
molecular mass of molecules based upon the motion of a charged particle in an 
electric field (Westermeier and Naven, 2002; Link, 1999).  Sample molecules are 
converted into ions in the gas phase and separated according to their mass:charge 
ratio (m/z).  Positive and negatively charged ions can be formed (Westermeier and 
Naven, 2002; Link, 1999).   
 
Biological MS is fast and very sensitive.  The two main lines of technological 
development that have dominated the field to date are based upon two different 
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methods of ionising analytes, matrix-assisted laser desorption ionisation/time of 
flight (MALDI-TOF) MS and electrospray ionisation (ESI) MS (Wilkins et al, 1997).  
Consequently, associated sample preparation procedures are substantially different.  
While ESI is mainly linked to liquid chromatographic instrumentation, MALDI-TOF 
is more suitable for high-throughput approaches and has until recently been better 
suited for large-scale proteomics (Wilkins et al, 1997).  
 
In comparison to other ionisation techniques such as ESI, MALDI tolerates moderate 
buffer and salt concentrations in the analyte mixture and almost exclusively produces 
singly charged ions (Wilkins et al, 1997).  For these reasons it has become the 
preferred ionisation technique for PMF analysis. 
 
1.3.12  Bioinformatics 
To date (June 2006), the complete genome of at least 409 organisms have been 
sequenced. The gene sequence data is available at 
http://www.tigr.org/tdb/mdb/mdbcomple.html.  Comprehensive studies at the 
proteome level have been published for Mycobacterium tuberculosis complex, H. 
pylori, Haemophilus influenzae, Mycoplasma pnuemoniae, Pseudomonas 
aeruginosa, Staphylococcus aureus, and Escherichia coli. 
 
In sequence homology, proteins in the database are theoretically digested with the 
relevant cleavage reagent, generating many hundreds of thousands of theoretical 
peptides resulting in a “virtual fingerprint”.  Each protein of interest under 
investigation is digested to give an actual PMF.    The actual PMF data derived from 
the mass spectrometry experiment is subsequently compared to these “virtual 
fingerprints” and the best theoretical/actual match is retrieved as the possible 
candidate proteins.  
 
Several on-line programs are available to perform this type of search, (including 
MASCOT at www.matrix-science.com, Profound at www.prowl.com; MS-FIT at 
www.prospector.ucsf.edu).  Accuracy, reliability and speed will vary depending on 
the program chosen.  Regardless of which program is used, four user variables are 
important for a PMF search.  These are 
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 peptide mass range;  
 specification of the cleavage agent;  
 error tolerance - the accuracy of mass measurement is determined by the 
calibration, the more accurate the mass spectrometer the greater the 
specificity; and 
 knowledge of amino acid residue modifications likely to be encountered e.g. 
methionine oxidation. 
 
In combination, high resolution and high mass accuracy allow the probable 
identification of proteins present in databases from as few as 3-5 peptides, depending 
on the size of the protein.  However, for this approach to give an unambiguous result, 
≥ 6 peptides of experimentally determined peptide masses should match the 
theoretical masses (Enroth et al, 2000).  The number of matched peptides was 
selected to cover at least 15% of the total amino acid sequence for high molecular 
mass proteins ( 100 kDa) and 60% of low molecular mass proteins ( 30 kDa).    
Low molecular mass proteins have fewer cleavage sites than high Mr proteins 
(Fountoulakis et al, 1998) and as such may result in an increased number of matches 
with other proteins with similar peptide masses, therefore a sequence match of ≥60% 
is required.  In high Mr proteins there is a greater number of peptide masses which 
reduces the probability of matches with other proteins.   
 
Each on-line search engine is capable of searching a variety of databases such as 
NCBI and SWISS-PROT.  However, each database differs in the number of proteins 
it lists.  For example by March 2003, the NCBI database has over 6000 H. pylori 
proteins listed whereas SWISS-PROT has only about 550.  The advantage of 
SWISS-PROT is that its entries are very thoroughly annotated.  However, given that 
a species like H. pylori which has approximately 1600 ORFs a search of SWISS-
PROT alone would mean that many peptide mass fingerprints identities would be 
missed.   
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1.4  Previous Studies versus the Present Study 
1.4.1  Jungblut’s study of H. pylori 
Jungblut et al (2000) was the first group to conduct a comparative 2-DE proteome 
analysis of H. pylori strains.  This study performed a preliminary global comparison 
of proteins from three different strains of H. pylori to identify immunodominant 
antigens and to compare effects of different biological conditions. The Jungblut 
group separated H. pylori (whole cell) proteins extensively by 2-DE gel 
electrophoresis and 152 proteins were identified by mass spectrometry.  The 
resulting 2-DE map is available at http://www.mpiib-berlin.mpg.de/2D-PAGE/.   
Jungblut compared three H. pylori strains, 26695 (a gastritis strain), J99 (a duodenal 
strain) and the ‘Sydney strain’ SS1 (a prominent strain used in animal models).    
Approximately 1800 proteins were resolved on large format 2-DE gels (23 cm x 30 
cm), and proteins were separated over the pI range of 4-10 and the Mr range of 5-150 
kDa and stained with silver. In addition to the comparative analysis of these three 
strains, Jungblut et al (2000) also studied the effects of different pH conditions on 
protein expression of H. pylori strain 26695 and identified the immunodominant 
antigens of this strain.  Strain 26695 was examined after culture in four different 
media at pH 5, 6, 7 and 8 and the proteins were separated using small 2-DE gel (size 
dimensions were not mentioned in the article). 
 
Jungblut’s group found that there was a high degree of proteomic variability between 
the three strains included in their study.  This contrasted with the genomic 
comparison of J99 and 26695 by Alm et al (1999) which indicated that there was a 
high degree of conservation (85%) in genomic organisation and gene order of these 
two strains.  The Jungblut study found that a number of proteins were subject to 
positional pI shifts and identified at least four proteins with amino acid substitutions, 
which affected the pI of these proteins.  These proteins were alkyl hydroperoxide 
reductase, superoxide dismutase, ribosomal protein L7/L12 chaperonin and GroEL. 
 
1.4.2  Enroth’s study of H. pylori 
Enroth et al (2000) was the second group to perform a comparative analysis of H. 
pylori isolates.   The Enroth study set out to determine whether H. pylori isolates 
isolated from three different disease groups could be grouped according to their 
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protein patterns.  This study also searched for disease-specific protein spots, which 
might be useful for H. pylori strain characterisation (protein markers).   Twelve 
different H. pylori isolates from three different patient groups (gastritis, duodenal 
ulceration and adenocarcinoma) were extracted and analysed by 2-D PAGE.  Enroth 
studied the whole cell protein extracts and water extracts of H. pylori isolates by 
intermediate precast gradient 2-DE gels (Bio-Rad Criterion format 110 mm width).  
Proteins were separated over the pI range 4-7 (water extracts) and 3-10 (whole cell 
extracts) and the Mr range of 5-150 kDa.   Enroth’s (2000) study compared twelve 
silver stained gels (i.e. a single gel per strain, four isolates for each disease group) by 
the use of specialised analytical software (BioImage 2-DE analyser version 6.1) and 
through the application of cluster analysis.  Eight spots were identified that were 
absent in certain isolates or significantly different in intensity between isolates. 
 
Cluster analysis of the twelve isolates was conducted by two different methods: i.e. 
average linkage and neighbour joining.  Cluster analysis utilised the number of spots 
matched i.e. qualitative rather than quantitative spot information.  The Enroth (2000) 
study found that some H. pylori isolates might be more associated with a specific 
disease than other isolates but that this may not apply to all disease related isolates. 
 
In addition, this study compared the immunodominant proteins of one 
adenocarcinoma strain and one duodenal ulceration strain through the application of 
large format gels (18 x 18 cm).  
 
The Enroth study found that less than 50 percent of the proteome could be matched 
between any two disease groups.  However, Enroth’s group only visualised 
approximately 600 spots on gels stained by silver.  This number was less than the 
2000 proteins visualised by Jungblut (silver stained gels).  The reason for the 
reduction in the number of proteins visualised was due to the use of small format 2-
DE gels, which would have decreased the spatial resolution of the protein spots.  
This would have resulted in co-migration of many protein spots, which would alter 
quantitative spot information and many spots may appear to be absent or unique 
spots may not have been resolved.   
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1.4.3  Current study of H. pylori 
This current study compares eleven H. pylori isolates isolated from patients with DU, 
GU and NUD as well as GI isolates (NCTC11637 and 26695) through the 
application of proteome analysis and cluster analysis.  Each disease outcome group 
consisted of three isolates except for gastritis that consisted of two isolates.  This 
study aims to determine whether H. pylori isolates can be sorted into disease groups 
according to their protein patterns.  Whole cell protein extracts of H. pylori isolates 
were examined using large format (18.5 cm x 18.5 cm) 2-DE gels using Tris-tricine 
and Tris-glycine buffer systems.  Proteins were separated over the pI range 4-11 and 
the Mr range 5-150 kDa.    
 
The study incorporated a minimum of four gels for each isolate under examination.  
There are 44 gel images included in the comparative image analysis for each 
protocol, with exception of Tris-glycine pH 6-11 which contained 40 gel images.   
An important feature of this study is the application of replicate groups.  Note that 
the Enroth (2000) study did not appear to utilise replicate groups.  It consisted of 
twelve gels: only one for each strain in the comparative analysis.  Neither was it 
apparent from the paper by Jungblut et al (2000) if replicate groups were utilised in 
their study.  There are two important reasons for the use of replicate groups.  The 
first reason is to confirm the validity of spots.  In order to be accepted as valid, the 
current study required that a particular spot should be observable in at least three out 
of four gel images for each replicate group.  The second reason is because of slight 
variation in quantitation due to experimental variables (i.e. loading and staining).  
Because of this, the volume of a given spot is best estimated by averaging results 
from several gel images.  
 
The present study is differs from the previous two studies in a number of ways: 
 compares eleven rather than the three isolates examined by Jungblut et al 
(2000);  
 the current study compares four disease groups;  
 it is the first study to compare gastric ulceration (GU) and non-ulcer 
dyspepsia (NUD); neither of these disease groups has been included in any 
other published study to date (December 2005);  
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 it greatly improves upon the spatial resolution and the number of observable 
proteins studied by Enroth et al (2000);  and 
 in addition, this study separates proteins in a pH range (10-11) which has not 
been previously examined by the other H. pylori comparative proteome 
studies.    
 
1.4.4  Comparisons between H. pylori isolates 
The number of spot matches between gels that may be obtained from a 2-DE 
proteome analysis of H. pylori is dependant on a number of factors.  These include: 
 
1. the number of isolates that are included in the study; 
2. the degree of relationship between the isolates; 
3. the resolution of the proteome maps; and 
4. the staining technique utilised. 
 
Isolates included in this study and their relationship   
Two variables that may affect the percentage of spots matching between isolates are 
the number of isolates that are included in an H. pylori study and the degree of 
relationship between the isolates.  If two isolates cause the same disease it is likely 
that they will share a greater percentage of common proteins (e.g. virulence proteins) 
than isolates associated with dissimilar outcomes.  Conversely, isolates from 
different disease groups might produce a lower percentage of matches due to 
differences in virulence factors. 
 
The current study compares four disease groups.  Three disease groups (GU, NUD 
and DU) consisting of three isolates each and a fourth (GI) containing two isolates.  
This will expand the study that was performed by the Jungblut et al (2000) group, but 
is one isolate short of the number included in the Enroth et al (2000) study.  The 
Jungblut group consisted of two isolates from two different disease groups, duodenal 
ulceration (J99) and gastritis (HP26995), and a third isolate which was the mouse-
adapted H. pylori strain `Sydney strain' SS1 (Lee et al., 1997).  The Enroth group had 
twelve isolates from three different disease groups, gastritis, duodenal ulceration and 
gastric adenocarcinoma. 
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Laboratory history of isolates   
Putative virulence factors of H. pylori include colonisation proteins, such as those 
involved in motility, adhesion and cytotoxocity. A study by Sung et al (2002) 
examined the effect of repeated serial laboratory subculturing of H. pylori.   This 
study found that, following the 64th serial subculturing of strain SS1, adhesion, 
motility and cytotoxicity had all decreased in comparison to the original culture. In 
addition, gastric inflammation produced in a Mongolian gerbil by the final 
subcultured strain was less severe (Sung et al 2002).  Therefore, given that GI1 and 
GI2 are gastritis isolates which have been maintained for a long period in laboratory 
culture it might be argued that these may give different results to those seen in the 
Enroth (Enroth et al, 2000) study.  However, the Microbiology Department at the 
Royal Perth Hospital has strict guidelines to limit the subculturing of H. pylori and 
therefore repeated subculturing is unlikely to be a factor in this study. 
 
Spot resolution   
The resolution of proteins influences the results obtained from any proteome study.   
The greater the spatial resolution (both with respect to pI and Mr) on 2-D gels the 
greater the possibility that slight differences in pI and Mr will be observable.  
However, if the resolution area is not large enough this will result in spots 
comigrating in both the x- and y-dimensions.  Overlapping spots, which may be a 
mixture of two or more proteins, make it difficult to obtain an accurate estimate of 
the quantitative and/or qualitative differences between isolates (Westbrook et al, 
2001).  Increasing the spatial resolution of the protein spots increases the number of 
spots visualised, provides additional data for comparative pattern analysis and 
subsequent protein identification (Gőrg et al, 2004; Westbrook et al, 2001).    The 
quality of comparative pattern analysis is dependent both on the complexity of the 2-
D gel images (e.g. the proteome of human cell lines is more complex compared to 
the comparative simplicity of the H. pylori proteome) and the quality of the program 
that analyses the images (e.g. advanced ProGensis, PDQUEST versus relatively 
unsophisticated freeware such as Flicker (see page 45). 
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The resolution area is also an important factor in the detection of low abundance 
proteins. The proportion of the total protein complement that can be seen on a gel for 
any cell or tissue will depend on the protein copy number per cell, on the quantity of 
material loaded on the gel and on the method of detection (Wilkins et al, 1997).  Low 
abundance proteins are often proteins of great interest, but difficult to detect on 2-D 
gels because more abundant proteins predominate. Abundant proteins (e.g. albumin 
in serum samples) have the appearance of large high-stain-intensity spots.  
Enrichment of specific subcellular fractions for low abundance proteins prior to the 
loading of the sample onto the first dimension will increase the number of detectable 
low-abundance proteins (Langen et al, 2000).   One procedure is sequential 
extraction of proteins from whole cell lysates or subcellular subfractions according to 
their differing solubilities (Molloy et al, 1998).  This is even more effective if 
proteins are then separated with narrow range pH IPG strips. 
 
 
1.5  Aims of the Investigation 
Primary aims of this study  
 To determine whether H. pylori isolates can be sorted into disease groups 
according to their protein patterns. 
 To identify qualitative and quantitative protein differences between the 
disease groups. 
Secondary aim of this study 
 To further expand the number of H. pylori proteins identified in previous 
studies. 
 To gain an insight into the proteins that may be involved in the disease 
groups e.g. virulence factors. 
 
 
 
 
 
 
 
  59 
 
    
 
2.1  Materials 
   
Reagent  Distributor 
   
Acetic acid  BDH Merck Pty Ltd 
  Kilysyth, Victoria, Australia 
   
Acetone  BDH Merck Pty Ltd 
  Kilysyth, Victoria, Australia 
   
Acrylamide 40%  Plus One Pharmacia Biotech 
  Upsala, Sweden 
   
Agarose  Sigma Chemical Co 
  St Louis, USA 
   
Ammonium persulphate  Bio-Rad Laboratories 
  Hercules, CA, USA 
   
Ammonium sulphate  ICN Biomedicals Inc 
  Aurora, Ohio, USA 
   
Ampholytes  Amersham Biosciences 
  Upsala, Sweden 
   
Bis-acrylamide  Bio-Rad Laboratories 
  Hercules, CA, USA 
   
Bromophenol Blue  Sigma Chemical Co 
  St Louis, USA 
   
Campygen plastic pouches  Oxoid Ltd 
  Detroit, MI, USA  
   
Campygen paper sachets  Oxoid Ltd 
  Detroit, MI, USA 
   
3-(3-cholamidoproyl)-  BDH Merck Pty Ltd 
dimethylammonio-1-propane   Kilysyth, Victoria, Australia 
sulfonate   
   
Coomassie Brilliant Blue G250  Bio-Rad Laboratories 
  Hercules, CA, USA 
   
Endonuclease  Sigma Chemical Co 
  St Louis, USA 
   
Filter paper wicks  Bio-rad Laboratories 
  Hercules, CA, USA  
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Reagent  Distributor 
   
Formaldehyde  Sigma Chemical Co 
  St Louis, USA 
   
Glutaraldehyde  Sigma Chemical Co 
  St Louis, USA 
   
Glycine  Bio-Rad Laboratories 
  Hercules, CA, USA 
   
Glycerol AnalaR®   BDH Merck Pty Ltd 
  Kilysyth, Victoria, Australia 
   
HCl  BDH Merck Pty Ltd 
  Kilysyth, Victoria, Australia 
   
Immobilised pH gradient  Pharmacia Biotech 
gel strips  Upsala, Sweden 
   
Isobutanol  BDH Merck Pty Ltd 
  Kilysyth, Victoria, Australia 
   
Lint free tissues  Kimberly Clark 
  Milsons Point, NSW, Australia 
   
Methanol  BDH Merck Pty Ltd 
  Kilysyth, Victoria, Australia 
   
Orange G  ICN Biomedicals Inc 
  Aurora, Ohio, USA 
   
Paraffin Liquid  Ramprie Laboratories 
  Welshpool, WA, Australia 
   
Parafilm  Pechiney Plastic Packaging 
  Chicago, IL, USA 
   
Piperazine diacylamide  Bio-Rad Laboratories 
  Hercules, CA, USA 
   
Pyroneg  Diversey 
  Sydney, Australia 
   
Phosphoric acid 85%  BDH Laboratory Supplies 
  Poole, England 
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Reagent  Distributor 
   
Polyethylene glycol  Sigma Chemical Co 
  St Louis, USA 
   
Ready-cast gradient gels  Bio-rad Laboratories 
  Hercules, CA, USA  
   
Sulfobetaine 3-10  Sigma Chemical Co 
  St Louis, USA 
   
SDS  Bio-Rad Laboratories 
  Hercules, CA, USA 
   
SDS Mr standards  Sigma Chemical Co 
  St Louis, USA 
   
Silver nitrate  BDH Merck Pty Ltd 
AnalaR   Kilysyth, Victoria, Australia 
   
Sodium acetate anhydrous  BDH Merck Pty Ltd 
AnalaR®   Kilysyth, Victoria, Australia 
   
Sodium azide  ICN Biomedicals Inc 
  Aurora, Ohio, USA 
   
Sodium carbonate anhydrous   BDH Merck Pty Ltd 
AnalaR®   Kilysyth, Victoria, Australia 
   
Sodium chloride  BDH Merck Pty Ltd 
  Kilysyth, Victoria, Australia 
   
Sodium glutamate  BDH Merck Pty Ltd 
  Kilysyth, Victoria, Australia 
   
Sodium thiosulphate  BDH Merck Pty Ltd 
  Kilysyth, Victoria, Australia 
   
Tributyl phosphine  ICN Biomedicals Inc 
  Aurora, Ohio, USA 
   
N,N,N’,N’-  Plus One Pharmacia Biotech 
Tetramethylethylenediamine  Upsala, Sweden 
(TEMED)   
   
Thiourea  BDH Merck Pty Ltd 
  Kilysyth, Victoria, Australia 
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Reagent  Distributor 
   
   
Tris(hydroxymethyl)-  Sigma Chemical Co 
aminoethane  St Louis, USA 
   
N,tris(hydroxymethyl)-methyl  BDH Merck Pty Ltd 
glycine  Kilysyth, Victoria, Australia 
   
Urea AnalaR®   BDH Merck Pty Ltd 
  Kilysyth, Victoria, Australia 
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2.2 List of Solutions 
All buffers solutions and agars were prepared using Millique high pure water. All 
buffers and solutions were freshly made for day of use, except were specified.   
 
Tris-glycine Buffer Systems (section 2.8.3) 
This buffer system was utilised for proteins>20 kDa. 
 
5x Tris/HCl Buffer  
1.9 M Tris 
Adjusted to pH 8.8 with conc. HCl 
Stored at -20OC 
 
PDA-Acrylamide Stock Solution (2.5% crosslinker) 
200 ml 40 % acrylamide solution  
51 mM Piperazine diacrylamide 
 
Anode Electrode Buffer 
0.75 M Tris 
0.77 mM Sodium azide 
Adjusted to pH 8.8 with conc. HCl 
 
Cathode Electrode Buffer 
0.19 M Glycine 
3.5 mM SDS 
 
10% Polyacrylamide Gel  
27 ml H2O 
10 ml 5x Tris/HCl Buffer 
12.5 ml Acrylamide stock solution 
250 l 10% Ammonium persulphate 
10 l Sodium thiosulphate 
16.5 l TEMED 
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Tris-tricine Buffer System (section 2.8.4) 
This buffer system was utilised for proteins < 20 kDa 
 
5x Gel buffer  
2.9 M Tris 
8.7 mM SDS 
Adjusted to pH 8.45 with conc. HCl 
Stored at -20OC 
 
Cathode buffer 
0.1 M Tricine 
3.5 mM SDS 
Adjusted to pH 8.3 with Tris 
 
Anode buffer 
0.19 M Glycine 
3.5 mM SDS 
Adjusted to pH 8.3 with Tris 
 
Bis-Acrylamide gel Stock solution (6% crosslinker)  
200 mls Acrylamide (40%) 
0.16 M Bis 
 
8.5% Polyacrylamide Gel  
9 ml 5x Gel Buffer 
12 ml Acrylamide stock solution 
3.1 M Urea  
400 l 10% Ammonium persulphate 
400 l Sodium thiosulphate 
59 l TEMED 
H2O make up to 50 ml 
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Miscellaneous Solutions 
Multiple surfactant solution (5 ml) (section 2.5) 
40 mM Tris 
33 mM CHAPS 
65 mM SB3-10 
2 M Thiourea 
5 M Urea 
3.2 ml H2O 
25 l Ampholytes 
2.5 l TBP 
5 l Orange Dye 
 
SDS Equilibration solution (100 ml) (section 2.8.5) 
20% 5x Tris/HCl Buffer (v/v) 
6.7% Acrylamide (40%) (v/v) 
20% Glycerol (v/v) 
6 M Urea 
70 mM SDS 
125 l TBP 
make up to 100 ml with H2O 
 
1x Tris/HCl Buffer 
5 ml 5x Tris/HCl Buffer 
20 ml H2O 
 
Stains for Gels (section 2.10) 
Colloidal Coomassie G250 Stain 
1.3 M Ammonium sulphate 
3.6% Phosphoric acid (85%) (v/v) 
34% Methanol (v/v) 
1.17 mM CBB G-250 
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Silver Staining Solutions 
Fixer 1 
40 % Methanol (v/v) 
10% Acetic acid (v/v) 
 
Fixer 2 
0.55 M Sodium acetate 
2 g Sodium thiosulphate 
30% Methanol (v/v) 
0.5% Glutaraldehyde (v/v) 
 
Silver 
11.8 mM Silver nitrate 
 
Developer 
0.28 M Sodium carbonate anhydrous 
0.1% Formaldehyde (v/v) 
 
Stop 
5 % Acetic acid (v/v) 
 
Drying Solution (section 2.11) 
50% Methanol (v/v) 
2.5 mM PEG 
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Table 2.1  Isolates included in this study 
 
 
Isolate Characteristics                            Patient Characteristics 
Strain Metronidazole Biopsy Disease Outcome Age Gender Country of
Year   origin 
GU1 NA 2001 Gastric Ulceration 50 Male UK 
GU2 Resistant 1997 Gastric Ulceration 58 Female UK 
GU3 Resistant 1997 Gastric Ulceration 46 Male Yugoslavia
      
DU1 Resistant 1996 Duodenal Ulcerations 33 Male UK 
DU2 Sensitive 1997 Duodenal Ulcerations 66 Male Australia 
DU3 Sensitive 1997 Duodenal Ulcerations 32 Male Hong Kong
      
NUD1 Sensitive 1997 Non-Ulcer Dyspepsia 47 Male Australia 
NUD2 Sensitive 1997 Non-Ulcer Dyspepsia 64 Female UK 
NUD3 Resistant 1996 Non-Ulcer Dyspepsia 64 Female Australia 
      
GI1 NA 1982 Gastritis NA NA Australia 
GI2 NA 1985 Gastritis NA NA UK 
 
 
NA = Not Available 
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2.3  Bacterial isolates 
There were eleven H. pylori isolates in this study. They were obtained from the 
Department Microbiology and Infectious Diseases at Royal Perth Hospital.  All of 
these isolates had originally been obtained from patient biopsies. The isolates are 
divided into four disease outcomes: GU, DU, NUD and GI (see Table 2.1).  Each 
disease outcome group consisted of three isolates except for gastritis that consisted of 
two isolates. The nine isolates comprising the GU, DU and NUD groups were 
obtained recently and had been subjected to minimal passage in the laboratory.  The 
other two isolates NCTC11637 (GI1) and 26695 (GI2) had been extensively 
cultivated in the laboratory since 1982 (Goodwin and Worsley, 1993a and 1993b) 
and 1987 (Alm et al, 1999), respectively.  A large proportion of the proteomes of 
isolates NCTC11637 (Lock et al, 2001) and 26695 (Jungblut et al, 2000; Myung-Je 
et al, 2001), had already been evaluated, therefore these were used as reference 
isolates.  None of the other nine isolates had previously been analysed in any 
published study. 
 
 
2.4  Culture conditions 
Each H. pylori stock culture was prepared by inoculation into 1 ml of horse blood 
and then stored at –80oC.   When H. pylori isolates were required, subcultures were 
obtained from the stocks by inoculation onto gonococcal heated blood (chocolate) 
agar plates. Bacterial cells were incubated at 37oC in Campygen plastic pouches and 
Campygen paper sachets for a period of three days.  
 
Confluent growth on at least three chocolate agar plates was needed to obtain 
sufficient cell numbers for adequate protein extraction. To achieve confluent growth, 
plates were subcultured at least three times.  For a preparation of whole cell proteins, 
cells were removed from three confluent plates and placed in a vial containing 1 ml 
20% sodium glutamate.  The bacteria were then lyophilised and stored at –80oC.  
Each vial contained about 20 mg of bacterial cells (dried weight). 
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2.5  Sample preparation 
A single sample preparation method starting with 1, 2 or 3 vials was tested. The 
vial(s) of each strain were rehydrated in a total of 3.2 mls of a 0.48% Tris-base 
solution then sonicated for 12 x 60 sec bursts at 50% duty cycle with a power setting 
of 6 using a Branson Sonifier 250 sonicator (Danbury, CT, USA) fitted with a 
microtip probe.  Nine volumes of cold methanol were added to the sonicated sample 
to precipitate the proteins and the material was stored overnight at -80 oC.  Each 
protein sample was placed in 1.5 ml centrifuge tube and centrifuged for 1 hour at 0 
oC at 21,000 g using a Beckman microfuge (Fullerton, CA, USA).  Pellets were air 
dried at room temperature for 40 minutes then resuspended in a combined total of 5 
mls multiple surfactant solution (MSS) and stirred for 1 hour at room temperature.  
In the final 15 minutes, 2 l (250 units per l) of endonuclease was added to each 
tube.  The resuspended sample was centrifuged at 15 oC for 1 hour at 21,000 g, and 
the pellets discarded.  The supernatants were divided into 500 l aliquots and stored 
at -80 oC until required. 
 
 
2.6  Wash-up 
Scrupulously clean glassware and apparatus is essential in electrophoresis as 
contaminants may affect the migration of proteins, the staining of gels and the 
subsequent identification of proteins. 
 
Glass Plates.  Glass plates were thoroughly scrubbed in deionised water and liquid 
Pyroneg.  All previous traces of polyacrylamide were removed.  Prior to use glass 
plates were washed with a small amount of methanol and wiped clean with low-lint 
tissues. 
 
Glass Gel-Staining Dishes. Following each use, sealable flat glass dishes were 
thoroughly washed using liquid Pyroneg and deionised water. After the majority of 
the stain was removed from the glass dishes, a small amount of methanol was used to 
remove any residual trace of Coomassie G250.  Finally, glass dishes were carefully 
wiped with low-lint tissues.  
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2.7  First dimension electrophoresis (isoelectric focusing) 
IEF was performed using 18 cm IPG strips with pH ranges of either 4.0-7.0 or 6.0-
11.0. Rehydration of strips with sample was performed as follows:  both ends of a 
Sarstedt (Numbrecht, Germany) 2ml disposable plastic pipette were clipped off and 
one end sealed with parafilm.  An IPG strip was placed in the pipette and 500 l of 
protein sample (in MSS) was introduced in such a way as to remain in contact with 
the upper (gel) surface of the strip.  The other end of the pipette was sealed with 
parafilm and strips were left to rehydrate for 24 hours at room temperature.  
 
IEF was performed using a Pharmacia Multiphor II (Pharmacia Biotech, Upsala, 
Sweden) apparatus. After rehydration was completed, strips were placed in the 
channels of an Immoboline dry strip kit (Pharmacia Biotech, Upsala, Sweden) on the 
Multiphor II.   Damp (with H2O) filter paper wicks were placed at the acidic and 
basic ends of the IPG strips, electrodes were placed in contact with the wicks and the 
tray was covered in paraffin oil prior to electrophoresis. Strips were electrophoresed 
using three programmed phases (Lock et al, 2001) for each method.  The first 
method utilised a PowerPac 3000xi (Bio-rad, Hercules, CA, USA) and second 
method a power supply EPS 3501 XL (Amersham-Pharmacia, Upsala, Sweden).   
Initially two alternative methods were investigated. 
 
1st Method  
Phase  Constant  Time   Safety Limit  
        (per six strips) 
1  300 V   2 1/2 hrs  1 mA/1 Watt 
2  1,000V   2 1/2 hrs  1 mA/1 Watt 
3  3,000V   20 hrs   1 mA/1 Watt 
Total Volt hours 63,200  
 
2nd Method  
Phase  Constant  Time   Safety Limit  
(per six strips) 
1  300 V   2 1/2 hrs  1 mA/1 Watt 
2  1,000V   2 1/2 hrs  1 mA/1 Watt 
3  3,500V   21 1/2 hrs  1 mA/1 Watt 
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Total Volt hours 78,450 
 
Generally the current did not exceed 150 A per strip.  After IEF, strips were stored 
at –80oC in a plastic Petri dish sealed with parafilm until required for the second 
dimension separation. 
 
 
2.8  Second dimension electrophoresis (SDS-PAGE) 
This study examined the separation of proteins in the second dimension using two 
different protocols (see Figure 2.1). The first used gradient polyacrylamide gels. The 
second involved homogeneous (single concentration) polyacrylamide gels using two 
different buffer systems, the Tris-glycine buffer system and the Tris-tricine buffer 
system. 
 
2.8.1  Gradient Gels 
Gradient gels have an increasing concentration of acrylamide from top to bottom, for 
example in a 10-20% gradient gel a 10% polyacrylamide solution at the top increases 
to 20% at the bottom of the gel.  With gradient gels, the overall separation interval is 
wider, and the linear relation interval between the logarithm of relative molecular 
mass (Mr) and the migration distance is wider than for homogeneous gels.  Also the 
pore sizes are continuously decreasing (Westermeier and Naven, 2002).  The manual 
preparation of gradient gels is much more time consuming than for homogeneous 
gels, and it is more difficult to obtain reproducible gel properties.  To obtain 
reproducible gradient gels this study utilised commercially available Bio-Rad Ready-
cast (Hercules, CA, USA) gradient gels T 10-16% (T = total polyacrylamide 
concentration). The gradient gels were run at a constant 25 mA per gel for 8 1/2 
hours at 10oC. 
 
2.8.2   Preparation of Homogeneous (Single-Concentration) Gels   
Homogeneous slab gels were prepared manually.  They were poured either using a 
Bio-Rad (Hercules, CA, USA) gel-casting stand (which makes one or two gels per 
stand) or a Bio-Rad Multi-Caster (Hercules, CA, USA) (which makes up to 12 
gels).The glass plates between which the gels were poured consisted of an outer plate  
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Figure 2.1  Second dimension protocols  
Diagrammatic representation of the relationship between the second dimension 
protocols utilised in this study. 
 
T = total polyacrylamide concentration (as weight/vol percentage) 
C = percentage of crosslinker 
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(22 x 20 cm) and smaller inner plate (20 x 20 cm). Plates were separated by 8 mm 
wide Bio-Rad (Hercules, CA, USA) 2-DE gel plate spacers (IPG adaptor kit) with a 
1 mm thickness, and clamped together with Bio-Rad (Hercules, CA, USA) clamps.  
Final gel size was ≈18.5 x 18.4 cm. Where a Bio-Rad Multi-Caster was utilised, 
clamps were applied after the gels had been removed from the casting apparatus and 
prior to 2-DE.  After the polymerisation solution had been poured between the glass 
plates, approximately 1 ml of water-saturated isobutanol was overlaid on the top of 
the polymerisation solution.  This ensured a straight polymerisation line at the top of 
the gel.  Gels were left to undergo initial polymerisation for 45 minutes at room 
temperature. After this, a 1.5 cm gap remained between the top of the glass plates 
and the upper surface of the gel.  The isobutanol overlay was poured off and the gel 
surface was given three quick washes with high purity H2O.  A 1x gel buffer solution 
was poured on top as an overlay and the gels stored at 4oC overnight.   Storage 
overnight allowed for more complete polymerisation of the gels. 
 
2.8.3  Tris-glycine buffer system 
The methods for the separation of proteins by a Tris-glycine buffer system in this 
study are those used by Lock et al (2001). 
 
Buffers. The Cathode Buffer (Tris-glycine) was prepared fresh for each 
electrophoresis run.  The Anode Buffer was a Tris-HCl solution that was re-used for 
a maximum 20 electrophoretic runs. 
 
Gel composition. This study used two formulations of homogeneous (single 
concentration) polyacrylamide gels with piperazine diacrylamide as the crosslinker. 
These formulations were 1) 13%T, 2.5%C (where T = total polyacrylamide 
concentration and C = % of crosslinker), with subsequent electrophoresis at 25 mA 
per gel for 5 1/2 hours, and 2) 10%T, 2.5%C gels at 20 mA per gel for 5 1/2 hours at 
10oC.   The gels of both formulations were electrophoresed until the bromophenol 
blue tracker dye had migrated to the bottom of the gel.  The 13% polyacrylamide 
gels were used to resolve low Mr proteins (7-20 kDa) whereas the 10% 
polyacrylamide gels were used for the optimal resolution of proteins with Mrs  20 
kDa. 
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2.8.4  Tris-tricine buffer system 
Buffers.  The Cathode Buffer (Tris-tricine) was prepared fresh each day.  The Anode 
Buffer was a Tris-glycine buffer that was re-used for a maximum of six 
electrophoretic runs. 
 
Gel composition.  A number of different gel compositions were prepared, based on 
that of Fountoulakis et al (1998).  The Fountoulakis method uses the combination of 
a separating gel and a stacking gel for the separation of proteins. The stacking gel has 
a low concentration (T value) % polyacrylamide.  The pH of the stacking gel is also 
lower than the separating gel (6.9% vs 8.9%). This causes the proteins to run quickly 
through the stacking gel and pile up in front of the stack/separating gel interface.  
This sharpens the protein bands.  Fountoulakis recommended two different 
separating gels for the improved resolution of low Mr proteins. In both cases, the 
crosslinker for these gels was N N’methylenebisacrylamide. 
 
Fountoulakis et al (1998) Procedure with Stacking Gel.  The first formulation of 
the separating gel consisted of a 10.4%T, 6%C containing 3.1 M urea.  The second 
consisted of a 10.4%T, 6%C gel containing 6.2 M urea.  The final separating gel size 
was 16.5 x 18.4 cm.  The stacking gels for both separating gel formulations had a 
composition of 5.4%T, 3%C, without urea, and was 2 cm x 18.5 cm in size.  The gels 
were electrophoresed at 40 mA per gel for 7 1/2 hours at 10oC. 
 
Modified Fountoulakis et al (1998) Procedure without Stacking Gel  This study 
also used a modified Fountoulakis procedure in which the stacking gel was omitted.   
There were two gel formulations utilised.    
 
The first formulation had a lower separating gel T value, 9.5%T and 6%C.  Three 
different urea concentrations were explored, 0 M, 3.1 M and 6.2 M.   Final gel size 
was 18.5 x 18.4 cm.  The 9.5% polyacrylamide gels, without stacking gels were 
electrophoresed at 40 mA per gel for 8 1/2 hours at 10oC 
 
A second formulation of the modified Fountoulakis procedure without a stacking gel 
consisted of a separating gel composition of 8.5%T, 6%C and contained 3.1 M urea.  
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The gels were electrophoresed at 40 mA per gel for 7 hours and 50 minutes at 10oC.  
This procedure was the one finally used in this study for the resolution of proteins 
with Mrs between 7-20 kDa. 
 
2.8.5  Second Dimension Electrophoresis  
Following IEF, and prior to electrophoresis in the second dimension, each IPG strip 
was soaked in 20 mls of SDS equilibration buffer in a plastic Petri dish and shaken 
on a reciprocating platform for 20 minutes at room temperature.  A solution of 0.5% 
agarose, briefly boiled in Cathode Buffer, was poured on top of the polyacrylamide 
gel and the re-equilibrated IPG strip was slid through the agarose solution into 
position on top of the gel.  The agarose was left to set for five minutes.  All gels were 
electrophoresed in the second dimension using a Protean II (Bio-Rad, Hercules, CA, 
USA) apparatus and a 1000 kV Bio-Rad power pack (Hercules, CA, USA).  The 
conditions which were dependent on the gel formulation (see sections 2.8.3 and 
2.8.4).  Cathode Buffer was freshly made for each electrophoresis run. 
 
2.8.6  After 2D-PAGE   
After the electrophoresis run was completed, the gels were removed and placed into 
a staining solution in Pyrex glass dishes with lids.  Two types of stain were utilised in 
this study, Coomassie Brilliant Blue Colloidal G250 and silver nitrate. (See Section 
2.10)  
 
 
2.9  Mr and pI 
2-D SDS-PAGE standards (Bio-Rad, Hercules, CA, USA) were used for estimating 
molecular masses and isoelectric points of sample spots in the gel. Three calibration 
2-DE gels were run for each isolate, using the following samples: 
 
A. 25 l 2-D SDS-PAGE standards alone (this sample was only electrophoresed 
once); 
B. 15 l 2-D SDS-PAGE standards plus 10 l bacterial protein sample ; and 
C. 25 l bacterial protein sample alone. 
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The first dimension was electrophoresed using pI 3-10 IPG strips (see section 2.7).  
The second dimension used the Tris-Tricine buffer system (see section 2.8.4).  Spots 
were visualised by staining with silver nitrate (see section 2.10).   In order to 
determine the pI and Mr of all the protein spots in a 2-DE gel the known values for a 
few spots need to be entered into PDQUEST (Bio-rad, Hercules, CA, USA).   With 
this data PDQUEST can calculate the pI and Mr for all the protein spots.  In order to 
do this a 2-DE gel was electrophoresed which consisted of standards of known pI 
and Mr.   A second 2-DE gel was performed which contained both standards and 
isolate protein sample.   A third gel with only isolate protein sample was run to assist 
in the determination of which protein spots would be utilised as landmark proteins.  
The known values of the standards was entered into PDQUEST and all three 2-DE 
gel types were compared.  Gel type A and B were matched by utilising the protein 
standards as points of reference (landmarks).   By comparing Gel type A and B 
landmark proteins spots were identified that were seen in the same corresponding 
position for all isolates.   PDQUEST was then able to calculate the Mr and pIs for all 
the spots seen in Gel type C. 
 
Landmark spots were used to set reference positions to compensate for slight 
positional differences of corresponding spots on different images due to gel 
distortion. These landmark spots are used by the program to align and position 
matchset gel images for matching.  Spots may be selected as landmark spots if they 
are well resolved and present in all members of the matchset in corresponding 
locations.  They are particularly valuable if selected at the edges of the image, if 
isolated from other spots or if located in or near regions of high spot concentrations. 
A minimum of 20 landmarks were distributed throughout each Standard Image.  
 
Matching is the process by which the analytical software program identifies spots in 
one or more gel images that are found in identical locations to some of those on the 
Standard Image.  This identification may be performed by auto-matching or manual 
matching of the protein spots. 
 
Manual matching is used if a legitimate spot is present in corresponding positions 
on one or more images but is not matched to the Standard Image by automatic 
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matching.  The spot is selected in the Standard Image and its corresponding position 
is highlighted in all the images of the matchset.  If this spot is also located in other 
images, it may then be selected there and matched.  
 
Auto-matching is the process by which the PDQUEST program automatically 
matches spots in a number of gel images to those on the Standard Image. The 
program’s algorithm matches spots between images by warping them to a common 
standard by reference to landmarks. 
 
Image Warping is a function that deforms images; all positions in one image plane 
are mapped to positions in another plane.  It is used to bring two or more images into 
alignment (Gustafsson et al, 2002). 
 
A Matchset is a set of gel images that has been grouped together for the purpose of 
qualitative and quantitative comparison.  Spots on one image can be compared to 
spots on every other image in the matchset. 
 
There are two types of matchsets: 1) level one matchsets (see Figure 2.2A) and 2) 
level two matchsets (see Figure 2.2B).  A level one matchset is created directly from 
gel image files.  It may contain some or all of the gel images of a given experiment.  
A level two matchset is created from the Standard Images of a number of level one 
matchsets. 
 
A Gel Image File is a fully processed image file of a gel.  This file is a duplicate of 
the original scan and is utilised in the matchset so it can be edited without losing any 
of the information contained in the original scan image (PDQUEST Manual). 
 
A Standard Image is a composite image that contains all the spots present in all the 
gel images in a particular matchset.  The starting point for generating a Standard 
Image is to enter all the spots detected into the Reference Image. 
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A Reference Image for a matchset is the gel image chosen as the best representative 
of all the images in that matchset, i.e. it contains the greatest number of well-resolved 
spots.  
 
 
2.10  2-DE Gel Staining 
 
Colloidal Coomassie G250 stain (Neuhoff et al, 1988; Lock et al, 2001)  This was 
prepared at least 24 hours ahead of use.  CBB G250 was dissolved in 50 mls of 
methanol and stirred at approximately 50oC for 20 minutes.  The ammonium 
sulphate, remaining methanol, phosphoric acid and high purity H2O were placed in a 
beaker and stirred at approximately 80oC until the ammonium sulphate was 
completely dissolved.  The CBB G250 solution was then added to the ammonium 
sulphate solution and stirred for the next 24 hours.  Immediately prior to use it was 
left stirring at approximately 80OC for four hours.  Following gel electrophoresis, 
each gel slab was stained in 300 mls of the CBB G250 suspension.   Gels were 
shaken at room temperature for 24 hours then the CBB G250 suspension was poured 
off and the gels were placed in a 1% acetic acid solution at room temperature for 8 
hours during which the 1% acetic acid solution was replaced twice in the first two 
hours.  Gels could then be stored in a 1% acetic acid solution in either glass trays or 
press-seal plastic bags. 
 
Silver nitrate staining of gels.  It was especially important that high purity water ( 
18 M/cm) was utilised at all steps of silver nitrate staining and that the glass dishes 
were thoroughly cleaned.  Gels were stained in Pyrex glass dishes, with lids, at room 
temperature. Each gel was soaked in Fixer 1 for at least one hour, and then placed in 
Fixer 2 for 1 hour.  The gel was then given four 15-minute washes with H2O and 
then placed in silver nitrate stain for 45-60 minutes.  The silver nitrate was poured 
off and the gel was given two quick rinses in H2O, then a three-minute wash in H2O.  
The gel was then transferred to a second dish containing the Developer and shaken 
until the majority of spots appeared to have developed.   The Developer was then 
poured off and Stop Solution added.  The gel was left in the Stop Solution for 5 
minutes then washed twice in H2O.  For storage, prior to scanning, the gel was 
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placed in a 1% acetic acid solution.  In this solution the gels could be either stored in 
glass dishes or in press-seal plastic bags. 
 
 
2.11  Gel Drying 
Gels could be dried for long-term storage.  Gel drying was performed after the gels 
had been scanned (see section 2.12.1). The gel was soaked in the Drying Solution for 
five hours.  Two sheets of cellophane were cut to a size 2 cm larger than the gel and 
then soaked with the gel in the last hour.  Gels were dried using a Bio-Rad (Hercules, 
CA, USA) Drying apparatus set to linear temperature ramping, at 55oC for 9 1/2 
hours.  
 
 
2.12  Image Analysis 
The comparative analysis software utilised in this study was PDQUEST version 
6.2.  PDQUEST is a specialised software package for the analysis and databasing of 
2-DE gel images.  The steps involved in image analysis include scanning, spot 
detection, spot editing, matching, formation of replicate groups, normalisation and 
comparison. 
 
Replicate Groups.  A replicate group is a set of gels that is prepared from the same 
protein sample using the same protocol where a protocol refers to the specific 
electrophoresis conditions that were used to separate proteins in a particular Mr and 
pI range.   
 
There are two reasons for the formation of replicate groups.  The first is to determine 
the validity of spots.  In order to be accepted as valid, this study required that a 
particular spot must be observable in at least three out of four gel images for each 
replicate group. In addition, slight variations in quantitation values needed to be 
adjusted, due to variables such as loading and staining.  The volume of a given spot 
is best estimated by averaging results from several gel images. 
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2.12.1  Scanning 
Gels were imaged by a Bio-Rad (Hercules, CA, USA) Scanning Densitometer GS-
700 using Multianalyst software version 1.02. Gels were placed on a neutral-density 
diffuser plate prior to scanning by the densitometer.  The following scanning 
parameters were used for all gels within this study:   
 
Light source  Red (electronic filter) for Coomassie G250 
stained gels. Greyscale for silver nitrate 
stained gels. 
 
Bits per pixel     8  
 
Resolution     150 dpi 
 
Mode     Transmission 
Optical filter    Neutral- density diffuser plate 
 
Using these parameters file sizes were usually  1.4 Mb. 
 
2.12.2  Automated spot detection 
Images were subjected to automatic spot detection with the Automatic Spot Wizard 
feature using the following parameters: 
 
The faintest spot was selected (this spot was different for each isolate).  This set the 
minimum intensity threshold for spot detection.  Next, the smallest spot was selected.  
This set minimum spot size. It usually consisted of a high molecular mass protein 
seen in a corresponding position for all isolates.  The smallest spot was not 
necessarily the faintest spot.  The largest spot was then selected on the gel image. 
The radius of the largest spot is used in the program methodology to determine 
background subtraction and level of streak removal required.  Background 
subtraction involved selecting a background region of the image, which contained no 
spots or streaks.  This step set the threshold that was required to differentiate between 
the spot and background. The gel image files usually displayed streaks in areas of 
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high spot concentration and at the edge of the gel image.  Streaks were removed from 
the image by selecting the remove vertical and horizontal streak option. Filtering 
methods were left at the default settings for all gel images. 
 
2.12.3 Spot editing 
Gaussian Spot.  PDQUEST uses Gaussian modelling to create “idealised” spot 
boundaries.  A Gaussian spot is a precise three-dimensional representation of a 
scanned spot.  Gaussian curves are fitted to the scanned spot in the X, Y and Z 
dimensions, where X and Y represent co-ordinates on the 2-D gel and the Z axis 
represents spot volume.  Additional modelling is then performed to create the final 
Gaussian spot (PDQUEST Manual). 
 
After spot detection was completed a processed gel image file and Gaussian gel spot 
image file was generated by the PDQUEST software.  These image files were 
utilised in matchsets at a later point. 
 
Parameters are set in order to obtain the maximum detection of spots. However, this 
usually results in a number of artifactual spots.  Therefore the next step involves 
manual spot editing.   
 
The majority of spot editing involves erasure of spots.  These are often clustered 
around the edges of the gel and are easily removed as groups.  Other artifactual spots 
such as air bubbles or streaks that are not deleted by the automated detection steps 
are individually deleted. 
 
Additionally some spots of low intensity or partially merged spots may be missed by 
the automatic spot detection algorithm. These spots are manually added to gel spot 
files prior to file matching.   
 
Gel Spot File contains a synthetic image with Gaussian representation of the spots in 
the Gel Image File (PDQUEST Manual). At least 6 successive Gaussian spot 
approximations are required to generate the Gel Spot File. 
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2.12.4 Matchsets 
Four replicate gels were electrophoresed for each isolate.   A replicate group (which 
contained the images for these four gels) was formed for each isolate. The protocols 
used in the present study were as follows (see Figure 2.2): 
 
Protocols optimising for low Mr proteins between 7-62 kDa 
 Proteins separated in the first dimension within the pH 4-7 range and in the 
second dimension using the Tris-tricine electrode buffer method. 
 Proteins separated in the first dimension within the pH 6-11 range and in the 
second dimension using the Tris-tricine electrode buffer method. 
 
Protocols optimising for high Mr proteins 62 kDa 
 Proteins separated in the first dimension within the pH 4-7 range and in the 
second dimension using the Tris-glycine electrode buffer method. 
 Proteins separated in the first dimension within the pH 6-11 range and in the 
second dimension using the Tris-glycine electrode buffer method.   
 
 
First Matching Strategies (level one matchsets).  The first matching strategy 
consisted of preparing a level one matchset containing all the gel images in a 
particular protocol.  The level one matchset consisted of 44 gels for each protocol (11 
isolates x 4 gels per strain) excepting Tris-glycine 6-11 gels in which there were 40 
gels (10 isolates x 4 gels per strain).  Due to the limited sample available for the 
eleventh isolate (GI2 - 26695), this sample was not separated by the Tris-glycine 
electrophoresis conditions for the pH range 6-11.  Isolate 26695 (GI2) was included 
in the study near the end and only a limited amount of sample was available.  In 
order to perform comparative proteome analyses a Standard Image needed to be 
created.  
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Figure 2.2  Construction of Matchsets   
A.  Organisation of experiments into a low level matchset. 
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Figure 2.2 Continued   
 
B. Creation of a higher level matchset.   The higher level matchset is made from four lower level 
matchsets, GU (gastric ulceration), DU (duodenal ulceration), and NUD (non-ulcer dyspepsia) 
consisting of three members (isolates) and GI (gastritis) containing only two members.  Each 
member includes four gel images. 
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Firstly, a gel was selected both visually and by PDQUEST as the Reference Image 
for the Standard.  The criteria for this selection were which gel contained 
 
 the largest number of spots as detected by PDQUEST; 
 the least streaks both horizontally and vertically; 
 no warping of gel image; and 
 the best separation of spots both horizontally and vertically. 
 
GU1 was the Reference Image for all matchsets in this study.  See the Appendix for 
examples of all replicate gel images in this study. 
 
The second step involved selecting landmark proteins. A minimum of 20 landmarks 
was selected.  
 
The third step was the placement of replicate gel images files into a replicate group 
(gel images GU1 [1-4] formed replicate group GU1).  
 
The fourth step involved the auto-matching of the Standard Image spots to the 
corresponding spots of all the gel images included in the matchset.  Those proteins 
that could not be auto-matched to the Standard were manually matched if necessary.   
 
After all the protein spots in the Standard had been matched, those spots which 
remained unmatched in the other three replicate images (i.e. spots present in all three 
images) of replicate group GU1 were added to the Standard.   The matchset was then 
auto-matched and manually matched again. 
 
The fifth step was to match spots from the gel image files of GU2 to those in the 
Standard.  Those spots that were located in at least three out of four gel image files of 
this strain’s replicate group were accepted as valid and added to the Standard.  When 
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the spot addition was completed, the spots in the matchset were auto-matched and 
manually matched to the Standard.  
 
The addition, auto-matching and manual matching of protein spots to the Standard 
was repeated for gel images of each replicate group in turn.  The order of spot 
addition to the Standard was GU1 (reference image), GU2, GU3, GI1, NUD1, 
NUD2, NUD3, DU1, DU2 and DU3, G3.   
 
The final Standard Image was representative of all the spots in the matchset.  
 
Second Matching Strategy (level 2 matchsets).  A level two matchset was 
generated from the Standard Images of level one matchsets.  The first step in this 
strategy involved the construction of four level one matchsets, one for each of the 
four disease outcomes (i.e. GU, DU, NUD and GI).  Isolates that were selected as the 
reference images for each disease group matchset were: 
 
Disease Outcome    Reference image 
Gastric ulceration    GU1 
Non-ulcer dyspepsia    NUD1 
Duodenal ulceration    DU2 
Gastritis     GI1 
 
The next step was to place landmarks for each level one matchset.  After this was 
completed, spots from each image in the matchset were auto-matched and then 
manually matched to the Reference Image as described for the first matching 
strategy.  Spots that could not be matched to the initial reference spots in the 
Standard were auto-added to the Standard then auto-matched to the other gels in the 
matchset.  This was repeated until every spot in the matchset was matched to a spot 
in the Standard.  Each completed matchset Standard Image consisted of all the spots 
present in all gel images for each disease outcome.  Replicate groups were formed 
for every level one matchset.   
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After the four level one matchsets were completed, the next step was to use them to 
generate a level two matchset.  To generate a high-level matchset a dialog box was 
opened, but instead of selecting the Matchset type as level one, level two matchset 
was selected.  The program then displayed those level one matchsets that were 
available for inclusion in the level two matchset.  A reference image for the level two 
matchset Standard was selected.  This was generated from the Gastric Ulceration 
matchset. The procedure for matching spots and auto-adding spots in the level two 
matchset was the same as for level one matchsets.   
 
 
2.12.5 Entering Mr and pI Data 
Mr and pI data were entered by using PDQUEST's enter MrpI data tool selecting a 
specific spot then entering the data in a dialog box.  At least 12 reference spots were 
used for each protocol.  The Mr and pI of these sample spots were estimated by 
reference to 2-DE standards (known Mr and pIs: see Section 2.8).  The sample spots 
utilised to enter Mr and pI data were present in corresponding positions for all 
isolates.   The program then used these sample spots as internal references to 
automatically assign Mr and pI to all other spots. 
 
 
2.12.6  Normalisation 
Before isolates were compared for differences in their proteomes (comparative spot 
analysis), the spot volumes of the different gel image files included in the matchset 
were adjusted by normalisation. Normalisation corrects for systematic differences 
due to variable protein loads and staining effectiveness. 
 
The normalisation procedure utilised was Total of All Valid Spots.  In this method, 
the raw volume of each spot in a member gel is divided by the total volume of all the 
spots in that gel that have been included in the Standard. 
 
2.12.7 Analyses 
After replicate groups had been formed, matching completed, and the protein spots 
normalised, analysis sets were set up to compare differences. In the first matchset 
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strategy, analysis sets were constructed for each of the four experimental protocols to 
compare differences between the disease outcome groups of each protocol matchset.  
Each disease outcome group, except gastritis, consisted of three replicate groups – 
one for each isolate.  In level 1 matchsets of the second matchset strategy, analysis 
sets were constructed to compare replicate groups within each disease group’s 
matchset for each experimental protocol.    
 
Quantitative and qualitative spot comparisons were undertaken in this study.  In 
order to compare quantitative or qualitative differences between two disease groups, 
within a level 1 matchset, differences had to be determined and Boolean sets 
constructed for both qualitative and quantitative differences.  The construction of 
analysis sets was the same for both matching strategies. 
 
Quantitative spot comparisons are composed of spots whose quantitation has 
increased or decreased “x” fold (where x is a user-determined value) or whose 
quantitation has changed above or within the fold change factor that was selected. 
 
Qualitative spot comparisons are composed of spots that are present in one gel but 
not in another.  A protein spot could appear to be absent because it is either a low 
copy number protein or the gene is turned off. 
 
An example of a Comparative Quantitative Analysis between two disease 
groups (Figure 2.3). A number of analysis sets were constructed to determine which 
protein spots had a three-fold increase in concentration in the GU disease group 
when compared to the NUD disease group.  The first step was to construct 
quantitative difference sets between each GU replicate group and the NUD replicate 
groups (i.e. GU1vsNUD1, GU1vsNUD2, GU1vsNUD3, GU2vsNUD1, etc).  
Boolean sets were then constructed to determine which protein spots displayed a 
greater than three-fold increase in concentration for all isolates within a disease 
group.  This required the construction of intersecting Boolean sets that were then 
used to construct a Master Boolean set i.e. the intersection of all Analysis sets.  The 
construction of analysis sets was also performed for both qualitative and 
quantitatively conserved proteins. 
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Figure 2.3 Example of Analysis sets  
Representation of the construction of analysis sets to compare differences between two disease 
outcomes in a level 1 matchset.  In this representation GU (gastric ulceration) isolates are compared 
with NUD (non-ulcer dyspepsia) isolates.  This comparison was undertaken using both quantitative 
and qualitative analysis sets. This procedure was used to compare GU vs GI, vs DU vs NUD.  
 
Difference Sets refers to quantitative or qualitative analysis sets. Each Boolean set represents the 
intersection of two other sets.  
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2.12.8  Exporting Matchset Data 
Raw data, generated by PDQUEST, for the spots of each isolate’s image consisted of 
protein spot volume (normalised), Mr and pI and the spot’s number.  The raw data 
was exported into an Excel (MAC version 10) file.  This raw data was then processed 
by SPSS Manual Version 11. 
 
 
2.12.9  Excel merging of overlapping pI and Mr ranges 
Each electrophoresis running condition for separating low Mr and high Mr proteins 
resolved them in two pH ranges pH 4-7 and 6-11, each range had a corresponding 
region of pH 6-7.   In order to obtain a complete pH 4-11 master map of H. pylori 
this pH 6-7 region in both pH ranges needed to be combined.  The spatial resolution 
on the x-axis was greater in the pH 4-7 region in comparison to the 6-11, therefore 
accurate matching of the pH 6-7 region could not be obtained.   Additionally because 
of the increased spatial resolution there was an increase in the spot numbers.  In 
order to obtain the most accurate spot data for a master pH 4-11 gel only the pH 7 
protein spots, from each pH region (4-7 and 6-11) was merged.  The 6-6.99 protein 
spots information was manually deleted from the pH 6-11 gels.  The pH 7 protein 
spots displayed in the 2-DE map were determined by PDQUEST, merged, and then 
the spot volumes were averaged.   This spot volume information was then included in 
the Excel files.   
 
Two different sets of electrophoresis conditions were used to separate proteins in the 
second dimension.  The current warping routines for image analysis programs are 
unable to match corresponding protein spots that have been separated on two 
different logarithmic scales.  Under these circumstances, volume information for best 
spatial resolution and separation of the particular spots under consideration.  Data for 
spots with Mr greater than 62 kDa were taken from the Tris-glycine gels because of 
the improved spatial resolution of these spots on such gels in comparison to those on 
Tris-tricine gels.   Data for spots with Mr below 62 kDa were taken from the Tris-
tricine gels; these protein spots were best resolved in the Tris-tricine gels, especially 
proteins with Mr between 7-20 kDa. 
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2.13  Cluster analysis 
Dendrograms indicating isolate similarities were derived by compiling all the spot 
data for the eleven isolates for each protocol into an Excel file.  Cluster analysis was 
performed using SPSS MAC Version 11 (Chicago, IL, US).  The first step was to 
select the type of classification to be utilised.  In the present case, similarities 
between the isolates were calculated using hierarchical cluster analysis. The 
parameters used were as follows: 
 
Parameter Selected Type 
Variable Spot volume 
Cases Isolates 
Clustered according to  Cases 
  
Statistics  
     Agglomeration schedule Yes 
     Single cluster solution 11 cases 
  
Dendrogram Vertical orientation 
  
Cluster Method Between-groups linkage 
Distance Measure Interval 
      1.  Squared Euclidean distance 
      2.  Euclidean distance 
 Binary    
 Simple matching 
 
Agglomeration schedule.  The results of the cluster analysis are summarised in a 
listing of the cluster numbers (assigned ID number = cluster number) being 
combined at each stage in the cluster analysis (SPSS Manual Version 11). 
 
Single solution.  Displays cluster membership for a single cluster solution with a 
specified number of clusters. 
 
Between-groups clustering.  The distance between two clusters is defined as the 
average of the distances between all (SPSS Manual Version 11). 
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Distance Measure allows a specific distance or similarity measure to be used in 
clustering.  SPSS does not plot actual distances but re-scales them to numbers 
between 0 and 25.  Lines, which are the measure of relatedness on a diagram, join the 
cases to indicate a clustering. Distance can be calculated in two different forms 
Interval and Binary.  Interval measures compare the quantitative values for variables 
(i.e. the volumes for spots) between cases (i.e. isolates) and binary measures compare 
the qualitative values for the variables (i.e. presence/absence only) (SPSS Manual 
Version 11). 
 
 Interval measure involves the similarity measures for interval data (Euclidean 
distance and Squared Euclidean distance). The data utilised were the protein volume 
for each variable (spot) present in each isolate.  Spot quantities ranged from 0-10,000 
(normalised), where 0 represents an absent protein.  The distance between two 
variables was measured using both Squared Euclidean distance and Euclidean 
distance.     
 
Euclidean distance (interval measure) is a dissimilarity measure for continuous 
data. The distance between two items is the square root of the sum of the squared 
differences in values for each variable (SPSS Manual Version 11).  
 
Squared Euclidean distance (interval measure).  A measure of distance between 
pairs of cases. The distance between two cases is the sum of the squared differences 
between the variables of the cases. This dissimilarity measure is used for continuous 
data (SPSS Manual Version 11).  
 
 SPOT NUMBER 1 SPOT NUMBER 2 
GU1 100 90 
NUD1 280 150 
 
 In the above example [values are normalised spot volumes (units determined by a 
computer algorithm)] the squared Euclidean distance is: (280-100)2 + (150-90)2 
which equals 1802 + 602, which equals 36,000.  A disadvantage with this measure is 
that when variables are measured on different scales variables that are measured in 
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larger numbers will contribute more to the computed distance than variables 
measured in smaller numbers. 
 
In binary measure (Squared Euclidean, Pattern difference and Simple matching) the 
spot volume values were converted to either 1 or 0, where 1 represented a spot 
present in a isolate and 0 represented an absent spot. The distance measure used to 
calculate the dissimilarity between isolates was Pattern difference.  Other measures 
in binary measure analysis (Simple matching and squared Euclidean distance) were 
applied in order to determine if the resulting dendrogram changed.   
 
Simple matching (binary measure) is the ratio of matches to the total number of 
values. Equal weight is given to matches and non-matches (SPSS Manual Version 
11). 
 
 
2.14  Peptide mass fingerprinting 
 
2.14.1  Spot Excision    
The majority of proteins of interest selected for mass spectrometry analysis were 
high-intensity spots (with the exception of 20 low-abundance proteins).  The more 
intensely stained a spot the higher the protein amount, which enhances the possibility 
of protein identification by mass spectrometry.  
 
The person performing the excision was gowned, gloved and masked, and hair was 
covered with a paper cap in order to help minimise keratin contamination of the gel.  
Protein spots were excised from the gel by hand with scalpels (Paragon, Sheffield, 
England).  The scalpel blade was flamed between each excision in order to burn off 
any fragments of gel that might carry over. Each spot was transferred into a 1.5 ml 
centrifuge tube (Sarstedt, Numbrecht, Germany).  The majority of spots excised were 
from the corresponding positions of at least two isolates (see Table 2.2).  Exceptions 
were spots 1-96 which were positionally conserved reference spots from strain 
NCTC11637.    
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Table 2.2  Proteins excised.   
Except where indicated all proteins were searched at 50 ppm and 1 missed cleavage. 
 
 Spot excision  Spot excision 
Spot ID Isolates Spot ID Isolates 
1 GI1 42 GI1 
2 GI1 43 GI1 
3 GI1 44 GI1 
4 GI1 45 GI1, DU2 
5 GI1 46 GI1, DU2 
6 GI1 47 GI1, DU2 
7 GI1 48 GI1, DU2 
8 GI1 49 GI1, DU2 
9 GI1 50 GI1 
10 GI1 57 GI1, GU1, GU2 
11 GI1 52 GI1, DU2 
12 GI1 53 GI1 
13 GI1 54 GI1 
14 GI1 55 GI1 
15 GI1 56 GI1, DU2 
16 GI1 57 GI1 
17 GI1 58 GI1 
18 GI1 59 GI1 
19 GI1 60 GI1, DU2 
20 GI1 61 GI1, DU2 
21 GI1 62 GI1, DU2 
22 GI1 63 GI1 
23 GI1 64 GI1, DU2 
24 GI1 65 GI1, DU2 
25 GI1 66 GI1 
26 GI1 67 GI1, DU2 
27 GI1 68 GI1, DU2 
28 GI1 69 GI1 
29 GI1 70 GI1 
30 GI1 71 GI1, DU2 
31 GI1 72 GI1, DU2 
32 GI1 73 GI1, DU2 
33 GI1 74 GI1, DU2† 
34 GI1 75 GI1 
35 GI1 76 GI1, DU2 
36 GI1 77 GI1 
37 GI1 78 GI1, DU2‡ 
38 GI1 79 GI1 
39 GI1 80 GI1, DU2 
40 GI1 81 GI1 
41 GI1 82 GI1, DU2 
§ Not Identified 
† 60 ppm  †† 70 ppm ‡ 2 missed cleavages   
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Table 2.2 Continued   
 Spot excision  Spot excision 
Spot ID Isolates Spot ID Isolates 
83 GI1, DU2 125 GI1, DU1, DU3 
84 GI1, DU2 126 GI1 
85 GI1, DU2 127 DU1, NUD2† 
86 GI1, DU2 128 DU2, NUD2† 
87 GI1, DU2 129 DU1, DU2 
88 GI1 130 DU2, DU3 
89 GI1, DU2 131 DU1, DU2, NUD1, NUD3† 
90 GI1 132 DU1, DU3‡ 
91 GI1, DU2 133 NUD3, NUD1, GI1†‡ 
92 GI1, DU2 134 GU1, GU2, NUD2††‡ 
93 GI1 135 DU1, DU2 
94 GI1 136 DU1, DU3 
95 GI1 137 DU1, GI1‡ 
96 GI1 138 NUD3, GU1, GU3 
97 GI1 139 DU1, DU2 
98 GI1 140 GU3, GU2, DU2 
99 GI1, DU2 141 GU3, GU2, GU1 
100 GI1 142 GU1, GU2 
101 GI1 143 NUD2, GI1‡ 
102 GI1, DU2 144 NUD1, NUD2 
104 GI1 145 GU1 NUD2 
105 GU1, GU2, GU3 146 GU1, GU2 
106 GU1, GU2, GU3 147 NUD2, NUD3 
107 GU1, GU2 148 GI1, NUD2, NUD3 
108 GU1, GU2, GU3 149 GI1, GU2, NUD3 
109 GU1, GU3 150 GI1, GU3, DU3 
110 NUD1, NUD2, DU1, DU3 151 GI1, DU2, NUD3 
111 NUD1, NUD3, DU2 152 GI1, DU2, NUD1 
112 NUD1, NUD3, DU2 153 GU1, NUD1 
113 DU1, NUD3 154 GI1, GU1, NUD1 
114 NUD3, DU1 155 GI1, GU1, GU2 
115 NUD1, NUD3 156 GI1, GU2, GU3 
116 NUD2, NUD3 157 GI1, GU2, DU3 
117 NUD1, NUD2 158 GI1, GU1, NUD3 
118 GU1, DU2 159 GI1, GU2, DU1 
119 GU2, DU1 160 GI1, GU1, NUD2 
120 GU1, NUD1 161 GI1, GU2, NUD1 
121 GU2, NUD3†‡ 162 GU1, NUD3 
122 GU1, NUD2 163 GU1, NUD2 
123 DU1, DU2† 164 GU1, NUD1 
124 DU2, DU3 165 GU2, NUD3 
 
§ Not Identified 
† 60 ppm  †† 70 ppm ‡ 2 missed cleavages   
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Positionally conserved refers to protein spots that are found in corresponding 
positions for all isolates included in the study.  Positionally conserved spots consist 
of two subsets 1) spots which vary by less than a factor of three or more 
(quantitatively conserved) and 2) spots which vary in volume by a factor of three or 
more. 
 
Mass spectrometry data was generated by either the Australian Proteome Analysis 
Facility (APAF) (Lock et al, 2001) or Proteomics International (Perth, Western 
Australia).   
 
2.14.2 The Australian Proteomics Facility (Lock et al, 2001) Procedure  
In-gel protein digests.  Gel pieces that had been stained with Coomassie G250 were 
washed for 1 hour in 60%, 0.05 M ammonium bicarbonate in 40% acetonitrile.  After 
washing, the gel pieces were dried under vacuum to allow maximum adsorption of 
the trypsin digest solution.  Gel pieces were rehydrated in 15l of trypsin digest 
solution (12.5 g/ml of trypsin solution containing 0.05 M ammonium bicarbonate) 
and incubated for 45 min at 4oC.  Unabsorbed trypsin solution was removed with a 
micropipette and the gel pieces further incubated overnight at 37C.  Ten l of 100% 
acetonitrile containing 1% trifluoroacetic (TFA) acid was added to the digest 
solution, and incubated at 25 C for 20 min. The extraction was repeated and pooled 
extracts were dried under vacuum to concentrate the samples to 1-2 l final volume.  
 
Mass spectrometry.  Samples were analysed in a Perseptive Biosystems Voyager-
DE STR MALDI-TOF mass spectrometer.  A nitrogen laser tuned to 337 nm was 
used to irradiate the sample in 0.5 l of matrix (-cyano-4-hydroxycinnamic acid 
[HCCA]), 10 mg/ml in 70% acetonitrile and 0.1% TFA) spotted onto the MALDI 
target plate.  A manual, internal calibration was performed using the 8421.51- and 
2211.11-Da peaks generated by the autolysis of trypsin.  Peaks were assigned 
manually using the GRAMS software package (Perseptive Biosystems, Framingham 
MA, USA).  Spectra were acquired in reflectron mode using a mass range of 800-
3898 Da. 
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The peptide masses were then used to search the SWISS-PROT and TrEMBL 
databases using the program PeptIdent.  Peptide mass fingerprint database results 
were searched by APAF. 
 
2.14.3  The Proteomics International Procedure 
In-gel protein digests.  Gel pieces that had been stained with Coomassie G250 were 
washed for 45 minutes at 37C with 50l of 25 mM ammonium bicarbonate in 50% 
acetonitrile. After washing, the gel pieces were dried under vacuum to allow 
maximum adsorption of the trypsin digest solution. Ten l of trypsin digest solution 
(12.5 g/ml of trypsin solution containing 25 mM ammonium bicarbonate) was 
added to each gel piece and the material incubated overnight at 37 C. Ten l of 
100% acetonitrile containing 1% TFA was added to the digest solution and this was 
incubated at 25 C for 20 min. The extraction was repeated and pooled extracts were 
dried under vacuum to concentrate the samples to 1-2l final volume.  
 
Mass spectrometry.  One l of each sample was diluted 1/10 with matrix HCCA 
(10 mg/ml in 50% acetonitrile and 1% TFA) and 1l spotted onto the MALDI target 
plate.  Samples were analysed with MALDI-TOF mass spectrometry (Voyager-DE 
PRO, Applied Biosystems Inc, Chicago, IL, USA). The instrument was calibrated 
with SIGMA peptide standards (bradykinin fragment 1-7, angiotensin II (human), 
P14R (synthetic peptide) and adrenocorticotropic hormone (ACTH) fragment 18-39 
(human) using HCCA as matrix. The following settings* were used. 
 
Mode of operation: reflector 
Extraction mode: delayed 
Polarity: positive 
Accelerating voltage: 20000 V 
Grid voltage: 76% 
Mirror voltage ratio: 1.12 
Grid wire: 0.01% 
Extraction delay time: 100 nsec 
Mass range: 600-5000 Da  
Number of laser shots: 50/spectrum 
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Laser intensity: 2200 
 
*Note these settings were unknown for the APAF data because it was lost due to 
their computer failure. 
 
The peptide masses were then used to search the NCBI and SWISSPROT databases 
using the MS-FIT program. 
 
 
2.15  Protein identification 
There are a number of peptide mass fingerprint on-line programs that may be utilised 
to search databases.   Each on-line program provides access to a range of different 
databases and parameters affecting the search result.  In the present study, several on-
line programs were examined to determine which program should be used.  The main 
parameters of interest were: 1) the type and number of accessible databases; 2) the 
ability to specify a particular species search, in particular H. pylori; 3) the ability to 
modify the Mr and pI ranges to be searched and; 4) the ability to specify particular 
protein modifications (including post-translational modifications).  Species filtering 
is a procedure that restricts database searches to a user-designated species or 
collection of species.  In the present study only proteins specific for H. pylori were 
initially of interest. 
 
Eventually the peptide mass fingerprints were analysed by using the on-line Protein 
Prospector program MS-FIT developed by the UCSF Mass Spectrometry Faculty 
(http://prospector.ucsf.edu/ucsfhtml4.0/msfit.htm). Both the NCBI and SWISS-
PROT databases (http://www.ncbi.nih.gov/Entrez/ and http://us.expasy.org/ 
sprot/sprot-top.html, respectively) were searched for protein identification. 
 
Monoisotopic peptide masses were used to search the database, allowing an observed 
molecular mass range of Mr  15%, a peptide mass accuracy of 50 ppm, and one 
partial tryptic cleavage.  The pI range selected was 3-11. Pyroglutamic acid 
modification of N-terminal glutamine, oxidation of methionine and acrylamide 
modification of cysteine were considered. In order to obtain strong matches, this 
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study searched for protein identities with six or more matching peptides (default is 
four).  Protein identification was confirmed by analysing spots obtained from the 
corresponding positions of at least two isolates. 
 
 
If proteins were not identified using the above parameters, the parameters of partial 
cleavage and/or peptide mass accuracy were extended (see Table 2.2 page 96 for 
parameters for each spot identified).  When the extension of these parameters did not 
result in protein identification, species filtering was removed.  Peptide mass 
fingerprints that resulted in a no hit answer with peptide mass accuracies of 50-100 
ppm were reanalysed to confirm the result. 
 
Possible post-translational modification of proteins was searched using MS-FIT and 
FindMod at http://us.expasy.org/tools/findmod/. 
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3.1  First dimension protein separation (isoelectric focusing) 
Two previously published studies of H. pylori employed broad-range IPG strips (pH 
3-10) (Lock et al, 2001; Jungblut et al, 2000) and were subsequently able to resolve 
381 proteins (Coomassie stained) and 1800 proteins (silver stained) respectively.  In 
addition, both studies found that, in comparison to other organisms, such as 
Mycobacterium tuberculosis, basic proteins were dominant in the H. pylori 2-DE 
patterns.  Jungblut et al (2000) stated that more than 70% of the predicted proteins 
had a pI 7.  This figure was somewhat higher than the actual observed 2-DE pIs of 
basic proteins in the present study that found that only 47% of the proteins had a 
pI7.   
 
Broad range strips do not have the spatial resolution of narrower range strips, which 
often results in two or more proteins comigrating.  In order to improve the spatial 
resolution and thereby increase the number of observable proteins, proteins in the 
present study were separated in two overlapping pH ranges 4-7 and 6-11 (Pharmacia, 
Upsala).   
 
3.2   Separation of proteins in the second dimension (SDS-PAGE) 
3.2.1   Gradient gels 
In the early stages of the project H. pylori proteins were separated in the second 
dimension using commercially pre-cast polyacrylamide gels [Bio-Rad Ready-cast 
gradient gels (10-16%)].  The electrophoresis method employed Tris-glycine 
electrode buffer.  The proteins were poorly resolved by these gradient gels.   
Problems consisted of slow migration of proteins, distortion of protein patterns, and 
insensitivity to silver staining. 
 
Slow migration of proteins  
Homogeneous (single concentration) 10% polyacrylamide gels prepared in this 
laboratory have an appropriate electrophoresis time of about 5 hours at 25 mA 
(constant current) per gel. Under these conditions, tracker dye, bromophenol blue 
(BPB), migrates to the bottom of the gel, and protein migrates across the whole area 
of the gel. Bio-rad instruction with the precast gradient gels recommended 16 mA 
per gel for 30 min, then 24 mA per gel for 4 hrs 40 min. When these conditions were 
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used, the BPB tracker reached the bottom of the slab as expected.  However, when 
the gel was stained with Coomassie G250, the proteins had migrated only about half 
way down the slab and the bottom half was blank. During the gradient gel run, 
voltages of about 500V were observed for a setting of 25 mA per gel, whereas 10% 
polyacrylamide gels have voltages of approximately 380-400V at the same setting. 
 
Distortion of protein patterns   
In order to increase the distance of protein migration on gradient gels, the 
electrophoresis time was lengthened.   After 8 hours at 25 mA per gel, the protein 
pattern was still well resolved but still only covered about two thirds of the gel (the 
BPB tracker had migrated off the gel). When the electrophoresis time was extended 
for longer than 8 hours the protein patterns became highly distorted and not only was 
there considerable streaking but also “reverse smiling” (see Figure 3.1),  an effect 
caused because there is a faster migration rate of proteins at the edges of the gel than 
in the centre. 
 
Insensitivity to silver staining   
Under the standard electrophoresis conditions used in this laboratory, silver is about 
20 times more sensitive than Coomassie G250 and produces low background 
staining. When the precast gradient gels were utilised, good results were still 
obtained with G250, but the silver staining sensitivity was reduced. In fact, silver and 
G250 had comparable sensitivity (Figure 3.1). In order to improve the number of 
protein spots visualised the development time was extended.  This did not improve 
the total number of proteins visualised and resulted in extremely high background 
staining.  Silver staining, however, is not a suitable method for comparisons of 
different proteomes because it produces variable proteomes.  This variability is the 
result of an operator determined stopping point in the development of the stain.  The 
proteome needs to be reproducible in order to obtain accurate quantitative and 
qualitative comparisons, therefore no further silver stain methods were examined. 
 
3.2.2   Crosslinkers 
Two different crosslinkers were used in this study.  The polyacrylamide gels 
electrophoresed with a Tris-glycine buffer system utilised piperazine diacrylamide 
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(PDA) as a crosslinker whereas gels electrophoresed with a Tris-tricine buffer system 
utilised N N’methylenebisacrylamide (Bis).  The Tris-tricine buffer system gels were 
run according to a modified Fountoulakis et al (1998) system using crosslinker at a 
concentration of 6%.  However, PDA is a more expensive crosslinker compared to 
Bis, which made it more economical to use Bis under these running conditions.  
However, when Bis was utilised at lower crosslinker percentages (10%T 2.5%C) this 
resulted in a greater swelling of the gels. When the gels were swollen this made it 
impossible to fit the whole gel onto the densitometer scanning plate.  Therefore PDA 
was utilised in the resolution of proteins separated on the 10%T 2.5%C gel. 
 
3.2.3   Running Conditions 
Electrophoretic Conditions   
Fast separations of proteins on large gels, within a few hours instead of overnight, 
resulted in spots that were less diffuse compared to those from overnight runs.  This 
was particularly noticeable for Coomassie stained gels.  Diffuse spots reduce the 
enzyme efficiency during in-gel digestion (Westermeier and Naven, 2002).  For this 
reason Coomassie stained gels, in particular those to be utilised for later mass 
spectrometry analysis, were never run overnight.  Instead, they were electrophoresed 
for 5 1/2 hours for Tris-glycine gels and 7 1/2 hours for Tris-tricine gels.  The current 
applied did not exceed 25 mA for Tris-glycine gels and 45 mA for Tris-tricine gels.  
If these settings were exceeded this resulted in vertically distorted protein spots.  
This may also have been due to uneven increases in the gel temperature generated by 
the high current. 
 
3.2.4   Tris-glycine electrode buffer gels 
The Tris-glycine buffer system is the conventional method for the separation of 
proteins in the second dimension.  It provides excellent resolution for proteins with 
Mr  15 kDa. 
 
The method by Jungblut et al (2000) and Enroth et al (2000) recommended a 
separation gel consisting of a 13% T, 2.5% C for the resolution of the entire 
proteome of H. pylori, (Mr 5-150 kDa), while a study by Lock (2001) indicated 
excellent resolution of proteins  20 kDa on a 10% T 2.5% C.  These studies 
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separated the proteins using the Tris-glycine electrode buffer system.  In the current 
study, the separation of H. pylori proteins was examined according to both of these 
methods, the first for the resolution of low molecular mass (Mr) proteins and the 
second for the resolution of proteins  20 kDa.   
 
Electrophoresis of proteins on 13% polyacrylamide gels using the Tris-glycine 
method (Jungblut et al, 2000; Enroth et al; 2000) achieved poor spot resolution of 
proteins with Mr below 20 kDa (see Figure 3.2).  These protein spots were poorly 
reproducible which would present problems in comparative proteome analysis, 
especially in the image analysis portion of the project.  Proteins with Mr  20 kDa 
displayed distinctive smearing and streaking.   In addition, staining with Coomassie 
G250 resulted in poor staining of these proteins.  The difficulties in the resolution 
and visualisation of low Mr proteins in this study was overcome by replacing the 
Tris-glycine buffer system with a Tris-tricine buffer system (see Results section 
3.2.5).  
 
The Tris-glycine method utilising 10% T and 2.5% C provided excellent resolution 
of proteins with Mr between 20-150 kDa and improved the spatial resolution of high 
Mr proteins  62 kDa (Figure 3.3).  The Mr region between 62-150 kDa displayed 
146 proteins and resolved an additional 66 protein spots that could not be efficiently 
separated by the Tris-tricine buffer system.   See section 3.3.1 for spot detection of 
proteins within the 62-150 kDa region. 
  
3.2.5   Tris-tricine electrode buffer gel  
Proteins with Mrs below 20 kDa are poorly resolved using a Tris-glycine Cathode 
Buffer because they co-migrate with the SDS front and this leads to streaking, 
smearing and poor staining by Coomassie stains (Westermeir and Naven, 2002).  A 
number of methods have been designed to examine low Mr proteins/peptides. The 
one used in this study was a method proposed by Fountoulakis et al (1998). 
 
Gel composition  
The method of Fountoulakis et al (1998) recommended a resolving gel consisting of 
a 10.4% T, 6% C containing either 3.1 M urea or 6.2 M urea.  This improved the 
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resolution of proteins with molecular masses between 10-20 kDa and molecular 
masses < 10 kDa respectively.   See Table 3.2 and Figure 2.1 for a summary of all 
the different separating gels and stacking gels %T%C compositions and buffer 
systems utilised in this study. 
 
This study initially separated proteins according to this method.  The gels were 
electrophoresed for 8 1/2 hours at 25 mA per gel.  Proteins separated at T 10.4% only 
migrated 2/3 of the way down the length of the gel. Although the low Mr proteins 
were well resolved, those with Mr > 20 kDa had poor spatial resolution and were 
compacted and streaked.  In the next series of experiments, the T value was reduced 
to 9.5% and the C value kept constant.  While this T concentration efficiently 
resolved the H.  pylori proteins with Mr 7-62 kDa, there was approximately an 8 cm 
gap at the bottom.  A T value of 8.5% was then selected and this provided the best 
separation of proteins in the y-axis. 
 
The next parameter examined was the concentration of urea in the polyacrylamide 
solution.  As previously noted, Fountoulakis et al (1998) recommended two urea 
concentrations, 3.1 M (for proteins Mr 10-20 kDa) and 6.2 M (for proteins Mr <10 
kDa).  In addition, the present study examined the effect of using a polyacrylamide 
solution without urea.  The gels with the lower urea concentration yielded an 
improved resolution of protein spots in the Mr 8-20 kDa region.  Gels containing 6.2 
M urea showed no improvement in resolution and, in some instances, displayed an 
increase in streaking.  Gels without urea displayed some problems in resolving of 
proteins with Mr < 14 kDa.  These problems included streaking and some poorer 
visualisation of low Mr proteins when using CBB G250.  The smallest Mr proteins 
that could be visualised when using the Tris-tricine technique, 3.1 M or 6.2 M urea 
concentration, had an observable Mr of about 7 kDa. 
 
Stacking gel  
A number of 2-DE studies that had previously examined methods to improve 
resolution of low molecular mass proteins in proteome analysis utilised a stacking 
gel (Fountoulakis et al, 1998; Kruft et al, 2001).  A stacking gel, which has a lower T 
concentration and crosslinking C concentration than the resolving gel, is employed to 
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stack proteins together and prevent their aggregation prior to entry into the resolving 
gel. However, for 2-DE (in spite of previous studies [Fountoulakis et al, 1998; Kruft 
et al, 2001]) the stacking gel is not required, because the proteins are already pre-
separated by isoelectric focusing and therefore do not aggregate prior to entry into 
the resolving gel.   
 
Omitting the stacking gel resolved a few technical, issues these being: 1) problems 
with reproducibility, the stacking gel did not consistently present a straight 
polymerisation line for each gel; 2) proteins get caught between the stacking gel and 
resolving gel and; 3) reduction in additional time-consuming steps in the preparation 
of two different gel types.  In addition, removal of the stacking gel increased the area 
for resolving proteins.  Therefore the final homogeneous Tris-tricine gel formulation 
of 8.5% T 6%C that was utilised in this study contained 3.1 M urea without the 
stacking gel.  This improved the resolution of proteins in the second dimension.  
 
 
3.3  Image analysis 
The comparative analysis software utilised in this study was PDQUEST version 
6.2.  For most isolates there were four experimental protocols (see page 80), the 
exception was strain 26695 for which there was no Tris-glycine pH 6-11 protocol.  
Strain 26695 was a late addition to this study and due to insufficient freeze-dried 
sample only three protocols could be completed.   
 
The protocols chosen for strain 26695 were selected based on where the majority of 
proteins were found to be located in other isolates.  The majority of high Mr proteins 
were located in the pH 4-7 region and for this reason improved resolution and 
separation of proteins in this region was essential and required separation by the Tris-
glycine buffer system (See results section 3.2.4).  For resolution of high Mr proteins 
(> 65 kDa) in the pH 6-11 region there was little difference in the protein patterns 
between the two buffer systems, therefore the Tris-tricine buffer system was utilised.  
The Tris-tricine buffer system meant that the proteins in the range 7-150 kDa could 
be compared between all isolates.   See Appendix figures A/1-A.22 for examples of 
Tris-Tricine gels utilised for comparison of H. pylori strains. 
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Therefore, there were 44 gel images included in the comparative image analysis for 
each protocol, with the exception of Tris-glycine pH 6-11 which consisted of 40 gel 
images. 
 
3.3.1  Spot detection  
The number of proteins detected within a region or the entirety of each gel was 
determined by PDQUEST, some manual detection was required.  Through this 
method the number of proteins within the Mr 62 – 150kDa for both Tris-Tricine and 
Tris-Glycine gels could be determined.  After spot detection and spot editing an 
average of 1168 spots were detected (Table 3.1, Figure 3.4) in the patterns for each 
of the eleven isolates (stained by Coomassie G250) included in this study.  Figure 3.4 
provides a visual display of an increase in the number of spots by silver nitrate.  An 
additional 350-400 proteins were visualised by silver nitrate.  Forty seven percent of 
the proteins were basic (pIs range 7-11) and the majority of high molecular mass 
proteins ( 70 kDa) were found to be situated in the pH 4-7 region.     
 
3.3.2  Matchset strategies    
Image analysis can be conducted at two levels, level 1 matchset (comparing original 
images from the disease groups) and the level 2 matchset (comparison of Standards 
from disease groups).    Both of these strategies were examined to identify the better 
procedure for comparative analyses of gel images.   
 
Level one matchset analysis involved the generation of four large matchsets each 
containing all the gels for a specific protocol (Figure 2.2A Methods section).  Level 
two strategy involved the construction of high-level matchsets each of which 
contained four level one matchsets (one for each disease group) (Figure 2.2B 
Methods section).  The major factors that differed between the strategies were: 1) the 
types of analyses that could be conducted; 2) the number of Boolean sets that were 
required in order to compare two disease groups; 3) formation of replicate groups; 4) 
use of original spot image files and; 5) reproducibility of spot matching between gel 
members. 
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Boolean sets construction   
The advantage of a level two matchset strategy was that it reduced the amount of 
time required to match and construct analytical Boolean sets for comparison of 
disease groups.  Each level two matchset consisted of four submatchsets (one 
submatchset for each disease group).  Each submatchset functioned as a grouping 
method.  The disadvantage of using the level two strategy for the PDQUEST 
program involved the type of information exported from one matchset standard to the 
higher level standard.  The matchset strategy utilised needed to be able to perform 
both quantitative and qualitative analysis between all the gels in this study.   The 
level two matchset strategy was only able to compare both quantitative and 
qualitative information between strains within a disease group.   All information that 
involved spot volume (quantitative) for each spot in each disease group standard was 
not exported to the H. pylori master standard, this meant that only qualitative 
analysis could be performed between disease groups.  Therefore, both quantitative 
and qualitative analyses within a matchset required the formation of a level one 
matchset strategy.    
 
Types of analyses that could be conducted   
The second matchset strategy made quantitative comparisons between the isolates of 
a particular disease outcome more easily handled.  Quantitative comparisons between 
isolates of a particular disease outcome in the first matching strategy involved the 
complicated construction of quantitative analysis sets coupled with Boolean sets in 
order to compare observable quantitative differences between these isolates (see 
Methods section 2.12.8). 
 
Spot matching reproducibility   
The major advantage of a level one matchset was the reproducibility of spot 
matching between member gels.   A level two matchset strategy compared the 
Standards (gel spot files) of each disease group whereas a level one matchset strategy 
compared the original image files to a computer generated Standard.   Any variability 
in the positioning of the spot centres in the Standards may result in incorrect 
matching of spots at the second level of the level two matchset.  Because level one 
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matchsets utilised original image files it was visually easier to determine computer 
errors in matching.   
 
The construction of high-level matchsets had a number of difficulties that could not 
be resolved by the PDQUEST algorithms currently available.  Therefore, it was 
determined that the better method for comparative analysis between all the isolates 
was the construction of a large level one matchset (i.e. first matching strategy) which 
contained all the original images for each protocol.   
 
3.3.3  Proteome reproducibility within replicate groups 
A replicate group was formed for each isolate within each protocol. Each replicate 
group consisted of four gels.  In order for a spot to be accepted as valid, this study 
required that it should be observable in at least three out of four of the gel images for 
each replicate group.  Within the region 9-70 kDa and within pIs 4.25-6.8, variations 
in the patterns between the replicate group gel images for each isolate were only 
slight.  They often involved very low abundance proteins that were poorly resolved 
(diffuse appearance). Outside of these ranges there was greater variation observed 
between replicate gel images, largely because of effects on the gel edges.     
 
Differences at the edges of gels included:  
1) distortions at the right edge for pI 4-7 and left edge for pI 6-11 (see Figure 
3.3);  
2) variability of proteins visible on the bottom edge of the gel.  Some proteins 
just visible on the bottom edge of some gels had migrated off the bottom of 
other gels and;   
3) overcrowding of very high Mrs, 70 – 150 kDa, proteins towards the top of 
gels in some replicate groups (see Figure 3.3). 
  
Excluding spots in these categories, the average number of proteins that were 
observed in only a single gel image of a replicate group was generally about 3/1168 
(or approximately  0.2%) of the total visualised proteome for each isolate. 
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After normalisation of the gel images, no significant variation in spot volume was 
observed between the replicate images for specific isolates.  Protein spots were 
considered to have a significant difference if the spot volume varied by a factor of 
more than three.   
 
The determination that a spot was significantly different if the spot volume varied by 
a factor of more than three was user determined.  Less than 124 spots varied by a 
factor of greater than five, of these only twelve were differently expressed between 
disease groups.  A factor of greater than two generated over 242 differently 
expressed protein spots, therefore a factor of greater than three was selected as being 
significantly different.  
 
3.3.4  Gel pattern comparisons between and  within groups  
Differences between the isolates within a particular disease group were established 
by comparing one isolate’s replicate group to that of another both qualitatively and 
quantitatively.   
 
Location of the majority of protein differences 
Comparative analyses between disease groups and isolates revealed that the majority 
of protein spot differences were located within the pI range 4-7 and the Mr range 20-
62 kDa.  Protein spots in the pH range 6-11 were observed to have a greater 
percentage of positional conservation than within pH 4-7.  
 
Qualitative comparison of proteomes  
Qualitative analysis indicated that there was a greater percentage of matching spots 
between isolates within each particular disease group than there was between isolates 
from different disease groups.  Matches between all three isolates within a disease 
group were 68% (GU), 68% (NUD) and 67% (DU) (see Table 3.2).  Gastritis, which 
only consisted of two isolates for the disease group, obtained a 78% match between 
the two expression maps.  For any two isolates within a group their proteomes 
matched by 76-77% (Table 3.3).   Comparison of all the isolates in the study showed 
that those from other groups gave lower match percentages.  For example, GU1 and 
GU2 were 77% similar whereas if DU1/DU2 DU3 patterns were matched to GU1 
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patterns the matches were only 67-69%.   This varied depending on the isolate.  
Some isolates were more closely related to the GU isolates than were others (see 
Table 3.3). 
 
Quantitative comparisons of proteomes 
A quantitative comparison was also performed for all four groups.  Quantitative 
analysis indicated that there was a greater percentage of matching spots between 
isolates within a particular disease group when compared to those isolates from other 
disease groups.  Matches between all three isolates within a disease group were 48% 
(GU), 48% (NUD), and 46% (DU). However, this was not indicated from the pattern 
comparisons of the gastritis isolates, which had a greater percentage match of its 
proteome with other gastric isolates.    Matching of spots by quantitative analysis 
between any two isolates within a disease group was lower than that by qualitative 
analysis by 20%.  This was due to the exclusion of the conserved portion of the 
proteome that did not vary by a factor greater than three or more.  Comparative 
quantitative analysis showed that 48% of the proteome of isolates within a disease 
outcome could be matched. 
 
3.3.5  Pattern expression comparisons 
A comparison of the eleven different patterns revealed high proteomic variability. 
Whereas 471 spots (40.6% of the proteome) migrated on gels at the same position for 
all isolates, there were at least 14 positional pI shifts (~1.2% of the proteome), 12-
14% differentially unique and 15-17% absent.    
 
The protein spots within the gel patterns for each isolate could be categorized into 
four subdivisions: 
 
1) strain-specific;  
2) positionally conserved spots which were either, 
i) quantitatively conserved (volume varied by less than a factor of three) 
ii) differentially expressed (whose volume varied by a factor of three or 
more);      
3) unique to a specific disease group; and 
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4) absent from a specific disease group. 
 
Strain-specific Spots   
These formed a very small subset of the H. pylori proteome.   Prior to the inclusion 
of the strain 26695 in the study, the strain-specific proteins comprised approximately 
2% of the total.  However, after the addition of strain 26695 the strain-specific spots 
comprised less than 2% of the total protein spots.     
 
The numbers of strain specific proteins for each isolate were GU1 24, GU2 32, 
GU3 30, GI1 30, GI2 22, NUD1 29, NUD2 19, NUD3 22, DU1 33, DU2 26 and 
DU3 22. 
 
Positionally Conserved Protein Patterns  
Comparison of the protein expression maps of the eleven isolates revealed that 471 
spots (40.6%) were found in corresponding positions on gels (Table 3.3).   
Comparative quantitative analyses between all the isolates revealed differences that 
could be further categorised into three subgroups  
 
1) quantitatively conserved spots whose volume varied by less than a factor of 
three.  These were 25% of the H. pylori proteome (291 spots); 
2) protein spots which quantitatively differed by a factor of more than three: 
were 12% of the proteome (142 spots).  While certain proteins were specific 
to particular disease groups others were shared with another disease group 
and; 
3) Protein spots that differed quantitatively but were not specific to any disease 
group were 3 % of the proteome (35 spots). 
 
Unique and Absent Proteins 
The present study was concerned with determining which proteins were specific for a 
disease outcome.   Each disease outcome group consisted of three isolates, with the 
exception of GI (two isolates).  The initial approach was to examine all possible 
three-isolate subsets (C114 =164) from the total 11 isolates.  For proteins to be 
classified as unique to a particular disease group they should only be found within 
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the particular three-isolate subset forming that disease group, and should be absent 
from all others.   Furthermore, it was predicted that the three three-isolate subsets 
having the largest number of uniquely shared spots should correspond to the three 
disease groups.  One hundred and sixty one of the three-isolate subsets included five 
or fewer such spots (see Table 3.4).  The three-isolate subsets that contained the 
largest number of unique spots were indeed found to be those that corresponded to 
the three disease specific groups.  It was found that the GU subset had 58 unique 
proteins the NUD 54 and the DU 55 (Table 3.6).   
 
GI was the only disease group that consisted of two isolates, both of which had been 
examined by previous researchers (GI1 [Lock et al, 2001] and GI2 [Jungblut et al, 
2000].  Therefore, to determine if there were any possible unique GI proteins, the 
two-isolate subsets were also examined (C112 = 55 subsets). Fifty four of the two-
isolate subsets contained six or fewer spots (summarised in Table 3.5).    It was 
found that the largest number of unique proteins in a two-isolate subset was found in 
the GI group (54 proteins) (summarised in Table 3.6).     
 
The present study was also concerned with determining which proteins were 
specifically absent for only one disease outcome.   In this case, the initial approach 
was to examine all possible eight-isolate subsets.  For proteins to be classified as 
specifically absent from a particular three-isolate isolate subset (C114=164 such 
subsets) the proteins should not only be absent from the subsets but also be present in 
all the remaining isolates.   It was predicted that the eight-isolate subsets, which had 
the largest number of absent spots would correspond to the three disease groups.  
One hundred and sixty one of the eight-isolate subsets contained four spots or fewer 
(see Table 3.7).  The eight-isolate subsets with the largest number of absent spots 
were indeed found to be those that belonged to the three disease specific groups.  
These were GU (39 proteins), NUD (44 proteins), and DU (38 proteins) (summarised 
in Table 3.6). 
 
For analysis of GI proteins, nine-isolate subsets were examined.  It was found that 
the largest number of specifically absent proteins in a nine-isolate subset was that 
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found in the Gastritis group(C119= 55 subsets and 34 proteins) (see Tables 3.8 and 
3.7). 
 
Standard image utilised to represent significant differences 
The standard image is a representation of all the spots located in all the images 
within a disease group.  A reference gel was used to generate the standard image and 
therefore all initial spots had the appearance of the reference image.  The reference 
gel did not contain all the spots within the disease group, therefore spots from 
another strain’s representative image needed to be added to the standard if it was not 
located on the reference strain’s image.   All additional spots added from other 
images in a matchset were also similar to its corresponding spot.   
 
For a spot to be considered unique to a disease group it had to be in images of all 
three strains within the disease group.  The spots in the standard image also included 
those that were located only in one or two strains of the disease group.  This meant 
that visual comparisons of each disease group’s standard images might reveal a false 
unique spot.    
 
In order for a protein spot to be quantitatively significant it had to have a spot 
intensity greater than three fold for all three strains in a matchset.   Since all initial 
spots in the standard image was based on the reference image this did not necessarily 
mean that the other images included in the matchset had the same appearance or spot 
intensity.   See the appendix for examples of gels utilised in matchsets.  Reference 
images were; 
 
 GU group – Figure A.1 and Figure A.12, 
 NUD group – Figure A.4 and Figure A.15, 
 DU group – Figure A.7 and FigureA.18, 
 GI group – Figure A.10 and Figure A.21. 
 
This study generated two types of standard images the first image standard based on 
the level one strategy and the second based on the level two strategy.  The level two 
strategy standards were used to display significant differences between disease 
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groups.  The level one strategy standard is representative of all spots for all eleven 
strains and was utilised for analysis.   If the level one strategy standard image was 
used it would have been impossible to observe unique and absent protein spots for 
each disease groups because all spots would have been represented.   Therefore the 
level two matchset strategy standard images were utilised to display the differences 
between disease groups and the actual comparisons were performed using the level 
one matchset strategy. 
 
 
3.4  Cluster analysis of protein patterns 
Cluster analysis was based on PDQUEST pattern match results (including 
normalised spot volume, Mr and pI).   Dendrograms were derived using two methods 
(see Figure 3.5).  The first method used the quantitative data (normalised spot 
volume) obtained from image analysis, while the second used the qualitative 
information (normalised spots absent or present).    In dendrogram A, which was 
derived from quantitative data, it was observed that isolates could be sorted into two 
major clusters i.e. gastric (including GU, NUD, and GI isolates) and duodenal (DU 
isolates) (Figure 3.5, Table 3.9).  In dendrogram B, in which clusters were based on 
qualitative data (proteins absent or present), isolates were divided into four 
subclusters: GU, GI, NUD, and DU.  The first three subclusters belonged to the 
gastric major cluster and the final subcluster of DU isolates formed the duodenal 
major cluster (Table 3.9).  Therefore, both dendrograms indicated that isolates fell 
within two major clusters: gastric and duodenal.   
 
 
3.5 Protein Identification 
The Coomassie spots generated by 2-DE using the IPG strip of pH 4.0–7.0 and 6.0–
11.0 were numbered, excised, and destained, followed by in-gel digestion using 
trypsin for peptide fingerprinting. The mass of the resulting peptide mixtures was 
measured by MALDI-TOF-MS.  Mass spectrometric analysis of proteins spots was 
largely conducted on specifically unique/specifically absent proteins and those spots 
that differed in volume by a factor greater than three.  Specifically absent in this case 
is determined by the presence of the protein at a particular x/y position in a gel for 
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eight/nine isolates but not for the other two/three isolates.  The spots that were 
excised from at least two different isolates within a disease group from the same 
position on gels.  For example if a specifically absent GU protein was examined this 
would require excision of the spot from the same site from GI1, NUD3 and DU1.   
Spectrometric analysis on specifically unique proteins was conducted on spots 
excised from the same site from two different isolates within the same disease group.  
For quantitative differences (by a factor greater than three) spots were excised from 
at least two isolates, each isolate had to belong to a different disease outcome.   
These spots were found in the same 2-DE gel location for all isolates.  Two hundred 
and forty spots were analysed in this project (see Table 2.2 for spots excised).  From 
these 240 spots, 181 protein spots were identified in this study and nine spots 
included in this study were also identified in a previous study conducted in this 
laboratory.  Fifty spots returned a “no match” in the database searches.   
 
The present study found a similar degree of high proteomic diversity to that indicated 
by past H. pylori comparative studies (Jungblut et al, 2000; Enroth et al, 2000) with 
only approximately 40% of the proteome being positionally conserved on 2-D gels.  
The 190 proteins identified by the comparative study fall into the following 
categories 1) conserved between all isolates (96 protein spots); 2) proteins that 
differed quantitatively by a factor of three between groups (24 protein spots); 3) 
proteins unique to and specifically absent from particular groups (42 protein spots) 
(see Table 3.10 for a list of tables and figures), 4) Flagellin proteins (8 protein spots); 
and 5)  protein spots that may have positional pI shifts that varied from a pI of 0.5-1 
were also identified (20 protein spots).  Positional pI shifts refers to spots that shift 
on the x-axis (i.e. pI shift) with no detectable shift on the y-axis (Mr conserved).  
Four protein spots that had pI shifts were previously identified by Jungblut et al 
(2000). These were ribosomal protein L7/L12, GroEL, superoxide dismutase (Sod) 
and alkyl hydroperoxide reductase.  Another three protein spots were identified in 
this study that also appeared to have positional pI shifts.  These proteins were 
fructose bi-phosphatase, DNA-directed RNA  subunit, and neutrophil activating 
protein (Figure 3.13 and Table 3.16).  Several proteins initially believed to be disease 
specific proteins were selected for comparison and analysed by MALDI-TOF.  On 
subsequent identification, these spots were found either to have a positional shift or 
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to be isoforms in a serial charge train.  Serial charge trains are protein isoforms that 
appear as a train of spots, usually horizontal, that differ in pI and/or Mr.  These may 
indicate post-translational modifications such as glycosylation or phosphorylation. 
 
Protein differences between the four disease groups, GU, DU, NUD and GI belonged 
to five categories (classifications in NCBI database).  These categories are proteins 
that are involved in: 
  
 metabolism;  
 cellular processes and signalling;  
 information processing; 
 pathogenesis and; 
 poorly characterised or unknown proteins   
 
Forty eight percent of the spots identified in this study were located in the poorly 
characterised and unknown proteins.  The other 52% of proteins had been 
categorised.  However, many of the functions of these proteins are still poorly 
understood. 
 
Many of the differences between isolates were located in the categories of 
metabolism and cellular processes and signalling.  The differences in the proteins 
between the GU group and the other groups was mainly in the category of 
metabolism.  These differences included thioredoxin reductase (GU absent spot 
number 121 [Table 3.14]), thioredoxin (GU up-regulated spot numbers 157 and 158 
[Table 3.15]), an iron (III) ABC transporter (NUD absent spot number 131 [Table 
3.14]), catalase (KatA) (DU down-regulated spot numbers 140-142 [Table 3.15]) and 
non-haeme iron containing ferritin (Pfr) (DU and NUD down-regulated spot numbers 
145 and 146 [Table 3.15]). 
 
The TrxA/TrxB, KatA and Pfr proteins are essential elements in protection against 
hydrogen peroxide. Other proteins, such as homoserine dehydrogenase, S-
adenosylmethionine synthetase 2, HP0431, and JHP0295 (see spot numbers 151 and 
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144 [Table 3.15]; 136 and 130 [Table 3.14] respectively]) represent differences in 
carbohydrate transport and metabolism.   
 
The FindMod program and The MS-FIT post-translational modification search 
parameter were used to identify probable post-translational modifications.  Nearly 
30% of all proteins identified were post-translationally modified, many with more 
than one modification (Table 3.17).  Many of the spots of interest were identified as 
multiple isoforms, probably resulting from post-translational modifications to the 
primary gene products. 
 
 
3.6  Comparison of theoretical and observed data 
Figures 3.14A and 3.14B show scatter diagrams comparing the observed properties 
of the 190 identified proteins on 2-DE gels with the predicted properties of the 
corresponding theoretical gene products.  In Figure 3.14A, observed Mr is plotted 
against theoretical Mr.  When total data is related to an equivalence plot (slope 1.0, 
passing through the origin), the correlation coefficient is 0.983 which is significant at 
the P<0.01 level.   From the data utilised in this study the majority of proteins 
showed Mrs closely to their actual Mrs (±15%) with eleven outliers.  In Figure 3.14B, 
observed pI values for the 190 identified proteins are plotted against theoretical pI 
values.  The equivalence plot correlation coefficient is 0.96 which was significant at 
the P<0.01 level (Note this figure was probably lower but due to the limits set by the 
SPSS program lower figures were not displayed).  The majority of proteins analysed 
correlated closely to the actual pI (±1.0) however, there were 14 possible outliers.  
The set of proteins predicted for H pylori and the set actually observed both 
displayed a bi-modal distribution with respect to pI (see Figure 3.15).  In each case, 
there were few proteins with pI near 7.0. 
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Figure 3.1  Separation of Proteins by Gradient Gels.  
 H. pylori proteins separated on 10-16% gradient polyacrylamide gels (Bio-Rad Ready-Cast 
gels) with Tris-glycine electrode buffer for 9 hours at 25 mA per gel.  Proteins were stained 
in A) by silver nitrate and in B) by Coomassie Brilliant Blue G250.  Determination of the 
molecular mass and pI of protein spots was obtained from the use of 2-D protein standards. 
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Figure 3.2  Comparison of Low Molecular Mass Separation Techniques.   
A) H. pylori proteins separated in the second dimension on a 13% polyacrylamide slab gel using 2.5% 
PDA crosslinker, Tris-glycine electrode buffer and electrophoresed at 25 mA per gel for 6 hours.  B) 
H. pylori proteins separated in the second dimension on an 8.5% polyacrylamide slab gel using 6% 
Bis crosslinker, Tris-tricine electrode buffer and electrophoresed at 40 mA per gel for 7 1/2 hours.  
Both gels were stained with Coomassie Brilliant Blue G250.  Determination of the molecular mass 
and pI of protein spots was obtained from the use of 2-D protein standards. 
4                                            pI                                      7 
4                                           pI                                       7 
150 
 
 
62 
 
 
 
 
Mr (kDa) 
 
 
 
20 
 
 
 
 
 
 
 
7  
150 
 
62 
 
 
 
 
Mr(kDa) 
 
 
 
20 
 
 
 
 
 
 
7  
Region of poor 
resolution of  low 
MW proteins 
Improved resolution 
of low MW proteins 
A 
B 
  120 
 
    
 
 
 
 
 
 
  
                                                                                               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3  Tris-glycine and Tris-tricine gels 
H. pylori proteins separated by 10% polyacrylamide gels using Tris-glycine buffer system at 20 mA 
per gel (Gels A and B).  Proteins separated by 8.5% polyacrylamide gels using Tris-tricine buffer 
systems (Gels C and D).  Gels A and C were separated in the first dimension by pH 4-7 IPG strips and 
Gels B and D were separated by pH 6-11 IPG strips.  These gels were stained by the modified 
Neuhoff method.  Gels separated by the Tris-glycine system show improved separation of proteins 
between 60-150 kDa.  Determination of the molecular mass and pI of protein spots was obtained 
from the use of 2-D protein standards. 
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Figure 3.4   Silver and Coomassie stained gels   
 
H. pylori GU1 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine electrode buffer 
at 40 mA per gel for 7 1/2 hours.  Proteins in Gel A (pH 4-7 IPG strip) and B (pH 6-11 IPG strip) 
were two overlapping gels stained with silver nitrate.   Proteins in Gels C (pH 4-7 IPG strip) and D 
(pH 6-11 IPG strip) were stained with Coomassie Brilliant Blue G250.   Determination of the 
molecular mass and pI of protein spots was obtained from the use of 2-D protein standards. 
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Figure 3.5  Cluster analysis dendrograms 
Two dendrograms showing the relationships among eleven H. pylori isolates.  Dendrogram A was 
produced by the method of average linkage using quantitative data, and B was produced by the 
method of average linkage using binary data (absent or present information).  On the left side are the 
isolate identities 
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Figure 3.6  Positional and quantitatively conserved proteins 46-150 kDa   
A digitised representation of the protein standard map of GU H. pylori isolates within pH 4-11 
processed by PDQUEST software. The numbered features are those that were harvested for peptide 
mapping.  Spots 1–22 represent the positional and quantitatively conserved proteins that were 
identified.   Spot 153 (see Table 3.15) is a differentially expressed protein its inclusion into this figure 
is due to the improved separation area and the fact that this spot is seen in all the isolates.  Data for 
these numbered spots are collated in Table 3.12. 
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Figure 3.7 Positional and quantitatively conserved proteins 7-46 kDa   
A digitised representation of the GI H. pylori isolates standard map within pH 4-11 processed by PDQUEST software. The features that have been highlighted are those that 
were harvested for peptide mapping.  Spots 23–96 represent the positional and quantitatively conserved proteins that were identified.   Data for these numbered spots are 
collated in Table 3.12. 
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Figure 3.8  Unique (GU) and Absent (DU) spots 
A digitised representation of the GU H. pylori isolates standard map within pH 4-11 processed by PDQUEST software. The features that have been highlighted are those that 
were harvested for peptide mapping.  Spots 97–102 represent the GU specifically unique proteins that were identified.   Spots 127-130 represent the DU absent proteins that 
were identified. Data for these numbered spots are collated in Table 3.13 and 3.14. 
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Figure 3.9  Unique (DU) and Absent (GU) spots 
A digitised representation of the DU H. pylori isolates standard map within pH 4-11 processed by PDQUEST software. The features that have been highlighted are those that 
were harvested for peptide mapping.  Spots 103–109 represent the DU specifically unique proteins that were identified.   Spots 120-126 represent the GU absent proteins that 
were identified. Data for these numbered spots are collated in Table 3.13 and 3.14. 
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Figure 3.10  Unique (GI) and Absent (NUD) spots 
A digitised representation of the GI H. pylori isolates standard map within pH 4-11 processed by PDQUEST software. The features that have been highlighted are those that 
were harvested for peptide mapping.  Spots 117–119 represent the GI specifically unique proteins that were identified.   Spots 131-134 represent the NUD absent proteins that 
were identified. Data for these numbered spots are collated in Table 3.13 and 3.14 
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Figure 3.11  Unique (NUD) and absent GI spots 
A digitised representation of the NUD H. pylori isolates standard map within pH 4-11 processed by PDQUEST software. The features that have been highlighted are those 
that were harvested for peptide mapping.  Spots 110-116 represent the NUD specifically unique proteins that were identified.   Spots 135-138 represent the GI absent proteins 
that were identified. Data for these numbered spots are collated in Table 3.13 and 3.14.   
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Figure 3.12  Proteins that are differentially expressed 
A digitised representation of the GI H. pylori isolates standard map within pH 4-11 processed by PDQUEST software. The features that have been highlighted are those that 
were harvested for peptide mapping.  Spots 139–162 represent the differentially expressed proteins (positionally conserved) that were identified.   Spot 153 is located on 
Figure 3.6.  Changes in spot intensities (factor greater than three) are given using GI isolates as the reference. Data for these numbered spots are collated in Table 3.14
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Figure 3.13 Proteins with pI positional shifts 
 
Figure 3.13A is a digitised representation of the two-dimensional gels of the GI H. pylori isolates that 
represents spots 164, 165 and 173 – 183 within the pH 4-7/7-50 kDa range.  These spots represent proteins 
that appear to be positionally shifted.   The 11 features that have been highlighted are those that were 
identified by peptide mapping.    The GI master map was the reference map used to compare which are the 
protein spots that may have shifted between the proteome maps of the isolates.  Protein spots detected by 
PDQUEST are shown. 
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Figure 3.13B is a digitised representation of the two-dimensional gels of the GI H. pylori isolates that represent spots 166 – 172 within the pH 4-11/50-150 kDa 
range processed by PDQUEST software 
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Figure 3.14 Scatter diagrams  
Comparison of the observed pI and Mw of the 2-DE protein spots that were selected for identification by 
mass spectrometry is compared to the theoretical pI and Mw of the gene products (www.tigr.com).  
Observed pI and Mr of protein spots is determined by the application of 2-DE standards in conjunction 
with the protein sample. (a) Observed Mr versus theoretical Mw.  The solid line is an equivalence plot.  (b) 
Observed pI versus theoretical pI.  Solid line, equivalence plot (slope 1.0).   
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Figure 3.15  pI Distribution of H. pylori proteins 
 
These figures represent the pI of the total observed proteome of H. pylori. 
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Table 3.1 Valid spots 
The number of valid protein spots resolved for each isolate examined in this study  
(Valid spots are defined as those that are located in the same position, on three out of 
four gels in a replicate group). 
 
 
 
 
             Number of Proteins 
Strain Tris-tricine gels Tris-glycine gels 
 CBB G250 Silver CBB G250 
    
GU1 1166 1586 1002 
GU2 1167 1580 1010 
GU3 1163 1560 1006 
DU1 1161 1575 1011 
DU2 1158 1567 1009 
DU3 1167 1584 1014 
NUD1 1152 1601 1007 
NUD2 1156 1576 1012 
NUD3 1156 1577 1016 
GI1 1165 1568 1003 
GI2 1150 NA 1001 
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Table 3.2 Summary of the %T%C and buffer systems 
 
Buffer System Separation gel Stacking gels  Urea 
 T% C% T% C% M 
Tris-Glycine 10 2.5   0  
 13 2.5   0  
      
Tris-Tricine 9 6   3.1  
 9 6   6 
 8.5 6   3.1  
 8.5 6   0  
      
Tris-Tricine with 10.4 6   3.1  
Stacking gel   5.4 3 6  
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Table 3.3 Spot matches between disease groups 
 
 
 
Spots common to two disease outcomes   
 GU NUD DU GI 
GU group 768 (66%) 598 (53%) 596 (50%) 654 (56%) 
NUD group  741 (64%) 569 (48%) 624 (54%) 
DU group   757 (65%) 603 (52%) 
GI group    894 (77%) 
     
Spots common to three disease outcomes    
GU and NUD and DU 502 (43%)   
GU and NUD and GI 540 (47%)   
DU and NUD and GI 522 (44.5%)   
     
Spots common to all isolates 471 (40.6%)   
 
 
 
.    
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Table 3.4  Spot matches between isolates 
The number of protein spots that matched between any two isolates. 
 
 
GU1 
 
GU2 
 
GU3 
 
NUD1 
 
NUD2 
 
NUD3 
 
DU1 
 
DU2 
 
DU3 
 
GI1 
 
GI2 
 
GU1 
1137 
(100%) 
887 
(78%) 
872 
(77%) 
841 
(74%) 
849 
(74%) 
844 
(74%) 
778 
(69%) 
780 
(69%) 
782 
(70%) 
825 
(73%) 
821 
(73%) 
GU2  
1138 
(100% 
872 
(77%) 
830 
(73%) 
838 
(73%) 
845 
(74%) 
767 
(68%) 
769 
(68%) 
776 
(70%) 
812 
(72%) 
803 
(71%) 
GU3   
1127 
(100%) 
815 
(72%) 
837 
(73%) 
818 
(72%) 
775 
(69%) 
773 
(69%) 
776 
(70%) 
807 
(72%) 
800 
(71%) 
NUD1    
1138 
(100%) 
884 
(77%) 
890 
(78%) 
779 
(69%) 
791 
(70%) 
787 
(70%) 
817 
(72%) 
803 
(71%) 
NUD2     
1160 
(100%) 
876 
(76%) 
798 
(70%) 
810 
(70%) 
797 
(70%) 
809 
(71%) 
822 
(72%) 
NUD3      
1146 
(100%) 
821 
(72%) 
803 
(71%) 
797 
(71%) 
804 
(71%) 
807 
(71%) 
DU1       
1120 
(100%) 
882 
(79%) 
848 
(77%) 
795 
(71%) 
785 
(70%) 
DU2        
1125 
(100%) 
855 
(77%) 
797 
(71%) 
787 
(72%) 
DU3         
1097 
(100%) 
759 
(73%) 
821 
(74%) 
GI1          
1120 
(100%) 
875 
(78%) 
GI2           
1124 
(100%) 
 
1
3
7
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Table 3.5  Three isolate comparisons 
The proteome of each isolate was compared with the proteomes of each combination of two 
isolates.  Proteins that were unique to each of the three isolates are shown in the table.   
3-Strain Subsets No of Proteins 3-Strain Subsets 
No of 
Proteins 
GU1/GU2/GU3 58 NUD2/NUD3/DU2 1 
GU1/GU2/NUD1 1 NUD2/NUD3/DU3 0 
GU1/GU2/NUD2 0 NUD2/NUD3/GI1 0 
GU1/GU2/NUD3 2 NUD2/NUD3/GI2 0 
GU1/GU2/DU1 3 DU1/DU2/DU3 55 
GU1/GU2/DU2 2 DU1/DU2/GU1 0 
GU1/GU2/DU3 2 DU1/DU2/GU2 0 
GU1/GU2/GI1 0 DU1/DU2/GU3 0 
GU1/GU2/GI2 1 DU1/DU2/NUD1 2 
GU1/GU3/NUD1 2 DU1/DU2/NUD2 2 
GU1/GU3/NUD2 1 DU1/DU2/NUD3 0 
GU1/GU3/NUD3 0 DU1/DU2/GI1 2 
GU1/GU3/DU1 0 DU1/DU2/GI2 2 
GU1/GU3/DU2 2 DU1/DU3/GU1 0 
GU1/GU3/DU3 0 DU1/DU3/GU2 2 
GU1/GU3/GI1 1 DU1/DU3/GU3 0 
GU1/GU3/GI2 1 DU1/DU3/NUD1 0 
GU2/GU3/NUD1 1 DU1/DU3/NUD2 0 
GU2/GU3/NUD2 1 DU1/DU3/NUD3 1 
GU2/GU3/NUD3 0 DU1/DU3/GI1 0 
GU2/GU3/DU1 1 DU1/DU3/GI2 1 
GU2/GU3/DU2 1 DU2/DU3/GU1 0 
GU2/GU3/DU3 1 DU2/DU3/GU2 3 
GU2/GU3/GI1 1 DU2/DU3/GU3 0 
GU2/GU3/GI2 0 DU2/DU3/NUD1 0 
NUD1/NUD2/NUD3 54 DU2/DU3/NUD2 1 
NUD1/NUD2/GU1 1 DU2/DU3/NUD3 1 
NUD1/NUD2/GU2 2 DU2/DU3/GI1 0 
NUD1/NUD2/GU3 1 DU2/DU3/GI2 0 
NUD1/NUD2/DU1 1 GI1/GI2 55 
NUD1/NUD2/DU2 0 GI1/GI2/GU1 5 
NUD1/NUD2/DU3 1 GI1/GI2/GU2 5 
NUD1/NUD2/GI1 1 GI1/GI2/GU3 3 
NUD1/NUD2/GI2 0 GI1/GI2/NUD1 2 
NUD1/NUD3/GU1 0 GI1/GI2/NUD2 0 
NUD1/NUD3/GU2 2 GI1/GI2/NUD3 1 
NUD1/NUD3/GU3 1 GI1/GI2/DU1 0 
NUD1/NUD3/DU1 0 GI1/GI2/DU2 1 
NUD1/NUD3/DU2 1 GI1/GI2/DU3 1 
NUD1/NUD3/DU3 2 GU1/DU1/NUD1 1 
NUD1/NUD3/GI1 0 GU1/DU1/NUD2 0 
NUD1/NUD3/GI2 1 GU1/DU1/NUD3 0 
NUD2/NUD3/GU1 0 GU1/DU2/NUD1 3 
 
 
 
 
  139 
 
    
 
Table 3.5 Continued 
 
3-Strain Subsets 
No of 
Proteins 3-Strain Subsets 
No of 
Proteins 
NUD2/NUD3/GU2 0 GU1/DU2/NUD2 1 
NUD2/NUD3/GU3 0 GU1/DU2/NUD3 1 
NUD2/NUD3/DU1 0 GU1/DU3/NUD1 1 
GU1/DU3/NUD2 0 GU2/DU3/GI2 0 
GU1/DU3/NUD3 0 GU2/NUD1/GI1 0 
GU2/DU1/NUD1 0 GU2/NUD1/GI2 0 
GU2/DU1/NUD2 1 GU2/NUD2/GI1 0 
GU2/DU1/NUD3 1 GU2/NUD2/GI2 1 
GU2/DU2/NUD1 0 GU2/NUD3/GI1 0 
GU2/DU2/NUD2 0 GU2/NUD3/GI2 0 
GU2/DU2/NUD3 0 GU3/DU1/GI1 0 
GU2/DU3/NUD1 0 GU3/DU1/GI2 0 
GU2/DU3/NUD2 0 GU3/DU2/GI1 0 
GU2/DU3/NUD3 0 GU3/DU2/GI2 0 
GU3/DU1/NUD1 1 GU3/DU3/GI1 1 
GU3/DU1/NUD2 0 GU3/DU3/GI2 0 
GU3/DU1/NUD3 1 GU3/NUD1/GI1 1 
GU3/DU2/NUD1 0 GU3/NUD1/GI2 0 
GU3/DU2/NUD2 0 GU3/NUD2/GI1 0 
GU3/DU2/NUD3 0 GU3/NUD2/GI2 1 
GU3/DU3/NUD1 0 GU3/NUD3/GI1 0 
GU3/DU3/NUD2 0 GU3/NUD3/GI2 0 
GU3/DU3/NUD3 0 DU1/NUD1/GI1 0 
GU1/DU1/GI1 0 DU1/NUD1/GI2 0 
GU1/DU1/GI2 0 DU1/NUD2/GI1 0 
GU1/DU2/GI1 0 DU1/NUD2/GI2 0 
GU1/DU2/GI2 1 DU1/NUD3/GI1 0 
GU1/DU3/GI1 0 DU1/NUD3/GI2 0 
GU1/DU3/GI2 0 DU2/NUD1/GI1 0 
GU1/NUD1/GI1 0 DU2/NUD1/GI2 1 
GU1/NUD1/GI2 1 DU2/NUD2/GI1 0 
GU1/NUD2/GI1 0 DU2/NUD2/GI2 0 
GU1/NUD2/GI2 0 DU2/NUD3/GI1 0 
GU1/NUD3/GI1 0 DU2/NUD3/GI2 0 
GU1/NUD3/GI2 1 DU3/NUD1/GI1 2 
GU2/DU1/GI1 0 DU3/NUD1/GI2 1 
GU2/DU1/GI2 0 DU3/NUD2/GI1 0 
GU2/DU2/GI1 0 DU3/NUD2/GI2 0 
GU2/DU2/GI2 0 DU3/NUD3/GI1 0 
GU2/DU3/GI1 0 DU3/NUD3/GI2 0 
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Table 3.6 Two isolate comparisons 
The proteome of each isolate was compared with the proteome of each other isolate.  
Proteins that were unique to each pair of isolates are shown in the table.   
 
 
Two-isolate Spots Two-isolate Spots 
Subset  Subset  
GI1/GI2 49 GU2/GU3 6 
GI1/GU1 2 GU2/NUD1 6 
GI1/GU2 6 GU2/NUD2 5 
GI1/GU3 1 GU2/NUD3 4 
GI1/NUD1 5 GU2/DU1 1 
GI1/NUD2 1 GU2/DU2 3 
GI1/NUD3 3 GU2/DU3 3 
GI1/DU1 2 GU3/NUD1 1 
GI1/DU2 4 GU3/NUD2 5 
GI1/DU3 3 GU3/NUD3 4 
GI2/GU1 3 GU3/DU1 1 
GI2/GU2 5 GU3/DU2 5 
GI2/GU3 1 GU3/DU3 3 
GI2/NUD1 3 NUD1/NUD2 3 
GI2/NUD2 3 NUD1/NUD3 4 
GI2/NUD3 1 NUD1/DU1 3 
GI2/DU1 3 NUD1/DU2 1 
GI2/DU2 3 NUD1/DU3 0 
GI2/DU3 3 NUD2/NUD3 0 
GU1/GU2 6 NUD2/DU1 5 
GU1/GU3 4 NUD2/DU2 3 
GU1/NUD1 4 NUD2/DU3 1 
GU1/NUD2 2 NUD3/DU1 6 
GU1/NUD3 4 NUD3/DU2 6 
GU1/DU1 6 NUD3/DU3 1 
GU1/DU2 1 DU1/DU2 6 
GU1/DU3 3 DU1/DU3 5 
  DU2/DU3 4 
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Table 3.7  Protein summary 
Summary of the numbers of proteins that were specifically absent from, or unique to, a 
specific disease group. 
 
 
 
GU Unique 58 (5.5%) 
DU Unique 55 (5%) 
GI Unique 54 (5%) 
NUD Unique 55 (5%) 
  
GU Absent 39 (3.5%) 
DU Absent 38 (3.5%) 
NUD Absent 44 (3%) 
GI Absent 34 (3%) 
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Table 3.8  Eight and nine isolate comparisons 
The proteomes of every combination of eight isolates (in the case of GI isolates) were 
compared for the absence of proteins. 
 
 
8 and 9 Strain Subsets No of Proteins 
NUD1/NUD2/NUD3/DU1/DU2/DU3/GI1/GI2 39 
GU1/NUD2/NUD3/DU1/DU2/DU3/GI1/GI2 1 
GU1/NUD1/NUD2/NUD3/DU1/DU2/DU3/GI1 1 
GU1/NUD1/NUD2/NUD3/DU1/DU2/DU3/GI2 1 
GU1/NUD1/NUD2/NUD3/DU2/DU3/GI1/GI2 1 
GU1/NUD1/NUD2/NUD3/DU1/DU3/GI1/GI2 2 
GU1/NUD1/NUD2/NUD3/DU1/DU2/GI1/GI2 4 
GU2/NUD1/NUD2/NUD3/DU1/DU2/DU3/GI1 2 
GU2/NUD1/NUD2/NUD3/DU1/DU3/GI1/GI2 1 
GU3/NUD1/NUD2/NUD3/DU1/DU2/DU3/GI2 1 
GU3/NUD1/NUD2/NUD3/DU1/DU2/DU3/GI1 2 
GU3/NUD2/NUD3/DU1/DU2/DU3/GI1/GI2 1 
GU3/NUD1/NUD2/DU1/DU2/DU3/GI1/GI2 1 
GU3/NUD1/NUD2/NUD3/DU1/DU3/GI1/GI2 1 
GU3/NUD1/NUD2/NUD3/DU1/DU2/GI1/GI2 1 
GU1/GU2/GU3/DU1/DU2/DU3/GI1/GI2 44 
NUD1/GU1/GU2/GU3/DU1/DU2/DU3/GI1 1 
NUD1/GU1/GU2/GU3/DU1/DU2/GI1/GI2 1 
NUD2/GU1/GU2/GU3/DU2/DU3/GI1/GI2 1 
NUD2/GU1/GU2/GU3/DU1/DU2/GI1/GI2 1 
NUD3/GU1/GU2/GU3/DU1/DU2/DU3/GI1 3 
NUD3/GU1/GU3/DU1/DU2/DU3/GI1/GI2 1 
NUD3/GU1/GU2/GU3/DU2/DU3/GI1/GI2 2 
GU1/GU2/GU3/NUD1/NUD2/NUD3/GI1/GI2 38 
DU1/GU2/GU3/NUD1/NUD2/NUD3/GI1/GI2 1 
DU1/GU1/GU2/NUD1/NUD2/NUD3/GI1/GI2 1 
DU1/GU1/GU2/GU3/NUD1/NUD2/NUD3/GI1 2 
DU1/GU1/GU2/GU3/NUD1/NUD2/GI1/GI2 1 
DU2/GU1/GU3/NUD1/NUD2/NUD3/GI1/GI2 2 
DU2/GU1/GU2/NUD1/NUD2/NUD3/GI1/GI2 2 
DU2/GU1/GU2/GU3/NUD1/NUD2/NUD3/GI1 2 
DU2/GU1/GU2/GU3/NUD1/NUD2/NUD3/GI2 1 
DU2/GU1/GU2/GU3/NUD2/NUD3/GI1/GI2 1 
DU2/GU1/GU2/GU3/NUD1/NUD3/GI1/GI2 3 
DU2/GU1/GU2/GU3/NUD1/NUD2/GI1/GI2 2 
DU3/GU1/GU3/NUD1/NUD2/NUD3/GI1/GI2 1 
DU3/GU1/GU2/NUD1/NUD2/NUD3/GI1/GI2 1 
DU3/GU1/GU2/GU3/NUD1/NUD3/GI1/GI2 1 
DU3/GU1/GU2/GU3/NUD1/NUD2/GI1/GI2 1 
GU1/GU2/GU3/NUD1/NUD2/NUD3/DU1/DU2/DU3 34 
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Table 3.9  Absent spots for two isolate subsets 
Specifically absent proteins that can be categorised into two-isolate subsets 
 
 
Isolates Spots Isolates Spots 
Absent Missing Absent Missing 
GI1/GI2 11 GU2/GU3 3 
GI1/GU1 2 GU2/NUD1 2 
GI1/GU2 1 GU2/NUD2 2 
GI1/GU3 4 GU2/NUD3 1 
GI1/NUD1 2 GU2/DU1 1 
GI1/NUD2 0 GU2/DU2 0 
GI1/NUD3 3 GU2/DU3 0 
GI1/DU1 3 GU3/NUD1 1 
GI1/DU2 2 GU3/NUD2 2 
GI1/DU3 0 GU3/NUD3 0 
GI2/GU1 2 GU3/DU1 1 
GI2/GU2 1 GU3/DU2 0 
GI2/GU3 0 GU3/DU3 0 
GI2/NUD1 4 NUD1/NUD2 4 
GI2/NUD2 3 NUD1/NUD3 4 
GI2/NUD3 0 NUD1/DU1 2 
GI2/DU1 2 NUD1/DU2 0 
GI2/DU2 0 NUD1/DU3 4 
GI2/DU3 2 NUD2/NUD3 1 
GU1/GU2 3 NUD2/DU1 3 
GU1/GU3 3 NUD2/DU2 0 
GU1/NUD1 2 NUD2/DU3 1 
GU1/NUD2 1 NUD3/DU1 4 
GU1/NUD3 1 NUD3/DU2 0 
GU1/DU1 0 NUD3/DU3 0 
GU1/DU2 0 DU1/DU2 4 
GU1/DU3 0 DU1/DU3 3 
  DU2/DU3 4 
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Table 3.10 Strain cluster membership 
Displays the qualitative and quantitative cluster membership of each isolate.  Clusters refers 
to each subgrouping of the isolates.   
 
Examination of two clusters for both quantitative and qualitative revealed that isolates 
belonged to two groups 1= gastric and 2= duodenal.  At four clusters qualitative 
dendrograms isolates belonged to four different groups 1= GU, 2= GI, 3= NUD and 4= DU.  
For the quantitative the only isolates that belonged to the same group at the four cluster level 
were the DU isolates. 
 
 
 
 
 
             Quantitative  Membership            Qualitative Membership 
Case 2 Clusters 3 Clusters 4 Clusters 2 Clusters 3 Clusters 4 Clusters 
       
GU1 1 1 1 1 1 1 
GU2 1 1 1 1 1 1 
GU3 1 2 2 1 1 1 
GI1 1 1 3 1 2 2 
GI2 1 1 1 1 2 2 
NUD1 1 1 3 1 1 3 
NUD2 1 1 3 1 1 3 
NUD3 1 2 2 1 1 3 
DU1 2 3 4 2 3 4 
DU2 2 3 4 2 3 4 
DU3 2 3 4 2 3 4 
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Table 3.11 List of Tables and Figures 
A list of the tables and figures that correspond to positional and quantitatively conserved 
spots and spot differences. 
 
 
 
 
Spot    
Number Figure  Table Group 
    
Positional and 3.12  
Quantitatively Conserved 
1-22  3.6  All pH 4-7 
23-96  3.7  All pH 4-11 
    
Unique spots  3.13  
97-102  3.8  GU  
103-109  3.9  DU 
110-116  3.11  NUD  
117-119  3.10  GI  
    
Absent spots  3.14  
120-126  3.9  GU 
127-130  3.8  DU 
131-134  3.10  NUD 
135-138  3.11  GI 
    
Differentially regulated 3.15  
Down  3.12   
139, 152,161,162   GU 
140-144, 146-148   DU 
150, 151,153, 154,  
156, 159, 145,146,   NUD   
149-154, 156, 155,   GI 
    
Up  3.12   
154, 157, 158   GU  
160   DU 
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Table 3.12  Positional and quantitatively conserved spots 
Spots number 1-22 excised from H. pylori within the pH 4-7 range and between 46-150 kDa 
(Figure 3.6). Spots numbered 23-96 excised from H. pylori within the pH 4-11 range and 
between 7-46 kDa (Figure 3.7) 
 
  Spot            
Spot  Homologs                     Mr                   pI 
No  Locus Protein Identity Theoretical 2-DE Theoretical 2-DE 
       
1 HP0109 Chaperone and heat  67051 68700 4.76 4.8 
   shock protein 70 †     
2 HP0109 Chaperone and heat  67051 68000 4.76 4.9 
   shock protein 70 †     
3 HP1195 Translation elongation  77020 80500 5 5.1 
  factor EF-G †     
4 HP1195 Translation elongation  77020 80100 5 5.2 
  factor EF-G  †     
5 HP0072 Urease β-subunit ‡ 61683 65100 5.9 5.6 
6 HP0072 Urease β-subunit ‡ 61683 64680 5.9 5.6 
7 HP0072 Urease β-subunit ‡ 61683 64000 5.9 5.65 
8 HP0072 Urease β-subunit ‡ 61683 64000 5.9 5.7 
9 HP0072 Urease β-subunit ‡ 61683 63800 5.9 5.7 
10 HP0072 Urease β-subunit ‡ 61683 62200 5.9 5.75 
11 HP0072 Urease β-subunit ‡ 61683 63800 5.9 5.8 
12 HP0072 Urease β-subunit 61683 62200 5.9 5.85 
13 HP0072 Urease β-subunit 61683 63800 5.9 5.9 
14 HP0072 Urease β-subunit 61683 63800 5.9 5.95 
15 HP0072 Urease β-subunit 61683 63800 5.9 6 
16 HP0072 Urease β-subunit 61683 62200 5.9 6 
17 HP1205 Translation elongation  43647 46610 4.93 4.9 
  factor EF-Tu ‡     
18 HP1205 Translation elongation  43647 46610 4.93 4.93 
  factor EF-Tu ‡     
19 HP1205 Translation elongation  43647 46610 4.93 5 
  factor EF-Tu ‡     
20 HP1205 Translation elongation  43647 46610 4.93 5.14 
  factor EF-Tu ‡     
21 HP1205 Translation elongation  43647 46510 4.93 5.2 
  factor EF-Tu ‡     
22 HP1205 Translation elongation  43647 46510 4.93 5.24 
  factor EF-Tu ‡     
23 HP1161 Flavodoxin 17492 17100 4.2 4.2 
24 HP1161 Flavodoxin 17492 17100 4.2 4.3 
25 JHP0381 Putative transcriptional 25500 27000 5.4 5.1 
  regulator     
26 HP0011 10 kDa protein 14500 12990 6.6 6.5 
27 H0614 Hypothetical protein  12983 12990 7 6.5 
              
 
†Lock et al (2001), ‡ identified by current study and Lock et al (2001) 
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Table 3.12 Continued 
 
 
  Spot            
Spot  Homologs                    Mr                   pI 
No Locus Protein Identity Theoretical 2-DE Theoretical 2-DE 
       
28 HP0390 Adhesin-thiol peroxidase  18354 18200 5.5 6.7 
29 HP1067 Chemotaxis protein  13915 12107 5 5.23 
30 HP0618 Adenylate kinase ‡ 21243 23384 5.3 5.22 
31 HP0618 Adenylate kinase 21409 23161 5.9 5.8 
32 HP0824 Thioredoxin 11584 11500 4.9 8.2 
33 HP1380 Prephenate dehydrogenase  29429 27100 7 7.1 
34 HP0073 Urease -subunit ‡ 26554 26600 8.5 8.2 
35 HP0073 Urease -subunit ‡ 26540 26600 8.5 8.7 
36 HP0073 Urease -subunit ‡ 26540 26600 8.5 7.6 
37 HP0073 Urease -subunit ‡ 26540 26600 8.5 7.6 
38 HP1564 Outer membrane protein  30151 25700 9.1 8.9 
39 HP1564 Outer membrane protein  30151 25700 9.1 9 
40 HP0231 Hypothetical protein  29490 27800 9.1 9.1 
41 HP0231 Hypothetical protein  29490 27800 9.1 9.2 
42 HP0175 Cell binding factor 2  34031 35900 9.3 8.9 
43 HP0175 Cell binding factor 2 34031 35850 9.3 9 
44 HP0175 Cell binding factor 2  34031 35800 9.3 9.2 
45 HP0175 Cell binding factor 2  34031 35800 9.3 9.3 
46 HP1201 Ribosomal protein L1 25266 28100 10.3 10.2 
47 HP0356 Hypothetical protein  27793 24300 9.5 9.1 
48 HP0955 Integrase/recombinase 42086 41200 9.7 9 
49 HP1118 γ- glutamyltranspeptidase*  ‡ 61099 41200 9.3 9 
50 HP1576 ABC transporter,  23484 41200 9.7 9.2 
  ATP-binding protein     
51 JHP1177 Ribosome releasing factor 20917 23300 8.6 8.1 
52 JHP0405 Protease Do  51714 52000 9.2 8.8 
53 JHP0405 Protease Do  51714 52000 9.2 8.9 
54 HP1286 Conserved hypothetical  20603 19400 9.2 8.8 
  secreted protein      
55 HP1286 Conserved hypothetical  20615 19400 9.2 9 
  secreted protein      
56 JHP1076 Hypothetical protein  20395 19100 6.9 7.1 
57 HP0721 Hypothetical protein  17520 16502 9.57 8.5 
58 HP1285 Conserved hypothetical  26298 24500 9.3 9.35 
  secreted protein      
59 HP1203 Transcription termination factor 20261 17100 7 7.7 
60 HP0829 Inosine-5'-monophosphate  51802 52300 7.7 7.6 
  dehydrogenase     
 
 
*γ- glutamyltranspeptidase –  Gamma-glutamyltranspeptidase 
† Lock et al (2001), ‡ identified by current study and Lock et al (2001) 
 
 
 
  148 
 
    
 
Table 3.12 Continued 
 
 
  Spot           
Spot Homologs                    Mr                    pI 
No Locus Protein Identity Theoretical 2-DE Theoretical 2-DE 
       
61 HP1111 Pyruvate ferredoxin  34956 33700 8.3 7.6 
  oxidoreductase, β-subunit     
62 HP1111 Pyruvate ferredoxin  34956 33700 8.3 8.1 
  oxidoreductase, β-subunit     
63 HP1302 Ribosomal protein S5 16538 18100 10.6 10.5 
64 HP1320 Ribosomal protein S10 11910 17300 9.9 9.5 
65 HP0110 Co-chaperone and  22040 22000 5.3 5.3 
  heat shock protein     
66 HP1311 Ribosomal protein L29  7683 6900 9.7 10.5 
67 HP0198 Nucleoside diphosphate kinase 15286 14607 8 7.4 
68 JHP0086 Alpha-1,2-fucosyltransferase 35159 40800 6.7 6.7 
69 JHP0537 Subunit of 2-oxoglutarate  41573 42300 6 6.7 
  oxidoreductase     
70 JHP0537 Subunit of 2-oxoglutarate  41573 42300 6 6.8 
  oxidoreductase     
71 JHP0178 Fumerate reductase‡ 27625 25700 5.3 5.3 
72 JHP1349 Membrane-associated  19122 18312 9.5 9.3 
  lipoprotein      
73 HP0073 Urease a-subunit ‡ 26540 26600 8.5 7.6 
74 JHP0939 Hypothetical protein  39251 26951 8.7 7.3 
75 HP0827 ss-DNA binding protein  9385 10142 9.5 9.3 
  12RNP2 precursor     
76 JHP0714 Uridylate kinase† 26172 27152 7.7 7.9 
77 HP0561 3-ketoacyl-acyl carrier  26668 26039 7.8 7.9 
  protein reductase †     
78 HP0194 Triosephosphate isomerase † 26707 25016 7.8 7.9 
79 HP0371 Biotin carboxyl carrier protein 17132 19498 5.4 5.3 
80 JHP1489 Pyridoxal phosphate  29720 26164 8 8.1 
  synthetase †     
81 HP0900 Hydrogenase expression/ 27310 27687 5.4 5.63 
  formation protein †     
82 HP0026 Citrate synthase ‡ 48350 47670 7.7 8 
83 HP0742 Phosphoribosylpyrophosphate  34824 12445 9.8 8.4 
  synthetase     
84 JHP1024 JHP1024 like protein 13669 13845 7.5 6.6 
85 JHP1024 JHP1024 like protein 13669 13360 7.5 6.7 
86 HP0835 histone-like DNA-binding  10383 11760 9.7 9.6 
  protein HU     
87 HP1173 Hypothetical protein  20585 16492 9.2 9.2 
88 HP1390 Hypothetical protein  19097 21629 4.5 4.8 
89 HP0913 Outer membrane protein 57063 56236 9.2 7.9 
90 HP0500 DNA polymerase III  42185 44618 5.5 5.7 
  β-subunit      
 
 
† Lock et al (2001), ‡ identified by current study and Lock et al (2001) 
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Table 3.12 Continued 
 
 
 
  Spot           
Spot Homologs                    Mr                   pI 
No Locus Protein Identity Theoretical 2-DE Theoretical 2-DE 
91 HP1390 Hypothetical 13553 11500 5.3 5 
92 HP0537 Hypothetical 13012 12333 9.7 7 
93 JHP0050 Cag 18  26840 27100 5.7 6.6 
94 HP1024 co-chaperone-curved DNA  32908 32811 8.5 8.6 
  binding protein A     
95 HP0602 Endonuclease III 25287 27747 6.2 6.8 
96 HP0811 Hypothetical 12842 11300 6.6 6.9 
       
 
 
 
† Lock et al (2001), ‡ identified by current study and Lock et al (2001) 
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Table 3.13 Specifically unique spots 
Abundant protein spots that are specifically unique for a particular disease group. 
 
 
 Spot            
Spot Homologs                     Mr                    pI 
No  Locus Protein Identity Theoretical Observed Theoretical Observed 
       
GU Unique Spots      
97 JHP0421 Hypothetical protein  18653 19286 5.6 5.67 
98 NA Alkyl hydroperoxide  20266 19608 5.8 6.12 
  reductase C22 protein     
99 orf50 Unknown 46666 46944 8.6 8.3 
100 HP0418 Hypothetical protein 38766 41258 7.1 6.65 
101 JHP0516 Hypothetical protein  40604 44027 5.5 5.74 
102 NA Conserved hypothetical  24227 25259 9.8 9.1 
  protein     
       
DU Unique Spots      
103 HP0377 Hypothetical protein 25315 32345 5.7 5.7 
104 JHP0376 Hypothetical protein  10316 10788 10.1 9.6 
105 HP0332 Cell division topological  8920 12584 8 8 
  specificity factor      
106 HP1437 Hypothetical protein   27735 26841 6.5 6.7 
107 JHP0051 Hypothetical protein 14130 13085 6.8 7 
108 JHP0140 Hypothetical protein   32859 31592 7.7 6.1 
109 HP0036 Hypothetical protein  38533 34584 10.2 8.7 
       
 NUD Unique Spots     
110 NA Hsp12 variant C 36081 34456 6 5.6 
111 HP1064 Hypothetical protein  10872 11898 9.4 8.8 
112 JHP1163 Putative protein 9125 11304 6.2 6.4 
113 HP0864 Hypothetical protein  25402 24812 8.8 9.2 
114 JHP1044 Hypothetical protein 131029 135212 8.5 5.2 
115 JHP1073 Hypothetical protein 33415 30722 7.6 7.1 
116 HP0484 Hypothetical protein 29378 25177 6.5 6.2 
       
GI Unique Spots      
117 NA 
Alkyl hydroperoxide C22 
protein 20266 19908 5.8 5.7 
118 HP0538 Cag17 cagN; JHP0486 35275 34456 8.6 8.56 
119 HP0842 Hypothetical protein 17755 18243 9.4 9.3 
       
 
NA – Not available 
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Table 3.14 Specifically absent spots 
Abundant protein spots that are specifically unique for a particular disease group. 
 
 
 Spot       
Spot  Homologs                     Mr                    pI 
No Locus Protein Identity Theoretical 2-DE Theoretical 2-DE 
       
GU Absent Spots      
120 HP0958 Putative protein  31126 34456 5.4 5.47 
121 HP0825 Thioredoxin reductase   34986 32325 6.4 5.9 
122 JHP0954 Hypothetical protein  16519 19056 5.6 5.3 
123 HP1499 Hypothetical protein  30855 36272 8.5 5.4 
124 JHP0955 hypothetical protein  25315 27564 5.7 5.8 
125 JHP0788 Hypothetical protein  36036 42137 6.1 5.8 
126 JHP0118 Hypothetical protein  16612 17300 9.3 9.1 
       
DU Absent Spots      
127 HP0944 Conserved hypothetical protein 13374 12604 5.3 5.28 
128 JHP1350 Hypothetical protein  23306 23282 7.8 5.4 
129 JHP0295 Hypothetical protein  33643 38714 5.4 5.3 
130 HP1078 Hypothetical protein  27122 25304 6.3 5.4 
       
NUD Absent Spots      
131 HP1562 Iron(III) ABC transporter,  37552 36997 9.2 9.2 
  periplasmic iron-binding protein      
132 HP0305 Hypothetical protein 20385 21485 9.3 9.2 
133 JHP0671 Hypothetical protein   49746 48345 6.8 6.6 
134 HP1285 Conserved hypothetical  26298 25517 9.3 9.7 
  secreted protein     
       
GI Absent Spots      
135 JHP0934 Hypothetical protein  40138 42939 5.1 5.9 
136 HP0431 Protein phosphatase 2C homolog 25964 25391 9.3 9.3 
137 JHP0896 Hypothetical protein  29007 38251 5.1 5.1 
138 HP0434 Hypothetical protein  45150 36800 9 7.6 
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Table 3.15 Differentially expressed proteins 
NS = no significant difference D = spot intensity down by a factor of three, U = spot intensity up by a factor of three 
 Spot          
Spot Homologs                     Mr pI  GI GU NUD DU 
No Locus Protein Identity Theoretical Observed Theoretical Observed Group Group Group Group 
139 HP0958 Putative protein 31126 35765 5.4 5.6 NS D NS NS 
140 HP0875 KatA catalase 58637 60700 8.6 8.7 NS NS NS D 
141 HP0875 KatA catalase 58637 59579 8.6 8.6 NS NS NS D 
142 HP0875 KatA catalase 58637 58979 8.6 8.4 NS NS NS D 
143 HP0197 S-adenosylmethionine  synthetase 2 42363 45211 6 6 NS NS NS D 
144 HP0201 Fatty acid/phospholipid  36484 38450 6.1 5.5 NS NS NS D 
  synthesis protein         
145 HP0653 Non-haeme iron containing  ferritin  19346 19511 5.4 5.6 NS NS D NS 
146 HP0653 Non-haeme iron containing  ferritin  19346 19584 5.4 5.5 NS NS D D 
147 HP0027 Isocitrate dehydrogenase  47532 42500 7.6 7.9 NS NS NS D 
148 HP0027 Isocitrate dehydrogenase  47532 42977 7.6 7.6 NS NS NS D 
149 HP0879 Hypothetical protein 23496 25432 5.6 5.3 NS NS D NS 
150 JHP0650 Hypothetical protein  47269 44860 6.4 6.6 NS NS D D 
151 JHP0761 Homoserine dehydrogenase 46427 44742 6.8 6.8 NS NS D D 
152 HP1520 Hypothetical protein  50574 52349 5.9 5.4 NS D D NS 
153 HP0453 Hypothetical protein 120115 131734 8 5.1 NS NS D D 
154 HP0614 Hypothetical protein  12983 12263 7 6.6 NS U D D 
155 HP1143 H. pylori predicted coding region  50645 46126 5.3 5.6 NS U U U 
156 JHP0052 Hypothetical protein 38221 42313 5.5 5.8 NS NS D D 
157 HP0824 Thioredoxin 11584 11900 4.9 5.2 NS U NS NS 
158 HP0824 Thioredoxin 11584 12000 4.9 6.9 NS U NS NS 
159 JHP0907 Putative protein 40755 40633 9.3 6.3 NS NS NS D 
160 JHP0154 Hypothetical protein 10390 12140 6.3 5.4 NS NS NS U 
161 HP0513 Recombinase RecA 37687 42425 5.6 5.6 NS D NS NS 
162 JHP0065 Hypothetical protein 14061 15551 5.2 5 NS D NS NS 
1
5
2
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Table 3.16 Positional 2-DE protein differences for 11 H. pylori isolates  
Symbols“←”, “→”, and “=” show positional shifts to the left, right or approximate similarity versus the reference isolate. 
Note: The reference isolate for the comparison of protein positional shifts was GI1. 
 
 Spot                  
Spot  Homologs                     Mr                    pI            
No  Locus Protein Identity Theoretical Observed Theoretical Observed GI1 GI2 GU1 GU2 GU3 NUD1 NUD2 NUD3 DU1 DU2 DU3 
163 HP0243 Neutrophil activating protein 16900 17044 5.6 5.8 = ← = = → = = = = = = 
164 HP0243 Neutrophil activating protein 16900 16639 5.6 5.6 = ← = = → = = = = = = 
165 HP0010 Chaperonin (groEL) 58200 60296 5.2 5.2 = = → = = = = = = = = 
166 HP0010 Chaperonin (groEL) 58200 58319 5.2 5.3 = = → = = = = = = = = 
167 HP0010 Chaperonin (groEL) 58200 58002 5.2 5.4 = = → = = = = = = = = 
168 HP0010 Chaperonin (groEL) 58200 57000 5.2 5.45 = = → = = = = = = = = 
169 HP0010 Chaperonin (groEL) 58200 56500 5.2 5.5 = = → = = = = = = = = 
170 HP0010 Chaperonin (groEL) 58200 57122 5.2 5.6 = = → = = = = = = = = 
171 HP0010 Chaperonin (groEL) 58200 57981 5.2 5.6 = = → = = = = = = = = 
172 HP0176 Fructose bisphosphate aldolase 33800 35200 5.9 5.9 = = = = = = = ← ← ← → 
173 HP0176 Fructose bisphosphate aldolase  33800 34563 5.9 6.05 = = = = = = = ← ← ← → 
174 HP0176 Fructose bisphosphate aldolase 33800 34703 5.9 6.2 = = = = = = = ← ← ← → 
175 HP1563 26 kDa protein 22200 21885 5.6 5.4 = → = = = → → → → → = 
176 HP1563 26 kDa protein 22200 21391 5.6 5.6 = → = = = → → → → → = 
177 HP1563 26 kDa protein 22200 20730 5.6 5.8 = → = = = → → → → → = 
178 HP1563 26 kDa protein 22200 21454 5.6 6.1 = → = = = → → → → → = 
179 HP1563 26 kDa protein 22200 21676 5.6 6.3 = → = = = → → → → → = 
180 HP1199 Ribosomal protein L7/L12 13746 12950 4.9 5.0 = → = = = = = = → = = 
181 HP0389 Superoxide dismutase 24500 23196 6 6.5 = → ← = = = ← = = → → 
182 HP1293 DNA-directed RNA   39400 40920 5.0 5.05 = ← ← ← = ← = ← ← ← ← 
  polymerase - subunit                
 
 
1
5
3
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Table 3.17  Potential post-translational modifications 
 
Spot No Protein Identity Possible Post-translational modification 
 
99 
 
 
 
orf5O 
 
 
Methylation, Acetylation, Trimethylation, 
Dimethylation, Bromination, Glucosylation, 
Deamidation 
100 Hypothetical HP0418 
 
Trimethylation, Dimethylation, Bromination, 
Glucosylation, Acetylation, Deamidation 
101 Putative protein JHP0516 
 
Phosphorylation, acetylation, bromination, deamidation, 
glucosylation, dimethylation 
104 Putative protein JHP0376 Phosphorylation, palmitoylation, glutathionylation 
105 Cell division topological  Glucosylation, methylation 
 specificity factor   
106 Hypothetical protein HP1437 
 
Dimethylation, methylation, acetylation, pyridoxal 
phosphate 
107 Putative protein JHP0051 Methylation, dimethylation, 
108 Putative protein JHP0140 
 
Methylation, dimethylation, trimethylation, acetylation, 
FAD 
109,118 Cag17 
 
Methylation, dimethylation, trimethylation, acetylation, 
deamidation, Glucosylation, palmitoylation 
111 Hypothetical protein HP1064 
 
Methylation, trimethylation, bromination, 
palmitoylation, FAD 
112 Putative protein JHP1163 Methylation, dimethylation 
113 Hypothetical protein HP0864 
 
Dimethylation, trimethylation, methylation, 
bromination, glucosylation, deamidation, acetylation, 
114 Putative protein  JHP1044 
 
 
Methylation, acetylation, trimethylation, dimethylation, 
bromination, glucosylation, palmitoylation, 
deamidation, pyridoxal phosphate, phosphorylation 
115 Putative protein JHP1073 
 
Dimethylation, trimethylation, glucosylation, 
palmitoylation, phosphorylation 
116 Hypothetical protein HP0484 Acetylation,  alkylation, methylation 
120 Putative protein JHP0892 Methylation 
121 Thioredoxin reductase 
 
Methylation, palmitoylation, acetylation, glucosylation, 
phosphorylation 
122 
Hypothetical protein  JHP0954 Trimethylation 
123 Hypothetical protein HP1499 Acetylation, palmitoylation, deamidation, 
124 Hypothetical protein JHP0955 Methylation, acetylation, glucosylation 
125 Hypothetical protein JHP0788 Methylation, trimethylation, acetylation, glucosylation 
126 Hypothetical protein JHP0118 
 
Methylation, dimethylation, trimethylation, acetylation, 
glucosylation 
127 Conserved hypothetical  Phosphorylation 
 protein HP0944  
128 Hypothetical protein JHP1350 Deamidation 
129 Hypothetical protein JHP0295  Trimethylation, phosphorylation 
130 Hypothetical protein HP1078 
 
Trimethylation, dimethylation, methylation, acetylation, 
bromination, 
131 Iron(III) ABC transporter, Methylation, dimethylation, acetylation, palmitoylation 
 periplasmic iron-binding 
protein  
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Table 3.17 Continued 
 
Spot No Protein Identity Possible Post-translational modification 
   
132 Hypothetical protein HP0305 Trimethylation, deamidation, glucosylation 
133 
Hypothetical protein  JHP0671 
Methylation, trimethylation, dimethylation, 
acetylation,  
  glucosylation, palmitoylation 
134 Conserved hypothetical 
secreted protein HP1285 
Phosphorylation, bromination, dimethylation, 
acetylation, deamidation, methylation 
135 Hypothetical protein JHP0934 
 
Glucosylation, methylation, acetylation, 
dimethylation, deamidation 
136 Protein phosphatase 2C 
homolog HP0431 
Phosphorylation, acetylation, methylation, 
dimethylation, trimethylation 
137 Hypothetical protein JHP0896 
 
Methylation, dimethylation, trimethylation, 
glucosylation, alkylation,  
138 
Hypothetical protein HP0434 
Methylation, dimethylation, trimethylation, 
acetylation, glucosylation, phosphorylation 
140, 141, 
142 
KatA catalase 
 
Methylation, dimethylation, trimethylation, 
glucosylation, acetylation, phosphorylation 
143 S-adenosylmethionine 
synthetase 2  
Palmitoylation, trimethylation, methylation, 
deamidation, acetylation 
144 
Fatty acid/phospholipid  
Acetylation, methylation, dimethylation, 
trimethylation,  
 synthesis protein glucosylation, phosphorylation  
145, 146 Non-heme iron containing   Methylation 
 ferritin   
147, 148 Isocitrate dehydrogenase  Methylation, deamidation, phosphorylation 
149 
Hypothetical protein HP0879 
Methylation, trimethylation, acetylation, 
glucosylation, palmitoylation 
150 
Hypothetical protein JHP0650 
Methylation, trimethylation, glucosylation, 
palmitoylation  
151 Homoserine dehydrogenase 
 
Methylation, dimethylation, trimethylation, 
bromination, phosphorylation, palmitoylation 
153 Hypothetical protein HP0453 
 
 
Methylation, dimethylation, trimethylation, 
bromination, glucosylation, phosphorylation, 
palmitoylation, alkylation, acetylation 
152 Hypothetical protein HP1520 
 
 
Methylation, dimethylation, trimethylation, 
phosphorylation, acetylation, palmitoylation, 
bromination 
162 Hypothetical protein HP0065 Alkylation, methylation 
154 Hypothetical protein HP0614 Methylation, dimethylation, glucosylation 
155 H. pylori predicted coding 
region HP1143 
Methylation, dimethylation, acetylation, 
glutathionylation 
156 Hypothetical protein JHP0052 
 
 
Methylation, dimethylation, trimethylation, 
phosphorylation, deamidation, acetylation, 
glucosylation 
159 Putative protein JHP0907 Methylation, trimethylation, phosphorylation 
161 Recombinase RecA Methylation, dimethylation, phosphorylation  
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4.1  Proteome Analysis of Microorganisms 
The complete genome of at least 131 microorganisms has been sequenced, including 
those of at least 40 pathogenic bacteria.  The gene sequence data is available at 
http://www.tigr.org/tdb/mdb/mdbcomplete.html. Comprehensive studies at the 
proteome level (i.e. with more than 200 proteins identified) have been published for 
Mycobacterium tuberculosis (Jungblut et al, 1999; He et al, 2003), H. pylori 
(Jungblut et al, 2000; Lock et al, 2001), Haemophilus influenzae (Langen et al, 
2000), Mycoplasma pneumoniae (Regula et al, 2000), Pseudomonas aeruginosa 
(Nouwens et al, 2002), Staphylococcus aureus (Cordwell et al, 2002) and 
Escherichia coli (Tonella et al, 2001).  The majority of comparative proteome studies 
between strains within these species have included only two strains.  H. pylori has 
been the only bacterial species to date (December 2005) in which proteomic 
variability has been compared between more than ten isolates (Enroth et al 2000).    
 
 
4.2   Comparisons between the H. pylori studies 
4.2.1  Isolates included in the study   
The Jungblut (Jungblut et al, 2000) study compared only one strain from each 
disease group, which would have reduced the number of proteins that could be 
matched between these isolates.  This is because, if the proteome variability between 
isolates was greater than that seen between groups then it would be expected that a 
study which compared only one strain from each group would find fewer matches 
between the proteomes.  The Jungblut (Jungblut et al, 2000) study was preliminary 
and only gave a possible indication of the degree of proteomic diversity between 
isolates; a high degree of proteomic diversity has since been further confirmed by 
both Enroth’s group (Enroth et al, 2000) and the present study.  The Jungblut study 
did not explore any similarities within groups and/or identify possible disease 
markers.   
 
Enroth (Enroth et al, 2000) compared three disease groups, two of which are also 
included in the present study (DU and GI).   In the current study, with the exception 
of two isolates (GI1 and GI2), all isolates are from recent biopsies (see Table 2.1 
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page 69).  The Enroth study stated that the isolates were obtained from “five patients 
with gastric adenocarcinoma (Ca), seven with duodenal ulcers (Du), and four with 
gastritis (GI), all endoscopically and histologically verified” but did not mention the 
year of each biopsy.  Therefore, it is unknown whether all the samples in the Enroth 
study were from recent biopsies or whether they had been maintained in the 
laboratory for a considerable time. 
 
Isolates maintained in the laboratory may evolve to adapt to their new environment 
during repeated laboratory subculturing.  This may, for instance, effect the 
expression of virulence factors.  In the present study only GI1 and GI2 had been 
maintained in the laboratory for any length of time. 
 
4.2.2  Spot resolution   
Enroth’s (Enroth et al, 2000) study had the smallest gel area (11 x 11 cm = 121 cm2) 
in comparison to Jungblut ((Jungblut et al, 2000) (23 x 30 cm = 690 cm2) and the 
current study (18.5 x 18.5 cm = 342.5 cm2).   The small resolution area of Enroth’s 
study would most likely have resulted in many protein spots comigrating.  Such 
overlapping of spots would have significantly affected the number of spots 
visualised, detection of low abundance proteins, spot matching, comparative 
analysis, and any subsequent cluster analysis.  For example, Enroth (Enroth et al, 
2000) stated that only 48% of matches could be obtained between two isolates within 
a disease group.   In comparison to the Enroth (Enroth et al, 2000) study the 
application of large format gels in the current study improves the spatial resolution 
and hence increases the number of protein spots visualised.  Therefore, the 
application of large format gels increases the number of possible matches between 
isolates within any particular disease groups.   
 
Jungblut’s (Jungblut et al, 2000) group had the greatest resolution area of 23 x 30 
cm.  Their study increased the length of the Mr axis spatial resolution by 11.5 cm in 
comparison to the gels utilised in the current study.  This increase would enhance 
detection of any differences in the Mr of proteins.  Proteins that appear to have a 
similar Mr in a gel with an 18.5 cm length might now appear as two individual spots 
in a larger gel.  However, the current study improved the pI resolution through the 
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use of two pH ranges on 18 cm IPG strips (pH 4-7 and 6-11 with an overlapping 
region of 3.6 cms =1 pH unit) giving an effective pI separation length of 32.4 cm.  
Jungblut (Jungblut et al, 2000) utilised a single 24 cm IPG strip of pH 3-10.  While 
Jungblut may have had better y-axis (Mr) resolution of proteins, the current study has 
the advantage of improved x-axis (pI) resolution.  This means that spots that may 
have co-migrated on the x-axis in Jungblut’s (Jungblut et al, 2000) study might 
appear as separate protein spots in the current study.   
 
The current study improved on the previous two studies in two ways: 1) on 
Jungblut’s resolution by increasing the pI separation length; and 2) on Enroth’s 
resolution by increasing the size of the gels in both dimensions.  In addition, a pH 
range (pH 10-11) was examined which had previously not been utilised in a H. pylori 
comparative study. 
 
4.2.3  Staining technique   
Gels may be stained by a variety of dyes.  Both Jungblut (Jungblut et al, 2000) and 
Enroth (Enroth et al, 2000) used silver nitrate staining techniques for the detection of 
proteins whereas the present study utilised Coomassie G250 colloidal dye for 2-DE 
comparative proteome analysis.   Silver staining techniques were not utilised for 
protein identification by Jungblut and Enroth studies, instead the alternative 
Coomassie was used.  The staining procedures utilised for protein identification for 
the Jungblut study was Coomassie Blue G-250. It could not be determined from 
Enroth’s article which type of Coomassie was utilised. 
 
While silver stains are more sensitive than Coomassie stains it is difficult to obtain 
gel-to-gel reproducibility and it is also difficult to perform quantitative comparisons.   
Coomassie G250 does not have these problems, the current study is the first H. pylori 
comparative study that effectively examines the proteomic differences both 
quantitatively and qualitatively.   
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4.3  The H. pylori proteome 
Eleven bacterial isolates of H. pylori were chosen for this study, comprising nine 
exclusive to this study and two that have previously been examined (GI1 and GI2).  
This comparison was undertaken primarily to detect protein markers whose presence 
might be correlated specifically with the development of one of four clinical 
consequences of H. pylori infection: DU, GU, NUD and GI. Comparative 2-D 
proteome analysis revealed that the H. pylori proteome was very diverse with only 
471 spots (40.6%), out of ~1168 per isolate, located at the same 2-D position for all 
isolates (Table 3.2).  In contrast, the comparative analyses of the 2-DE patterns of 
strains within each of the species of S. aureus (Cordwell et al, 2002), M. tuberculosis 
(Jungblut et al, 1999; He et al, 2003), Haemophilus ducreyi (Scheffler et al, 2003), P. 
aeruginosa (Nouwens et al, 2000) and E. coli (Champion et al, 2000) were found to 
be highly conserved.    The Cordwell (2002) study which compared S. aureus strains 
8325 (methicillin sensitive) and COL (methicillin resistant), showed that they shared 
the same pattern of spots except for 12 in COL and 11 in 8325, 23 altogether.  This 
was less than 4% of the total proteome for these strains.  This is different from the 
results obtained with H. pylori included in this study in which comparison of any two 
isolates associated with a disease state displayed at least 280 protein spot differences 
for each isolate (24% of the protein spots).  Additionally this study found that 
isolates from different disease states displayed at least 373 protein spot differences 
(32% of the protein spots) (See Table 3.3).  However, another factor in the degree of 
dissimilarity observed between isolates in the present study is the number of isolates 
included.  The majority of comparative proteome analysis studies only included two 
or three isolates.  Except for the Enroth (2000) study, the present study is the only 2-
DE proteome analysis to include more than four isolates. 
 
The H. pylori proteome displayed a bi-modal pI distribution with a greater 
percentage (57%) of the spots being located in the acidic range (Figure 3.15).  There 
were few protein spots located at the pH 7-7.5 range.   Spots were well resolved 
throughout the 2-DE gels, however, there were only a few spots (30) in the high Mr 
basic range, pH 7-11.  Figures 3.3B and 3.3D demonstrate how few protein spots 
were located in the alkaline Mr range 62-150. 
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4.4  Basic proteins of H. pylori 
In contrast to other microorganisms whose proteomes have been studied, basic 
proteins form a large proportion of all 2-DE patterns of H. pylori isolates 
investigated (Jungblut et al, 2000; Enroth et al, 2000).  This corresponds with the 
high pI values calculated from the protein sequences deduced from the genes of H. 
pylori.  For example, from the genomic sequence of H. pylori strain 26695 it was 
calculated that more than 70% of the predicted proteins have theoretical pIs greater 
than 7.0, compared to about 40% in H. influenzae and E. coli (Tomb et al, 1997).   
However, results from the current study indicated that only 47% of the H. pylori 
proteome (averaged over 11 isolates) had protein spots with an observable pI > 7.0 
this was less than might be expected from the predicted proteins (70%).   From 
figures 3.3 and 3.4, it can be seen that there were more protein spots in pI range 4-7 
than is seen in the pI range 6-11.  This might suggest that at least 23% of the basic 
proteins of H. pylori may not be represented in the present study. The proteome map 
of E. coli also showed that predicted, basic proteins were not fully represented in the 
observed proteome map (<35% basic proteins) (Tonella et al, 2001).  There are many 
possible reasons for the basic proteins not being fully represented in the observed 
proteome.  These include extraction procedures, low copy numbers per cell, 
limitations of the technology (i.e. staining techniques) and predicted versus observed 
basic proteome (i.e. effects of post-translational modifications).  Additionally, when 
H. pylori is removed from its acidic environment many of these basic proteins that 
may have been required for colonisation in a hostile in vivo environment may have 
ceased expression in vitro. 
 
The protein extraction procedure in this study utilised Tris base 40 mmol (high pH ~ 
11.00).   Acidic proteins tend to extract more effectively at a high pH.  This is 
because when proteins are a long way from their pI their maximum charge tends to 
increase their solubility in an aqueous solution.  However, basic proteins in an 
alkaline solution are closer to their pI and may precipitate and be lost to solution.   
Therefore, an alkaline extraction procedure will reduce the number of basic proteins 
in the sample.    Low pH extraction procedures were not explored in this study, 
which only compared H. pylori whole cell proteins extracted by one particular 
procedure.  Further studies are required to examine different acidic extraction 
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procedures to determine which would provide the best resolution and increase in the 
number of alkaline proteins.   Additional comparative studies can then be performed 
providing an additional protocol for the comparison of H. pylori disease groups. 
 
It was noted in this study that there were only 30 proteins with a Mr of 70-150 kDa 
within the pH 7-11 region whereas, the pH 4-7 region had greater than 120 high Mr 
proteins (Figure 3.3).  There are three possible explanations for why the observed 
high Mr proteins in the basic region are poorly represented; these are the Mr, 
hydrophobicity of the proteins and the method of extraction (previously mentioned).  
Proteins with Mr greater than 150 kDa are not generally seen on standard 2-DE gels 
as these proteins are often lost during the isoelectric focusing step.  One possible 
reason for the low numbers of high Mr proteins in the pH 7-11 region is that large 
molecular mass proteins do not enter the IPG strip readily.   Membrane proteins are 
very hydrophobic with many having pIs greater than 8.0.   These very hydrophobic 
proteins need to remain soluble not only during the extraction procedure but also, 
during the IEF process, especially at their pI, which is the minimum solubility for 
each protein.  This is not always possible to achieve in spite of advances in 
detergents and organic solvents for dissolving proteins. 
 
 
A recent study examined the separation of basic proteins in H. pylori (Bae et al, 
2003) and attempted to overcome the poor representation of basic proteins in 
proteome maps.    Utilisation of the techniques in this study might have provided a 
slight improvement in the representation of the basic H. pylori proteins.  Initially the 
Bae group utilised the standard 2-DE separation for strain 26695 and obtained good 
resolution across the entire pH 6-11 range, however there were few resolved spots in 
the high Mr region of the gel beyond pI 9.5.  The current study also found that there 
were few resolved high Mr spots (70-150 kDa) in the pH 6-11 range.   
 
Subsequently in order to provide an improved separation of the highly basic proteins 
the Bae et al (2003) study utilised a pH 9-12 IPG constructed with an N-
acryloylaminoethoxyethanol (acrylamido) matrix which was combined with 
improved porosity for the separation of high mass proteins.  This however, did not 
alter the results observed for high Mr proteins and only increased the number of 
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observable proteins beyond pI 9.5 by 15.  The Bae et al (2003) study also attempted 
to prefractionate the basic protein by a GradiflowTM and identify these proteins with 
liquid chromatography/mass spectrometry (LC/MS).   The Gradiflow is a versatile, 
liquid-based protein separation device that separates proteins according to pI (or 
charge) in a liquid phase (Locke et al, 2002).  Analysis of the predicted H. pylori 
proteome indicated that 68 proteins possess a pI of greater than 10.   However, Bae et 
al (2003) were only able to identify 5 of these (7.35%) after pI prefractionation.     It 
was not possible to explore the Bae et al (2003) and Locke et al (2002) procedures in 
this study for two reasons.  These procedures were explored after the experimental 
procedures in this study were completed.   Additionally specialised pH 9-12 IPG 
strips are not commercially available and need specific equipment to produce them.   
IPG strips produced within a specific laboratory are not always reproducible for each 
experiment. 
 
Basic proteins remain difficult to resolve using 2-DE despite the advances in the 
alkaline range IPGs that have improved the quality and reproducibility of separations 
in the range of pH 6-11.  The lack of better separation at more alkaline pH may be 
due to the lack of suitable acrylamido buffers, or the instability of the proteins 
themselves, at extremely alkaline pH.  
 
 
4.5  Separation of Low Molecular Mass Proteins 
The low Mr proteins of various organisms may include proteins with essential 
biological functions that cannot be visualised and identified using the Tris-glycine 
buffer systems because of insufficient spot resolution in the lower Mr range.  Proteins 
with Mrs below 20 kDa are poorly resolved using a Tris-glycine Cathode Buffer 
because they co-migrate with the SDS and this leads to streaking, smearing and poor 
staining by Coomassie stains. In order to overcome the limitations of the Tris-glycine 
system this study separated H. pylori proteins smaller than 20 kDa using Tricine gels.  
When Tricine is used as a trailing ion, it moves in front of the SDS front, which 
improves the resolution of low Mr proteins (Westermeir and Naven, 2002). 
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Proteins were efficiently resolved using a Tricine gel without a stacking gel, and 3.1 
M urea in the polyacrylamide gel.  In addition, there was excellent resolution of 
proteins between Mr 20-62 kDa.  Approximately 90 protein spots with Mr  20 kDa, 
which previously could not be reproducibly resolved in this study by the Tris-glycine 
buffer system, were resolved in this region.   On the Tris-tricine gels that were silver 
stained, approximately 120 proteins were visualised with Mr below 20 kDa (see 
Figure 3.4).  Approximately 20% of these proteins had Mr  10 kDa.   The fact that 
only a few proteins with Mr  10 kDa were visualised may by partially due to 
insufficient binding of the stain by the low Mr proteins.  CBB stain complexes with 
basic amino acid residues, such as arginine, tyrosine, lysine and histidine (Link, 
1999).  Smaller proteins would be expected to contain fewer molar quantities of 
these residues in comparison to many high Mr proteins.  As a result, this would affect 
the degree to which these low Mr proteins were stained.  Another possible 
explanation is that the majority of small Mr proteins ran off the gels.  Alternatively, 
the low Mr proteins were not expressed in sufficient amounts to be detected on the 2-
D gels. 
 
The Tricine method for the separation of low Mr proteins applied in the current study 
differed from the procedure developed by the Fountoulakis et al study (1998) for H. 
influenzae.  Their study reported a streaked appearance and inefficient resolution of 
proteins greater than 25 kDa. When the H. pylori proteins were separated by a 
methodology that utilised their procedure this resulted in inefficient separation.  
Alterations in the Tricine method resulted in an improved resolution of proteins 
between 7-62 kDa.  This differed from the Fountoulakis study that only obtained 
efficient resolution for proteins between 5-20 kDa.  This may be due to three possible 
reasons: 1) their use of a stacking gel; 2) they used a 10.4% acrylamide solution 
whereas this study utilised a 8.5% acrylamide solution and; 3) differences between 
the species of bacteria.  
 
The removal of a stacking gel increases the area in the y-axis for the separation of 
proteins and this may reduce the number of overlapped spots, thus improving the 
resolution of proteins between the Mr 20 and 62 kDa.  The total acrylamide 
concentration (T) may increase the degree of streaking of proteins because when (T) 
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increases the pore size decreases.  This study utilised a T concentration of 8.5% 
while Fountoulakis utilised 10.4% therefore the pore size would have been larger in 
this study which may have decreased streaking.  The decrease in pore size would not 
affect the separation of low Mr proteins but would result in resistance for the 
movement of high Mr proteins movement.  The majority of H. influenzae proteins 
separated by 2D PAGE are detected in the pH 4-7 region (Link et al, 1997; Langen et 
al, 2000) whereas in H. pylori proteins are bipolar with 55% in the pH 4-7 range.  An 
increase in the number of proteins within a particular pH region may increase the 
proportion of overlapping proteins in the x-axis.  The Tricine gel method utilised in 
this study helped to improve the separation of the small proteins, however a number 
of potentially small Mr proteins below 7 kDa were not observed implying that 
improvements for the detection of low Mr proteins of H. pylori may be required.  
These might include the use of dyes such as SYPRO Ruby and Liquid 
Chromatography-Mass Spectrometry. 
 
 
4.6  Theoretical versus observed proteome 
Alm et al (1999) predicted that the genome of the H. pylori isolates 26695 and J99 
encode for 1552 and 1495 proteins, respectively.  In the present study, the whole cell 
protein patterns of the H. pylori isolates revealed approximately 1160 proteins when 
stained by CBB G250 and about 1580 proteins stained by silver in the 2-DE gels 
(Table 3.1).   Given that the entire genome of H. pylori encodes for approximately 
1500 proteins it would seem that the majority of the proteome of this organism has 
been observed.  However, the total number of protein spots observed by 2-DE may 
be greater than the number of theoretical predicted proteins, since a number of 
proteins can be processed by proteolytic enzymes or modified by processes such as 
methylation, phosphorylation, and acetylation.  Post-translational modifications will 
increase the number of protein spots per gene product that are observed on the 2-DE 
gels.  From this the global proteome of H. pylori would actually be greatly reduced 
from its original 1160 proteins. 
 
The formation of dimers and truncation of proteins has been observed in many 
protein spots in 2D gels (Krah et al, 2003; Verdan et al, 2003; Pichoff et al, 1995; 
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Pichoff et al, 1997).  Dimers of proteins will double the Mr of the protein and a 
truncation can give an observed Mr less than the theoretical Mr.  There are also 
proteins that are processed into two or more subunits and appear to be fragmented. 
 
Once each protein has been associated with a particular H. pylori gene, its apparent 
Mr and pI, as estimated by its mobility on a 2-DE gel, may be compared with the 
theoretical Mr and pI of the unmodified product of the gene.  Figure 3.14 consists of 
scatter diagrams comparing the observed properties of proteins on 2-DE gels with the 
predicted properties of the corresponding theoretical gene products (www.tigr.com).   
 
4.6.1  Posttranslational modifications 
A large number of the 2-DE pI values highly corresponded to the theoretical pIs of 
protein spots in the pH 4.0 - 7.0 range (Figure 3.14b).  However, the pI values for the 
protein spots in the pH 7.0–11.0 2-DE gels showed a larger variation from the 
theoretical pIs.  Eleven of the pI data points in the plot were outliers in the pH range 
7.0-11.0, these were spot numbers 74, 83, 89, 92, 108, 114, 123, 128, 138, 153 and 
159.    The remaining three outliers in the pH 4.0-7.0 range were spot numbers 28, 32 
and 158.  Spots were considered outliers when the pI variation was greater than 1.0.  
The post-translational processing and modification of proteins may explain why the 
2-DE and theoretical pIs match less closely than the 2-DE Mr and theoretical Mr.   
 
In this study, the expression products of many ORFs appeared in the form of a 
horizontal serial charge train within the 2-DE gel. This may have resulted from 
different isoforms of one protein with differently charged side groups caused by 
post-translational modifications. Examples of this phenomenon are the following 
identified proteins: translation elongation factor EF-Tu (HP1205) five spots, catalase 
(HP0875) three spots, alkyl hydroperoxide reductase (HP1563) eight spots, urease 
alpha-subunit (HP0073) six spots, and chaperone and heat shock protein GroEL 
(HP0010) 12 spots (Figure 3.6).  The post-translational modifications of these 
proteins would have major effects on their charge properties while making little 
change to their size.   The urease beta subunit located at 65 kDa and within pH 5.6-
6.2 was the only protein identified where the post-translational modifications had an 
observable alteration in its Mr (Figure 3.6).  Urease beta subunit was observed as two 
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rows of spots separated by a Mr change of 5 kDa.  Protein charge trains have been 
observed in previous proteome studies of H. pylori (Fischer and Haas, 2004; Lock et 
al, 2001) and may be a common feature of eukaryotic and prokaryotic proteins.   
 
4.6.2  Observed Mr versus Theoretical Mr 
In general, the estimated Mr of the proteins in the 2-DE gels closely matched their 
theoretical values.  In Figure 3.14a, the 2-DE molecular mass is plotted Mr against 
theoretical Mr. When the total data is related to an equivalence plot (slope 1.0, 
passing through the origin), the correlation coefficient is 0.983 which is significant at 
the P<0.01 level.  Eleven of the Mr data points 49, 50, 64, 74, 83, 87, 103, 105, 112, 
137 and 138 were outliers in the Mr plot, six of these proteins have no known 
function.   The Mr of five of these outliers differed by ±33% (spot numbers 49, 50, 
74 83 and 105), four of these proteins had a known function.  The intact protein Mr, 
pre-filtering, is imperfect because sequences in protein databases often exist as 
dimers, fragmented, and subunit forms (MS-Fit information website).   It is for this 
reason that when a protein match could not be found within the ±15% range that the 
range would be expanded to try and find a protein match.  Outliers in this study are 
defined as those where the observed Mr differs by > ±15% from the theoretical Mr.  
These Mr outliers might be the result of dimers, truncations or can be subunits of the 
same protein.    
 
Dimers and Truncation 
Dimers are compounds formed by the joining of disulphide bridges among similar 
chains.   Artificial dimerisation can occur during the run of the second dimension but 
this will cause smearing on the gel.   Dimerisation has little effect on the pI and can 
occur in the first dimension if an insufficient amount of a reducing agent such as 
dithiothreitol is used.  This reason for dimerisation is unlikely to occur if tributyl 
phosphate is used.   Alternatively, dimers can occur in vivo, and the concentration of 
reducing agent in the sample buffer insufficient to break all the disulfide bonds.  H. 
pylori proteins have been identified that form dimmers.  A particular example is the 
26 kDa protein, HP1563, (known as alkyl hydroperoxide reductase) a protein that 
consists of a number of isomers (Spot numbers 175-179) (Figure 3.13B, Table 3.16).  
Krah et al (2003) identified eight different alkyl hydroperoxide reductase spots, one 
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spot had an apparent Mr that was double the theoretical mass of the protein.   The 
Krah et al (2003) study found evidence that this spot contained dimers of the protein 
because cysteine-containing peptides were not found in the dimer spot.   It was 
believed in this instance that alkyl hydroperoxide reductase formed dimers in vivo.  It 
has also been found that other members of the peroxiredoxin family form 
homodimers or even decamers (Wood et al, 2002).   ABC-ATPases have been found 
to form head-to-tail dimers in E. coli and Sulfolobus solfataricus (Verdan et al, 
2003).  Given that alkyl hydroperoxide reductase has been found to form dimers in 
H. pylori it is possible that this has also occurred in the ABC transporter, ATP-
binding protein (spot number 50, Table 3.12).  Another protein that might form 
dimers in H. pylori is the cell division topological specificity factor (spot number 
105).  Studies in E. coli (Pichoff et al, 1997) and two-hybrid yeast analyses (Pichoff 
et al, 1995) did not find dimerisation of this protein.   Further investigations would be 
required to determine if it occurs in H. pylori. 
 
Truncation has been found to occur in H. pylori heat shock protein GroEL either as 
N-terminally truncated or C-terminally truncated spots (Krah et al, 2003).  This 
truncation may have occurred in phosphoribosylpyrophosphate synthetase (spot 
number 83) such, truncation of both the N-terminal and the C-terminal might account 
for a significant 2/3 difference of the observed Mr.  This truncation effect might also 
have occurred in hypothetical protein JHP0939 (spot number 74). 
 
Subunits  
Gamma-glutamyltranspeptidase (spot number 49) located at pI/ Mr 9.0/40 appears to 
be a truncated protein but might be one of two subunits for this protein.  Figure 3.7b 
shows its location on the proteome map and Table 3.12 shows the difference between 
the 2-DE observed Mr and the theoretical Mr.  This corresponds to the study of Krah 
et al (2003) in which two gamma-glutamyltranspeptidase proteins were detected, one 
at pI/ Mr 8.7/40 and the other at pI/ Mr 6.7/20.  Gamma-glutamyltranspeptidase has 
been shown to consist of two subunits in E. coli K-12 (Hashimoto et al, 1995).  The 
current study and the Hashimoto study did not identify a spot corresponding to the 
whole protein (theoretical Mr 61 kDa).   Therefore, it is most likely that this apparent 
truncation is due to the existence of two subunits for this protein. 
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4.6.3  Protein Modal Distribution  
When the current study analysed the protein isoelectric points of H. pylori, a bimodal 
pattern was observed, with few proteins in the plot having pI values near 7.5 (Figure 
3.15).    Recently Van Boegelen et al (1999) analysed several bacteria and identified 
a distinct bimodal pattern of pIs with peaks centred at approximately pI 5.5 and pI 9.  
Because the cytoplasm of most cells has a pH near neutrality (pH 7.2 - 7.4) it may be 
difficult to maintain protein structure, rigidity and solubility near their isoelectric 
points.  Although the causes for and general bimodality were not established it was 
suggested that it may be a result of the relationship between intracellular pH values 
and protein pI values (Van Bogelen et al, 1999).  The bimodal distribution of protein 
pIs with pIs greater than, or less than, pH 7.0 has been observed in M. tuberculosis 
(Brooke et al, 1998), E. coli (Blattner et al, 1997) and previous studies of H. pylori 
(Lock et al, 2001) and may be a general characteristic of prokaryotes.    Studies of H. 
pylori, including the current study, have observed that there appears to be a greater 
number of basic proteins in both the observed and theoretical proteomes than has 
been found for other bacteria, such as E. coli (Tonella et al, 2001).  These proteins 
may enable H. pylori to survive in its naturally acidic habitat. 
 
4.6.4  In vitro and in vivo  
The theoretical proteome can differ from the observed due to variations in an 
organism’s environment.  The H. pylori isolates 26695 and J99 consist of 1600 and 
1520 gene products, respectively.  Certain proteins are only stimulated under specific 
environmental conditions that may not be fully reproduced in vitro, for example pH, 
heat and stress, iron starvation and oxidative stress.  An in vivo study would be 
required to investigate the combined effect of these factors on protein expression.  In 
addition, the interactions of outer member proteins, Cag PAI proteins and 
vacuolating cytotoxin with the host may only be examined in vivo.   As it was not 
possible to examine protein differences in the in vivo environment by 2-DE only a 
portion of the entire genome of the H. pylori isolates was observed. 
 
A number of in vitro and animal studies have been conducted investigating virulence 
factors.  However, it is evident that an organism may express different proteins when 
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grown under laboratory conditions compared with when it is grown in vivo.  It has 
been observed in past studies that various isolates of H. pylori have exhibited a 
sudden and complete loss of proteins that are constitutively expressed under in vivo 
conditions when grown in vitro (Manos et al, 1998).  One example of a protein where 
this can occur is catalase (spot numbers 140-142, Figure 3.12 Table 3.15).  In the 
Manos et al (1998) study it was found that two isolates UNSW-RU1 and UNSW-N6 
ceased expressing catalase after 35 and 30 passages respectively. The current study 
did not observe the loss of the expression of this protein most likely due to the low 
number of subcultures.  This study only allowed four subcultures to reduce any 
morphological changes to the organism that can occur after repeated subcultures. 
 
H. pylori catalase is a monomer lacking peroxidase activity and shares several 
properties with catalases of eukaryotic organisms. The protein catalase is expressed 
in vivo in response to oxidative stress in the gastric environment.  Once the selective 
pressures are relieved by culturing in vitro the expression of catalase is no longer 
required and this results in catalase-negative isolates (Manos et al, 1998).  However, 
when this bacterium is restored to the gastric environment the catalase expression 
returns to normal (Manos et al, 1998). 
 
Growing H. pylori in vitro would therefore fail to examine the bacteria-host 
interactions under the multiple environmental conditions that occur in the gastric 
environment.  However, the difficulty of examining proteins obtained from biopsies 
by 2-DE proteome analysis is the inability to obtain sufficient material for detection 
on gels.  Although new detection techniques have been developed (e.g. SYPRO 
Ruby) these still have limitations in the amounts of protein that may be observed.  
Additional techniques would be required to enhance the observation of low copy 
proteins.   
 
 
4.7  Cluster Analysis of H. pylori 
Using match results obtained from PDQUEST, two subclustering analyses 
(qualitative and quantitative) were performed to determine if the isolates could be 
grouped according to their disease type.  Hierarchical clustering was performed to 
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form dendrograms (Figure 3.5).  The nodes of the tree represent the individual 
objects, while the branches of the cluster the nodes according to similarity or 
difference, which are represented by branch length.  Strikingly, in both analyses 
isolates within a disease group clustered together into branches of the tree. Slight 
variations were observed between the different dendrograms in the order in which 
the isolates appeared within the groupings.  The qualitative dendrogram suggested 
that isolates from the same patient group clustered together independently of the 
calculation method.  In addition, the qualitative dendrogram formed two major 
clusters – gastric and duodenal.  However, the quantitative dendrogram did not 
reveal that isolates from specific disease groups clustered together but suggests that 
isolates from the same environment (gastric or duodenal) formed clusters.  The GU, 
NUD and GI isolates were more closely related than were the DU isolates to those 
within the other disease groups (Table 3.9). To some extent, these two dendrograms 
indicate that there might be disease-specific proteins.  This corresponds to a cluster 
analysis of H. pylori which found that some isolates within each disease group 
clustered together (Enroth et al, 2000). 
 
 
4.8  Variability among H. pylori isolates 
Bacteria have varied genomes that reflect the phenotypic differences that facilitate 
adaptation to diverse environments.  Bacteria that are subjected to rapidly changing 
environments display genomic plasticity that leads to the generation of sub-strains 
with various adaptations (Aras et al, 2003).  This high degree of genetic variability, 
such as present in H. pylori, may also contribute to long-term host adaptation. Host 
selection of variants that are well adapted to particular environmental constraints is 
one mechanism for regulating host-microbial interactions (Vicente et al, 1999).  The 
expression of bacterial genes can be regulated in response to environmental cues to 
allow rapid adaptation to changing conditions, for example Hsp12 (de Vries et al, 
2003) and FrpB (Delany et al, 2001b). To optimize their chances for survival and 
growth, bacteria employ different strategies to adapt to their environment.  These 
strategies include spontaneous point mutations, recombination with other bacterial 
cells, and intragenomic rearrangements involving mobile gene elements or repetitive 
DNA sequences; this genetic diversity may be spontaneous (Arber, 2000).  
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Initially the genomes of 26695 and J99 were believed have an overall genomic 
conservation and gene order (Alm et al, 1999).  However, comparative proteome 
analyses of different isolates of H. pylori has since revealed that H. pylori is highly 
variable (Jungblut et al, 2000; Govorun et al, 2003).  Nevertheless, considering the 
high sensitivity of isoelectric focusing to changes in single amino acids this proteome 
variability may reflect the exact chemical structure of the protein species and not the 
presence of proteins with different functions. The 2-DE approach analyses the 
genetic variability at the protein species level.  Further the identification of protein 
species of different H. pylori isolates will detect differences in the proteins.  This 
study identified nine proteins which showed variability in their migration on the gels 
and this could be due to 1) post-translational modifications GroEL, TsaA, SodF, 
Rpl7/12, Fba, RpoA and NapA (see Table 3.16), 2) mutations Flagellin A (FlaA) and 
3) plasmids (orf5O) (see spot no 99). 
 
4.8.1  Post translational modifications 
Comparison of the 11 isolates included in this study revealed that there were seven 
proteins with different pI values (shifts) on the different proteome maps (Table 3.15). 
These differences were found for the housekeeping protein groEL, enzymes involved 
in free radical and hydrogen peroxide catabolism (SodF, NapA and TsaA), fructose-
biphosphate aldolase (Fba) and DNA-directed RNA polymerase alpha subunit 
(RpoA) and ribosomal protein l7/12 (Rpl7/12).  These changes may be attributed to 
possible posttranslational modifications.  Two previous studies have also noted the 
existence of these pI shifts.  Jungblut et al (2000) compared the amino acid 
composition of ten H. pylori proteins.  Three proteins were found to have an identical 
composition and three proteins had amino acid exchanges without a net charge 
change which did not appear to affect their 2-DE gel positions (Jungblut et al, 2000).  
However, the other four proteins (GroEL, TsaA, SodF and Rpl7/12) had amino acid 
exchanges that resulted in a net charge change that altered the 2-DE gel pI values 
(Jungblut et al, 2000).   The study by Govorun et al (2003) identified GroEL, SodF, 
TagD, Omp18 and Tig proteins with a 2-DE gel pI shift.  The present study has 
increased the number of proteins with observed 2-DE pI shifts to include an 
additional three proteins, these being Fba, RpoA and NapA.   
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4.8.2  Variation in gene expression 
H. pylori isolates over time have all evolved in relative isolation in the stomach of 
individual humans.  The very special habitat of H. pylori at the surface of gastric 
epithelial cells or in the mucous layer covering the epithelium suggests that this 
bacterium has evolved specialized features for adaptation.  There are variations in the 
virulence factors of H. pylori that are not produced by the effects of subculturing 
(e.g. FlaA).  There are two possible explanations for these variations. These are 
mutations or deletions and adaptation to the host environment.  Some of the 
variations may be the result of one or more possibilities. 
 
The H. pylori isolates examined in this study showed considerable diversity in their 
expression of flagellin proteins.  Examination of the eleven isolates in the current 
study showed that not all isolates expressed the same quantity of FlaA (see Appendix 
Figures A.23, A.24 and A.25).  In some isolates the amounts of FlaA produced 
varied from undetectable to an abundance.  In this study it was found that in vitro 
GU1 FlaA was barely visible and in Tomb 26695 it was not detected while another 
isolate NUD3 produced six times the spot intensity of the isolates DU1, GI1 and 
NUD1.   These differences in spot intensities between the isolates was also noted for 
FlaB and FliM.  Other proteins involved in flagellin expression that might have been 
co-expressed with this protein were not noted because this study only examined 
differences between disease groups (specifically absent/specifically unique) or 
positionally conserved/differentially regulated spots for all isolates.   Further studies 
would need to be conducted in order to correlate other possible co-expressed proteins 
using FlaB and FliM as reference points. 
   
GU1 was obtained from a recent biopsy in June 2001 and was only subcultured four 
times in the laboratory which means that its poor flagellin production is unlikely to 
be the result of repeated laboratory subculturing.   In contrast GI2 (26695) had 
undergone repeated subculturing and from the protein pattern did not appear to 
produce FlaA, whereas GI1 (NCTC11637), which was originally isolated in 1982, 
produced abundant levels of FlaA.  GI1 FlaA displayed equivalent spot intensity to 
isolates, obtained from three recent biopsies, while other isolates NUD2, NUD3 and 
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DU2 displayed an abundance of FlaA in comparisons to all the other isolates.   
Therefore if the variation of FlaA expression was due to spontaneous mutations from 
repeated subculturing then both isolates GI1 and GI2 should not have detectable 
levels of FlaA in their proteome.  The most likely explanation is that another factor is 
influencing the variation of FlaA. 
 
Mutations or deletions of specific genes may result directly or indirectly in the 
expression of other H. pylori gene products.  Genetic mutations in specific genes 
have been shown in past studies (Figura et al, 2004; van Amsterdam and van der 
Ende, 2004).  Bacterial flagella are essential for the motility of H. pylori to enable 
the colonisation of the gastric mucosa and to attain robust infection.  CagA (Figura et 
al, 2004) and other genes such as ylxH (van Amsterdam and van der Ende 2004) may 
be essential for the assembly of flagella and the motility of H. pylori.  In the Figura et 
al (2004) study it was found that the disruption of cagA, by gene deletion, that the 
lack of CagA expression reduces the expression of both flagellin A and flagellin B, 
two central components of flagella (Figura et al, 2004)  The decreased expression 
was found to be sufficient to result in a non-motile strain.  H. pylori YlxH (HP1034) 
is described as an ATP-binding protein with homology to the MinD family of 
ATPases that are involved in chromosome partitioning (NCBI database). However 
because H. pylori strains contain a MinD homologue (HP0331) it is believed that 
YlxH does not play a role in cell division (van Amsterdam and van der Ende, 2004). 
The deletion of the ylxH gene results in a non-motile strain in which the FlaA is 
down regulated and flagella are absent.   Therefore it is believed that the H. pylori 
YlxH protein is essential for the assembly of flagella and hence for the motility of H. 
pylori (van Amsterdam and van der Ende, 2004). 
 
4.8.3  Plasmids as a source of proteomic diversity  
Approximately 50% of H. pylori strains carry cryptic plasmids ranging in size from 2 
to about 100 Kb; however, the role of these plasmids is not well understood (Penfold 
et al, 1988).  H. pylori can distribute a high number of diverse genetic modules 
within the species.  Different combinations of modules might be created by 
recombination (deletion and insertion) and selected for by the needs of the bacteria in 
their individual hosts.  Plasmids can acquire chromosomal genes and genes from 
  174 
 
    
 
other plasmids by transposition and recombination.  These plasmids with newly 
acquired genes will now produce different proteins and if the plasmids are acquired 
by other strains they will alter the proteome of the strains.  If these plasmids are 
advantageous to their new host then these strains will have a selective advantage.  
Plasmids can be transferred between bacteria by transduction, transformation (Ando  
et al, 1999; Hofreuter and Haas, 2002) and conjugation, however plasmid 
conjugation has not yet been proven for H. pylori.   Several genes that are involved 
in the transformation process have been identified (Ando et al, 1999; Hofreuter et al, 
1998). 
 
The GU isolates studied here produced a unique protein of unknown function orf5O, 
the best homologue to the hypothetical protein HP1334 (spot no 99 Table 3.13), an 
open reading frame which has been found to be located in/on plasmid pHel5 
(Hofreuter and Haas, 2002).  This suggests that the GU strains either have plasmids 
encoding orf5O, have acquired it from a plasmid of the pHeI5 type or were the 
source of the orf5O encoded by pHeI5.  Hofreuter and Haas (2002) theorised that the 
pHe15 and pHe14 plasmids might provide a possible explanation for the 
macrodiversity of H. pylori strains.  The carriage and/or integration of plasmids 
represent an important source of genetic material that may play an important role in 
genetic diversity and the diseases produced by a strain. 
 
 
4.9  Conserved proteins   
In the present study, 471 spots (40.6% of the proteome) were found to be positionally 
conserved.  Positionally conserved spots were of two subsets: 1) spots which vary by 
less than a factor of three (quantitatively conserved); and 2) spots which vary in 
volume by a factor of three or more.  Thirty percent of the proteome is quantitatively 
conserved.  One hundred and twenty proteins of the 471 spots, which were 
positionally conserved, were identified (Table 3.12).    These included 96 proteins 
that were quantitatively conserved (Figures 3.6, 3.7 and Table 3.12) and 24 proteins 
where expression differed by a factor greater than three (Figure 3.12 and Table 3.16).    
Fifty eight of the 120 positionally conserved proteins (48%) identified were protein 
isomers that may be due to post-translational modifications.   
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Fifty four of the 120 proteins were identified as being positionally conserved were 
found to belong to the following categories: electron transport proteins (5); 
translation factors (6); transcription factors (4); redox-oxidation proteins (2); cations 
(3); aspartate family (4); tricarboxylic acid cycle proteins (6); surface structures (2); 
urea related proteins (15); degradation of proteins (2); peptides and glycopeptides 
(3); salvage and interconversion of nucleosides and nucleotides (2); DNA restriction 
modification and repair (2); ribosomal proteins (3); synthesis and modification (1); 
fatty acid and phospholipid metabolism (2); detoxification (3); general cellular 
processes (5); central intermediary metabolism (4); molybdopterin (2); glutathionine 
(3); and gluconeogenesis (2).   
 
Initially this study included ten isolates.  A comparison of the ten isolates found that 
48% (566 spots) of the proteome was conserved.  After the addition of strain 26695, 
the conserved proteome was reduced to 40.6%.  It is possible that if more isolates 
were included in the study that the percentage of conserved proteome might be even 
further reduced.  
 
From the 2-D proteome map of the isolates included in this study it has been 
concluded that H. pylori is highly diverse with relatively few protein spots in 
common to all isolates.  The conserved proteome covers a broad selection of proteins 
many of which are essential for maintenance of the cell.  However, while many 
genes are essential, alterations, such as post-translational modifications can alter the 
proteome such that a comparison between the proteome of two similar isolates could 
appear dissimilar.  An example of this is fructose bisphosphatase that is located in the 
same position in the 2-DE gel for only seven out of the eleven isolates (Table 3.16).  
 
 
4.10   Proteomic Differences between Disease Groups 
Sixty six significant protein spot differences, both specifically absent/unique and 
differentially expressed, were identified between the four disease groups, GU, DU, 
NUD and GI.  Eleven of the 66 protein spots were isomers, KatA three isomers; Icd 
two isomers; TrxA two isomers; HP0958 – two isomers; and Pfr two isomers.  These 
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proteins could be considered under five categories (according to classifications in the 
NCBI database).  These categories are: 
  
 metabolism – 14% (9 spots)  
 cellular processes and signalling – 7 % (5 spots)  
 information processing – 9% (6 spots)  
 pathogenesis – 3% (2 spots) 
 poorly characterised or unknown proteins – 67% (44 spots) 
 
Spot differences between disease groups where the proteins had known functions 
were: 
 one disease group versus three disease groups 
o DU - KatA, Icd, MetK, MinE, PlsX, JHP0295, JHP0140, YjgF, SpaP 
o NUD – MiaB, Hsp12 variant C and CeuE 
o GU – HP0958, TrxA/TrxB and RecA 
o GI – Ptc1, Predicted GTPases 
 two disease groups versus two other disease groups 
o DU and NUD – Pfr, ComGF, Hom 
o GI - CagN 
 
4.10.1  GU Unique and Absent Proteins 
Thirteen disease specific proteins were identified for the GU isolates (six unique and 
seven absent).  The specifically unique proteins (Figure 3.8 and Table 3.13) were 
either poorly characterised proteins or those with no known function.  
 
Out of the seven absent proteins identified, three had a known or homologous 
function, the remainder had no known function or were poorly characterised (Figure 
3.9 and Table 3.14).   
 
4.10.1.1 Unique Proteins 
Unknown protein Orf5O (spot number 99) 
As discussed in section 4.7.3 the role of H. pylori plasmids is not well understood.  
Plasmids can be grouped into at least two separate classes, one with homology to 
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plasmids of the Gram-positive bacteria replicating via the “rollingcircle” mechanism 
(Kleanthous et al, 1991), the other belonging to into the group of iteron-containing 
plasmids and replicating via the theta mechanism (de Ungria et al, 1999).  H. pylori 
contains five plasticity zones which have been speculated to have been obtained by 
horizontal gene transfer (Hofreuter and Haas, 2002).  The plasmid pHe15 contains 
open reading frames with homology to products of genes clustered in plasticity zone 
three of H. pylori 26695 (Hofreuter and Haas, 2002).   Such gene sequences can be 
exchanged between H. pylori plasmids and the H. pylori chromosome. 
 
Further, proteins encoded by pHel5 and pHel4 have homology with products of 
genes widespread in the chromosomes of H. pylori 26695 and J99 Orf5O (best 
homologue to hypothetical protein HP1334 - 36.2%, HP0879 26.7%, JHP0812 
33.5%) (Hofreuter and Haas, 2002).  HP1334, HP0879 and JHP0812 are all poorly 
characterized proteins whose functions are unknown. 
 
4.10.1.2  Absent Proteins 
HP0958 (spot number 120) 
This is a Zn-ribbon protein, possibly a nucleic acid-binding protein belonging to the 
information processing category of replication, recombination and repair.  
 
This particular protein is part of a serial charge train.  Another protein in the charge 
train was identified as a down-regulated protein of the proteins found in the isolates 
in other disease groups (see page 188).  Therefore, the absence of this HP0958 in the 
GU isolates is most likely due to its decreased expression.   
 
The zinc ribbon C(H/C)CC, metal (zinc) binding motifs are structurally diverse and 
are present among proteins that perform a broad range of functions in various cellular 
processes, such as DNA replication, repair, transcription and translation, and 
metabolism and signalling (Vallee and Falchuk, 1993).  For example, the zinc 
ribbon, metal-binding motif is highly conserved amongst the TF (II) Bs of eukaryotes 
and the Archae and is found in several proteins that are involved in transcription such 
as TFIIS, RNA pol II subunits and TFIIE (Wang et al, 1998; Jeon et al, 1994; Frick 
and Richardson, 2001).  Given the multiple functions of proteins having a Zn-ribbon, 
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it is not possible to determine the function of this zinc-ribbon protein in H. pylori.  
However, recent research has proposed that HP0958 is essential for normal motility 
and flagella production in H. pylori (Pereira and Hoover, 2005; Ryan et al, 2005).  
 
Motility is an essential colonization factor for H. pylori in experimental infection 
models (Eaton et al, 1989; Eaton et al, 1996; Holger et al, 2003).  Flagella are 
composed of two subunits Flagellin A (FlaA) (spot number 183 - 188), Flagellin B 
(FlaB) (spot number 189 – 193) (Kostrrzynska et al, 1991) and the flagellar hook 
component (FlgE) (O’Toole et al, 1994).  The production of these flagellar proteins 
is regulated by at least three RNA polymerases; sigma factors 80 (RpoD), 54 
(RpoN) and 28 (FliA) (Alm et al, 1999; Tomb et al 1997) and by anti-sense 28 
factor (FlgM) (Colland et al, 2001; Josenhans et al 2002).  The study by Pereira and 
Hoover (2005) found that cells defective in the HP0958 gene expressed very small 
amounts of FlaA and FlaB and had no observable FlgE.  There was no alteration in 
the expression of RpoN and FliA whereas the expression of FlgM (spot number 194) 
was increased nine-fold in the HP0958 mutant in comparison to the wild-type 
(Periera and Hoover, 2005).  Other important regulators whose expression was 
decreased in the strain which had a mutation in HP0958 were FlhA and FlhF.  When 
Perier and Hoover compared the production of FlaB, FlgE and FlaA it was found that 
these proteins were significantly reduced in the mutant strain.  
 
In the present study it was observed that in the isolates GU1, GU2 and GU3 the spot 
intensity for HP0958 was decreased more than three-fold in comparison to the other 
isolates.  However, another notable characteristic of all eleven isolates was the 
production of FlaA, FlaB and FlgM.  Spot intensities varied from non-existent (GI2) 
to highly abundant (NUD3 and DU2) but did not correspond to alterations in the 
production of HP0958.  Isolates in the GU disease group had similar spot intensities 
for HP0958 but not for the proteins FlaA, FlaB and FlgM.  The expression of these 
proteins in GU1 was almost non-existent.  In the GU2 isolate it was found that the 
expression of these proteins was equivalent to GI1 and DU1 however, DU2 which 
had a strong spot intensity for HP0958, had a similar expression of FlaA, FlaB and 
FlgM to GU1.  NUD3 was found to have abundant levels of these proteins but had a 
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reduced level of expression of HP0958 in comparison to DU2 but it was not a 
significant difference.    
 
HP0825 (spot number 121) 
Thioredoxin reductase (TrxB) belongs to the cellular processing and signalling 
category of proteins and the posttranslational modification, protein turnover, 
chaperones group.  In the proteome of 26695 (Tomb et al, 1997) at least two isomers 
of TrxB were identified.  One isomer had a pI of 5.93 and a Mr of 33.5 kDa and the 
other a pI of 6.42 and a Mr of 36 kDa.      
 
In this study TrxB was not identified in GU isolates however, its counterpart, TrxA, 
in the thiol-dependent reduction-oxidation system was present as a highly abundant 
protein.  TrxA was seen as a differentially up-regulated protein in the GU isolates in 
this study.      
 
The redox protein thioredoxin (TrxA) and the associated enzyme thioredoxin 
reductase (TrxB) constitute a thiol-dependent, oxidation-reduction system that can 
catalyse the reduction of certain proteins by NADPH, usually with high selectivity 
(Holmgren, 1985).  In anaerobic bacteria, the generation of low redox potential 
reductants, such as TrxA, can be used to assist electron flow to specific substrates.  
Thioredoxin reductase catalyses the reduction of the oxidised thioredoxin (Trx-S2) 
by NADPH, and the reduced thioredoxin (Trx-[SH]2) is the disulphide reductase 
(Swissprot database).  There are two nearly identically subunits to this enzyme.  Each 
subunit contains 1 mol of FAD per subunit and a NAD(P)H and FAD binding motif. 
 
There are two explanations for the absence of TrxB in the GU isolates.   The first is 
the differential expression of the thioredoxin system so that TrxB is down regulated 
in response to oxidative stress.  Although TrxB was not observed this does not mean 
that it is not being expressed.  It may be produced in insufficient quantities to be 
detected by Coomassie.  Alternatively, a shift in the molecular mass may have 
occurred due to post-translational modification so that this protein spot appears to be 
absent.  However, given that TrxA was down regulated in the isolates in the other 
disease groups the differential regulation of TrxB is the most likely explanation.  
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Windle (1999) has shown that the thioredoxin system in H. pylori behaves as a stress 
response element by secreting TrxA in response to chemical, biological and 
environmental stresses.    The differential expression of TrxA and TrxB, and other 
redox active proteins in response to various stressors, has been observed both in 
eukaryotic cells and in Staphylococcus aureus (Berggren et al, 1996; Reddy et al 
1999).   Oxidative stress has been shown to result in the down-regulation of TrxB 
activity and an increase in the TrxA activity in cultured small intestine epithelial cells 
(Higashikubo et al, 1999).   While the effects of oxidative stress on H. pylori 
expression of the thioredoxin system have not yet been fully reported, it is possible 
that a similar response occurs in this organism.  Two other proteins that are 
differentially regulated in response to oxidative stress were also identified in this 
study, these are non-haeme iron (III) ferritin (NUD and DU isolates [see page 196]) 
and catalase (DU [see page 192]).   
 
HP1499 (spot number 123) 
This is predicted to belong to the HKD family of nucleases.  
 
This HKD sequence motif has been found in a variety of enzymes having a very 
widespread range of activity, including phospholipase D, endonucleases, 
phosphatidylserine synthases (PSS), cardiolipin synthases, as well as proteins having 
no known function in vivo (Koonin, 1996; Morris et al 1996).  The majority of 
investigations of enzymes with the HKD motif have been performed with 
phospholipase D (PLD).  PLD is a membrane-associated protein in which the 
protein’s interaction with the membrane may be mediated by two or more domains 
(Xie et al, 1998).  The common denominator of proteins belonging to this PLD 
superfamily of enzymes is that they all perform catalysis involving a phosphorous 
atom.  The PLD superfamily of enzymes catalyse the hydrolysis of phospholipids 
into phosphatidic acid and have a polar head group (Leiros et al, 2004).    
 
In addition to this hydrolytic activity, PLD enzymes also catalyses a 
transphosphatidylation reaction in vitro to form new phospholipids (Waite, 1999).  
Even at very low levels (1%) of ethanol, transphosphatidylation can be preferred, 
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resulting in the almost exclusive production of phosphatidylethanol rather than 
phosphatidic acid and choline (Waite, 1999). This reaction is unique to PLD 
enzymes and thus provides an unambiguous indication of the presence of PLD 
activity (Leiros et al, 2004).    
 
Mutation of the HKD motifs residing in region I or IV renders PLD proteins inactive 
but does not affect expression of the protein (Xie et al, 1998).  If mutation in the PLD 
protein is due to a truncation this would result in a Mr shift, which in turn, would 
result in an apparently specifically unique protein in the GU group.  Further 
investigation is required to ascertain the reason why the HP1499 protein was not 
detected in the GU isolates.   
 
 4.10.2  Unique and Absent Proteins in DU Isolates 
In this study eight unique proteins (Figure 3.9 and Table 3.13) and four absent 
proteins (Figure 3.8 and Table 3.14) were identified in the DU isolates. 
 
4.10.2.1  Unique Proteins 
HP0332 (spot number 105) 
The MinE (cell division topological specificity factor) protein belongs to the cellular 
processing and signalling category.  This protein is involved in cell cycle control, 
mitosis and meiosis.    Both MinE (spot number 105) and MetK (spot number 143) 
are two proteins that were identified in this study, which have possible roles in cell 
division.  The role of MetK is described in section 4.9.6. 
 
In E. coli cell division is controlled by the Min system.  It consists of three proteins 
MinC, MinD, and MinE.  These are necessary for site-specific inhibition of septation 
at the cell poles (Pichoff et al 1997: de Boer et al, 1992).  MinC is the inhibitor of 
cell division and is activated by MinD.  The MinD protein has two functions, as well 
as activating MinC it interacts with the MinE topological specificity factor (Pichoff 
et al 1997: de Boer et al, 1992).  The MinE protein regulates MinC in a topological 
fashion and allows septation at the central region of the cell but prevents it at the cell 
poles.   Currently it is not known how the MinE protein suppresses the MinC/MinD-
mediated inhibition of division.  The absence of the MinC or MinD protein or the 
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overexpression of minE results in the blocking of division being suppressed at the 
cell poles as well as at the mid cell, leading to minicell formation (de Boer et al, 
1992).  H. pylori does not contain a homologue to MinC but the homologue to the 
MinD and MinE have been identified (Doig et al, 1999).    
 
 
JHP0140 (spot number 108) 
This is predicted to be a periplasmic solute-binding protein belonging to the poorly 
characterised category whose general function is predicted only.  
 
Periplasmic solute-binding proteins (SBPs [also called ABC transporters]) are part of 
a transport system that is composed of two cytoplasmic membrane domains and two 
peripheral membrane-associated ATP binding domains (Driessen, 2000).  In Gram-
negative bacteria these SBPs freely diffuse into the periplasm, however in gram-
positive bacteria they are bound to the cell membrane and some are bound to the 
membrane domain (Obis D et al, 1999).  The SBP transporters are required for the 
uptake of a number of small molecules that include amino acids, metal ions and 
sugars (Higgins, 1992). SBPs are high affinity, ATP driven, transporters that function 
in a unidirectional manner to drive the accumulation of solutes against high 
concentration gradients (>10, 000-fold) (Higgins, 1992).  Currently there is no 
known function for this protein in H. pylori. 
 
JHP0376 (spot number 104) 
This has no known function but is predicted to be a nucleic-acid-binding protein 
involved in transcription termination and therefore would belong to the information 
processing category.   
 
This protein is homologous to the following proteins: HP1049 in H. pylori 26695; 
CJ0135 in Campylobacter jejuni NCTC 11168 and HH1012 in H. hepaticus ATCC 
51449.  These proteins also have no known function. 
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HP0377 (spot number 103) 
This belongs to the poorly characterized category of proteins and has no known 
function.   
 
HP0036 (spot number 109), JHP0051 (spot number 107) and HP1437 (spot 
number 106) 
These proteins have no known function.   
 
4.10.2.2  Absent Proteins 
HP0944 (spot number 127) 
This protein belongs to the YjgF/YER057c/UK114 family. This family belongs to 
the information processing category and is involved in transcription. 
 
The YjgF/YER057c/UK114 family is a highly conserved class of proteins that is 
widely distributed in bacteria, Archaea, plants and other eukaryotes. A wide variety 
of biological roles has been attributed to these proteins depending on the organism 
examined.  A number of the proteins have been described as putative translation 
inhibitors based on experiments with the human (hp145 or PSP1) and rat 
homologues (rp145 or L-PSP).  Both of these proteins inhibit cell-free protein 
synthesis in the rabbit reticulocyte lysate system (Schmiedeknecht et al, 1996).  It has 
also been characterised in a few bacterial species such as Bacillus subtilis (Rappu et 
al, 1999).   In B. subtilis, the protein is required for adenine-mediated repression of 
purine synthesis (Sinha et al, 1999).  In yeast, the homologue appears to play a dual 
role in mitochondrial maintenance and the regulation of isoleucine biosynthesis.  
However, to date (December 2005) the precise biochemical function of this protein 
in H. pylori species remains unknown (Schmitz and Downs, 2004).    
 
In several organisms, strains lacking an YjgF homologue have a defect in branched-
chain amino acid biosynthesis.  In strains lacking yjgF the specific activity of 
transaminase B, which catalyses the last step in the synthesis of isoleucine, was 
reduced (Schmitz and Downs, 2004).   
 
  184 
 
    
 
Therefore, based on homology with proteins belonging to other species, it is possible 
that this protein also functions as an inhibitor in H. pylori.  In addition it was found 
from the comparison between the genome of the two isolates J99 (a DU isolate) and 
26695 (a GI isolate) that this gene product has a different pI in each strain (Alm et al, 
1999).  The theoretical pIs of J99 and 26695 were 5.2 and 4.5 respectively (NCBI 
database).   In this study the YjgF protein was found to have an observed pI of 4.5 in 
the GU, NUD and GI isolates studied.  If all DU isolates have a similar pI for the 
YjgF as J99 then it would be expected that it would be absent at the pI of 4.5 
observed for YjgF homologue in the GU, NUD and DU isolates.  Another reason 
why this particular protein was not found in the DU isolates at the pI of 5.2 is 
because it may be a low copy protein.  Low copy number proteins would not be 
detectable in a proteome map. 
 
JHP1350 (spot number 128) 
This protein is homologous to SpaP a member of the antigen I/II family of collagen-
binding surface adhesion proteins.  This is a poorly characterized category whose   
general function can only be predicted.  
 
The antigen I/II proteins are a family of related surface polypeptides that have been 
largely examined in species of oral streptococci.  These studies found that members 
of the antigen I/II family are highly conserved adhesions with approximately 65 to 
70% primary sequence similarity (Demuth and Irvine, 2002).  In oral bacteria these 
proteins initiate and develop a biofilm by mediating interactions of oral streptococci, 
other oral bacteria, cell matrix proteins (e.g. type I collagen) and salivary 
components (Demuth and Irvine, 2002).   These proteins have also been shown to 
interact with eukaryotic collagen and human fibronectin and laminin (Baddour, 
1994).  The interactions of antigen I/II are thought to contribute to the formation of 
streptococcal abscesses.  H. pylori has been shown to bind to connective tissues 
collagen I, II IV, laminin, fibronectin and vitronectin (Trust et al, 1991).  H. pylori 
binds strongest to laminin and collagen type IV but only weakly to collagen type I, 
II, fibronectin and vitronectin (Trust et al, 1991).   The ability of H. pylori to bind to 
components of the basement membrane would represent an important virulence 
characteristic for this organism.  There have not been any studies to determine what 
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effect the absence of the collagen type I binding adhesion would have on the 
colonisation and virulence of the organism.  Given that H. pylori binds weakly to 
collagen type I (Trust et al 1991) it is possible that loss of the JHP1350 a homologue 
to SpaP might not have any affect on the ability of the organism to colonise the 
gastric mucosa.   Alternatively the extracellular matrix components of connective 
tissue, for example collagen type I, may play a role in the formation of duodenal 
ulcers.  The expression of collagen binding adhesions might be a reflection of 
duodenal ulcer formation.   For example, if DU isolates prefer binding to collagen 
type II or IV in the duodenum then adhesions for this type of connective tissue would 
be expressed while collagen type I binding adhesions would down-regulated or cease 
expression.  Further examination would be required to determine the actual function 
of JHP1350 and its possible role in collagen type I binding.   
 
JHP0295 (spot number 129) 
This is predicted to be a xylanase/chitin deacetylase protein belonging to the 
metabolism category and is involved in carbohydrate transport and metabolism.  
 
Xylan is a major hemicellulose component of the plant cell wall.  Small amounts of 
plant fibres are degraded by microbes in humans.  Microbial digestion of plant 
materials is significant and occurs mainly in the caecum and large intestine after 
prior host digestion in the stomach and small intestine (Hespell and Whitehead, 
1990).  
 
Xylanases are secreted into the media that contains pure xylan or xylan-rich residues. 
They are usually inducible enzymes (Balakrishnan et al, 1997) but some research 
studies have also observed constitutive production of xylanases (Hespell and 
Whitehead, 1990; Khasin et al. 1993; Lindner et al, 1994).  Because xylan cannot 
enter the microorganism, the expression of xylanase is stimulated by low molecular 
mass xylan fragments.   These low molecular mass fragments include xylose, 
xylobiose, xylooligosaccharides, heterodisaccharides of xylose and glucose and play 
a key role in the regulation of xylanase biosynthesis (Kulkarni et al, 1999).  The 
fragments are released from xylan by a small amount of constitutively produced 
xylanase (Bastawde, 1992; Kulkarni et al, 1999).  The component that stimulates 
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induction differs depending on the microorganism.  For example, in Trametes trogii 
it is mostly xylan (Levin and Forschiassin, 1998), whereas in Trichosporon cutaneum 
(Liu et al, 1998), xylanase is induced by xylan and is repressed in the presence of 
glucose.  In T. trogii (Levin and Forschiassin 1998) and Staphylococcus sp. SG-13 
(Gupta et al, 1999) xylanase production is enhanced in the presence of amino acids. 
Gupta et al (2000) reported an improved xylanase production by Staphylococcus sp. 
SG-13 in a medium containing wheat bran. The regulation of xylanase secretion by 
microorganisms is still not completely understood.  It would not be surprising that 
dietary components would induce xylanase in H. pylori but the significance of why 
only the DU isolates were found to be producing it is not known. 
 
Spot number 130  
This protein has no known function.  
 
 
4.10.3  Unique and Absent Proteins in NUD Strains 
In this study, eleven disease specific NUD proteins were identified.  These consisted 
of seven unique (Figure 3.11 and Table 3.13) and four absent (Figure 3.10 and Table 
3.14).   
 
4.10.3.1  Unique Proteins 
All the unique proteins, with the exception of fructose-biphosphate aldolase, that 
were identified in the NUD disease group have no known function or are poorly 
characterised. 
 
HSP12 variant C 
This protein has no known function. 
 
The hsp12 gene present in the H. pylori isolates NUD1, NUD2 and NUD3 is a 
member of the gene family 12 and its transcription is induced after growth under 
stress conditions of 42oC, iron restriction and low pH (de Vries et al, 2003).  Other 
proposed functions include penicillin binding, a weak β-lactamase activity and the 
maintenance of H. pylori’s spiral shape (Krishnamurthy et al 1999).  However, there 
is currently no clear function for this family of proteins.    Due to the stress activation 
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of hsp12, it was proposed that this gene plays a role in stress survival.  One belief is 
that Fur, a regulator of iron uptake, may regulate the expression of hsp12 under 
conditions of iron starvation (de Vries et al, 2003).  However, there was no evidence 
that expression of hsp12 affected growth under normal or stress conditions.     
 
The hsp12 locus was found to be not only strain specific but also H. pylori specific 
(de Vries et al, 2003).  There is no precise homologue of the hsp12 gene present in 
the genome sequences of H. pylori strains that have been sequenced.  For example 
the 26695 and J99 strains contain hsp12 variant A and B respectively (Alm et al, 
1999; Tomb et al, 1997).  Other variants found in strains include variant C and the 
alleles I, II, III, IV and V that contain unknown genes (Chanto et al, 2000).  The high 
diversity of the hsp12 gene is most likely due to recombination and may require the 
presence of H. pylori strains.  It has been theorised that the diversity of the hsp12 
gene is the result of adaptation to the host environment and plays a role in the 
persistent colonisation of H. pylori to its specific host (de Vries et al, 2003).  The de 
Vries et al (2003) study suggested that these genes might interact with the host 
environment by stress regulation and genetic variation.    However, there is still no 
evidence that the expression of the hsp12 gene is associated with any particular 
disease outcome. 
 
HP1064, HP0864, JHP1044, and HP0484 (spot numbers 111, 113, 114, and 116).   
These are proteins that have no known function. 
 
JHP1163 and JHP1073 (spot numbers 112 and 115)  
These proteins are poorly characterised. 
 
4.10.3.2  Absent Proteins 
HP1562 (spot number 131) 
This is an Iron (III) ABC transporter, periplasmic iron-binding protein (CeuE) and is 
involved in inorganic ion transport and metabolism and belongs to the metabolism 
category. 
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There are two environmental conditions that may affect the expression of CeuE.  
These are iron starvation/iron excess and nickel excess.  
 
The mechanisms by which H. pylori acquires Fe2+ and Fe3+ from the host are still 
poorly defined.  There are a number of outer membrane proteins, which may serve as 
receptors for haeme (Worst et al, 1995).  Human lactoferrin can also be used as a 
sole Fe source (Husson et al, 1993) and a putative lactoferrin binding protein has 
been identified (Dhaenens et al, 1997).  In conditions of iron starvation Fur, an iron 
regulator, is able to prevent the expression of some iron transport proteins. 
 
H. pylori possesses the FeoB transporter, which has an important role in the 
acquisition of Fe2+.  Other transport proteins involved in the transport of Fe across 
the membrane include CeuE and FrpB.  CeuE, a homolog of the iron (III) ABC 
transporter, periplasmic iron-binding protein (Tomb et al, 1997), may function in the 
shuttling of Fe3+ across the periplasmic space (Velayudhan et al, 2000).   The FrpB 
protein is a homolog of the Fe limitation-inducible outer membrane protein of 
Neisseria meningitidis (27.6% amino acid identity and 49.5% similarity) that belongs 
to the family of TonB-dependent receptors (Tomb et al, 1997).   
 
Iron concentrations have both direct and indirect effects on the expression of the iron 
network genes (van Vliet et al, 2002)   Proteins that respond to variations in the iron 
levels include KatA (Harris et al, 2002), Pfr (Delany et al, 2001a), iron transport 
proteins (e.g. FrpB and CeuE) (Delany et al, 2001b; van Vliet et al, 2001), Fur (Ernst 
et al, 2005) and Hsp12 variant C (de Vries et al, 2003).  In iron abundant 
environments the expression of iron transport proteins of H. pylori is decreased.  
Conversely, under iron restricted conditions the expression of iron transport proteins 
including CeuE is increased (van Vliet et al, 2002).  This differs from other bacteria 
where the iron transport proteins are down regulated.   
 
A constant supply of nickel ions is required for the synthesis and activity of a number 
of metalloenzymes that play a crucial role in prokaryotic and eukaryotic cells 
(Eitinger and Mandrand-Berthelot, 2000). If nickel ions accumulate, they will then 
inhibit microbial cell growth and exhibit a toxic effect.   Therefore, the level of 
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nickel ions needs to be tightly regulated by controlling its transport and/or by storing 
it in protein complexes.  Transport proteins include the NixA (HP1077) and AbcCD 
(HP1576/1577).  A nickel storage protein is believed to be HP1427 (Mobley, 1999).  
There are a number of transition metal pumps that are believed to play a role in the 
intracellular ion composition (Melchers et al, 1998).    Nickel excess affects Pfr, Fur, 
FrpB4, ExbB/ExbD, CeuE, CheV, FlaA, FlaB, HrcA, GrpE, DnaK, Omp11, Omp31 
and Omp32 by repressing these protein products (Contreras et al 2003).  Nickel 
excess also upregulates UreA, UreB, (van Vliet et al., 2002), NixA and CopA2 
(nickel transport proteins) and Hpn (nickel storage) (Contreras et al, 2003). 
 
JHP0671 (spot number 133) 
This is 2-methylthioadenine synthetase (MiaB) and is a translation protein belonging 
to the information processing category.  
 
MiaB (a homologue of 2-methylthioadenine synthetase in H. pylori), in E. coli, is 
involved in the methylthiolation of the adenosine 37 residue modification of tRNAs 
specific for codons beginning with U, except tRNAI,V Ser (Esberg et al, 1999; Pierrel 
et al, 2002).   MiaB, a Fe-S enzyme, contains a cysteine cluster reminiscent of iron-
binding sites.  MiaB is a monomeric iron-sulphur protein that is able to assemble into 
three possible clusters 4Fe-4S, 3Fe-4S and 2Fe-2S (Pierrel et al, 2002).  This protein 
is believed to be a member of a superfamily of proteins that uses the combination of 
a Fe-S cluster and AdoMet to initiate radical catalysis whose iron centre may be 
essential for activity (Pierrel et al, 2002).  On the other hand, the miaB gene has been 
shown to encode the thiotransferase required in tRNA modification, the first step of 
the pathway.  This suggested that the MiaB protein is involved in C–S bond 
formation (Esberg et al, 1999).  Deficiency in methylthiolation leads to a decreased 
efficiency of the corresponding tRNAs and an increased spontaneous mutation 
frequency (Connolly and Winkler, 1989).  The increase in spontaneous mutation may 
be an advantage to the organism under conditions of environmental stress.  
Examinations of this protein have been conducted on organisms such as E. coli 
(Pierrel et al, 2002) and Salmonella typhimurium (Buck et al, 1982) but its precise 
function is still not known in H. pylori.  Under conditions of iron starvation, this 
protein might be down regulated, resulting in it not being detected on 2-DE gels.  If 
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spontaneous mutation has occurred this may give the NUD isolates an advantage 
under iron restricted conditions. 
 
HP0305 and HP1285 (spot numbers 132 and 134 respectively) 
These two absent proteins have no known function.     
 
4.10.4  Unique and Absent proteins in GI Isolates 
 
4.10.4.1 Unique Proteins 
HP0538 (spot number 118)  
This protein is Cag17/CagN expressed by the gene locus located in the cag 
pathogenicity island and is involved in pathogenesis.   
 
The cag pathogenicity island (PAI) is a 40-kb insertion that is a complex structure of 
many different genes involved in virulence.  The cag17/cagN gene is one of many 
genes located on the cag pathogenicity island; others include cagA, cagS and cagT 
(Censini et al, 1996; Tomb et al, 1997).  Damage to any of a number of genes in the 
pathogenicity island has the potential to disrupt other virulence genes of H. pylori 
(Figura et al, 2004).   It has been found in certain cases that disruption of the cagA 
gene affects the expression of both flagellin A and flagellin B (FlaA and FlaB) and 
may affect post-transcriptional events (Figura et al, 2004).  These two elements of 
flagella are essential components for H. pylori motility which is necessary for it to 
colonise the gastric mucosa and are crucial for persistent infection (Ottemann and 
Lowenthal, 2002).   
 
Variability among the genes contained on the cag pathogenicity island may 
determine the degree of virulence and disease outcome of a particular strain.  For 
example, strains lacking both cagE and cagT, were more frequently found in patients 
with chronic gastritis (Ikenoue et al, 2001).  The presence of CagN in the GI isolates, 
may be characteristic of GI isolates and may be related to the type of disease they 
cause.  CagN may affect the expression of other proteins. 
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NA (spot number 117) and HP0842 (Spot number 119) 
These two proteins have no known function. 
 
 
4.10.4.2 Absent Proteins  
There were four specifically absent proteins (Figure 3.11, Table 3.13) that were 
identified. 
 
HP0431 (spot number 136) 
HP0431 is an uncategorised protein. Its possible function may be a protein 
phosphatase 2C homologue (Ptc1). Reversible protein phosphorylation plays a 
central role in a variety of cellular mechanisms, including the control of metabolism, 
the cell cycle, cell proliferation and differentiation (Tatsuya et al, 1993).  Tyrosine 
phosphorylation is affected by the activities of both protein tyrosine kinases and 
protein tyrosine phosphatases (PTPases).  The PTPase family is extremely diverse 
and possibly consists of proteins with more than one role (Charbonneau and Tonks, 
1992).  PTP1 and PTP2, similar to PTPases in eukaryotes, are found in bacteria, 
either individually, or together, with no known function (Tatsuya et al, 1993).  
Mutation of the Ptc1 function in Saccharomyces cerevisiae was found to be 
nonessential, however, ptc1 and ptp2, double mutants, showed a marked growth or 
germination defect at 37oC (Tatsuya et al, 1993).  The phosphate activity of Ptc1 is 
dependent on the presence of the divalent cations, Mg2+ or Mn2+, and it hydrolyses a 
serine phosphorylated substrate in their presence.  Therefore, the absence of Ptc1 
would have no effect on the function of this protein.  However, if there was an 
additional loss of the ptp2 gene this would have an effect (Tatsuya et al, 1993).  
However, the absence of the ptp2 gene product was not detected as an absent protein 
for the GI disease group.  Therefore, it is possible that the lack of the Ptc1 protein 
might not have any affect on the cell cycle, cell proliferation and differentiation of H. 
pylori.  The function of Ptc1 has not yet been determined for H. pylori and further 
studies would be needed to determine the effect of the protein’s absence on the 
organism’s growth.  Additionally insufficient Mg2+ or Mn2+ might reduce the activity 
and expression of this protein.  This might be possible if the expression levels were 
insufficient for detection by the techniques utilised in this study. 
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Predicted GTPases (dynamin-related) (spot number 138) 
This is a poorly characterized protein where the general function is predicted only.  
 
Numerous isoforms and homologues of dynamin related GTPases have been found in 
a variety of eukaryotic organisms from yeasts to humans (e.g. humans, S. cerevisiae, 
Trypanosoma brucei and Arabidopsis) (Obar et al, 1990; Rothman et al., 1990; 
Dombrowski and Raikhel, 1995; Gammie et al, 1995; Gu and Verma, 1996).  A 
characteristic feature of the dynamin family is the conserved N-terminal GTPase 
domain (Bourne et al, 1990).  However, the rest of the polypeptide sequence is less 
well conserved.  It has a variety of different functions in each organism.  In yeast, it 
is involved in the maintenance of mitochondrial morphology (Jin et al, 2003).  In 
humans, dynamin is a large molecular mass (100 kDa), GTP-binding protein, 
consisting of three isoforms dynamin-1, dynamin-2 and dynamin-3 (Suzuki et al, 
2001).   Dynamin has also been shown to function in apical transport of intracellular 
vesicles (Kreitzer et al, 2000). Thus, dynamin is currently thought to catalyse many 
essential steps in vesicle formation and traffic (Kirchhausen, 1998).  It was found 
that dynamin may play a role in intracellular vesicle formation and the transport of 
VacA (H. pylori vacuolating cytotoxin) (Rothman et al, 1990; Suzuki et al, 2001).  
The possible absence of GTPase (dynamin-related) may imply that VacA is not 
present in the GI isolates included in this study.   It has been reported in previous 
studies that CagA and VacA are two important virulence proteins that may increase 
the severity of the disease outcome (Graham and Yamaoka, 2000).  However, both 
proteins are not necessarily expressed in all isolates. 
 
Other Absent Proteins 
The two other absent proteins HP0934 (spot number 135) and JHP0896 (spot number 
137) have no known function. 
 
4.10.5  GU Differentially Regulated Proteins 
Only four GU differentially regulated proteins (Figure 3.12, Table 3.15) were of 
sufficient abundance to enable identification, these were: 
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HP0958 (spot number 139) 
A down-regulated Zn-ribbon protein, possibly nucleic acid-binding with no known 
function.  
 
This study found that this protein is part of a serial-charge train (see page 173).  The 
serial-charge train in NUD, GI and DU isolates consisted of two protein spots.  The 
first protein spot in the charge train, number 120, was identified as an absent spot in 
the GU isolates.  The second protein, spot number 139, had a greater than 3-fold 
reduction in the GU isolates.  Therefore, given that this protein in the charge train has 
a decreased spot intensity the absence of protein spot number 120 is most likely 
because it has a decreased expression.   
 
HP0824 (spot numbers 157 and 158) 
An upregulated thioredoxin protein that belongs to the cellular processing and 
signalling category and is involved in posttranslational modification, protein turnover 
and chaperones. 
 
In this study, TrxB (HP0825), with a 2-DE gel location of 33.5 kDa/pI 5.8, was 
identified as a specifically absent protein in the GU isolates.  However, its 
counterpart TrxA (HP0824) in the thiol-dependent, reduction-oxidation system was 
present as an up-regulated protein for the GU isolates.  While the two explanations 
mentioned on page 174 are both possible the most likely explanation for differences 
between the GU isolates and other isolates is a response to oxidative stress.   
 
HP0153 (spot number 161) 
This is a down regulated recombinase A (RecA) belonging to the information 
processing category and is involved in replication, recombination and repair.   
 
H. pylori strains display a high rate of mutation, but the diversity of this organism is 
additionally increased by horizontal gene transfer and recombination between strains.  
However, the rate of infections with multiple strains is not very common.  Since H. 
pylori is naturally competent for transformation, horizontal gene transfer is thought 
to occur mainly by this mechanism (Suerbaum et al, 1998).  Most H. pylori strains 
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are naturally competent for DNA uptake therefore RecA recombination may be 
essential for DNA transformation.   Homologous recombination between H. pylori 
strains not only plays a role in genomic variability through uptake of DNA from 
neighbouring cells but also is involved in maintaining genome integrity (Matic et al, 
1995).  
 
The ability to manage environmental stress is very important for the survival of H. 
pylori.  It is exposed to many different types of stress when it infects the stomach e.g. 
low pH and oxidative stress.  Some types of stress could result in DNA damage that 
might induce a repair response.  The RecA protein plays a role in recombination and 
is a regulatory protein that responds to certain types of DNA damage and mediates 
derepression of the SOS regulon (Walker, 1984).  The net affects of SOS induction 
are many and include increased DNA repair, an increased rate of mutation, inhibition 
of cell division, and prophage induction (Walker, 1984).  The SOS response is 
important in the repair of DNA damage caused by exposure to reactive oxygen 
species produced by immune cells during bacterial infection.  Thompson and Blaser 
(1996) found preliminary evidence, that recA mutants were more susceptible to low 
pH and antibiotics.  This suggests that RecA may be important for survival of H. 
pylori during infection of the gastric mucosa.    
 
HP1520 (spot number 152) (shared with NUD) 
This protein has no known function and is down regulated.  
 
JHP0065 (spot number 162)  
This protein belongs to the cellular processes and signalling category and is involved 
in posttranslational modification, protein turnover, and is a chaperone protein. 
 
4.10.6  DU Differentially Regulated Proteins  
The DU disease group had the largest proportion of proteins that were down 
regulated in comparison to the other disease groups (see Figure 3.12 and Table 3.15).  
See section 4.9.7 for proteins that were down regulated in both DU and NUD 
isolates.  
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HP0197 (spot number 143) 
This is S-adenosylmethionine Synthetase (MetK) belonging to the metabolism 
category and is involved in coenzyme transport and metabolism.  
 
It is uncertain what the precise role of a decrease in MetK production might be in the 
physiology of DU isolates as its function has only been inferred from studies in other 
organisms.   MetK is an enzyme which donates methyl groups to DNA and many 
other compounds (Wei and Newman, 2002; Cantoni, 1951).  S-Adenosylmethionine 
(SAM) is synthesized in all cells from ATP and methionine and regulates cell 
growth, differentiation, and function (Mato et al, 1997).  
 
A study of E. coli found that when metK expression was limited, methylation of 
DNA decreased and cell division was hampered (Wei and Newman, 2002).  In 
section 4.10.2.1 another protein, HP0332 also has a role in cell division.  In 
organism, cell division de Boer et al (1992) found that when the topological 
specificity factor MinE was overexpressed that cell division was suppressed.  It is 
possible that MinE is not a specifically unique protein but instead it might have been 
overexpressed.  The decrease in MetK in conjunction with a possible overexpression 
of MinE implies that DU isolates may have a lowered rate of cell division.  
Alternatively, it has been suggested that MetK plays a role in oxidative stress.  For 
example, in eukaryotes  in vivo study on the antioxidant properties of MetK in Fe2+ 
oxidation it was found that this protein exerts direct antioxidant action, mainly 
through iron chelation and inhibition of Fe2+ autoxidation (Caro and Cederbaum, 
2004).  
 
HP0201 (spot number 144) 
This is a fatty acid/phospholipid biosynthesis enzyme (PlsX) involved in lipid 
transport and metabolism and was found to have a greater than three-fold decrease in 
DU isolates.   
 
In E. coli, half of the fatty acid biosynthesis genes (fab) are clustered together.  The 
plsX gene which is located upstream of fabH is considered to be part of this cluster 
due to its role in phospholipid biosynthesis (Larson et al, 1984; Zhang and Cronan, 
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1998).  The fab cluster genes and plsX have been reported in H. pylori although these 
genes are arranged differently.   While fatty acid biosynthesis has attracted some 
interest in other organisms such as Bacillus subtilis and E. coli (Zhang and Cronan, 
1998; Larson et al, 1984) little has been done in H. pylori.  The function of PlsX is 
still poorly understood but is believed to be one of two enzymes, which are involved 
in the pathway to produce phosphatidic acid, a key phospholipid synthesis 
intermediate (Rock and Cronan, 1982).   
 
Studies involving the E. coli plsX gene and fab cluster have indicated that rpmF and 
plsX are cotranscribed and as such could play an important role in coordinating 
ribosome synthesis with cell-membrane synthesis (Podkovyrov and Larson, 1995).  
Since PlsX spot intensity in the DU isolates is decreased in comparison to the other 
isolates this may reflect a decreased synthesis of the protein homologous to RpmF in 
H. pylori as well.  If the co-transcription of these proteins is important, then this 
decrease in production may reflect differences in cell membrane synthesis of DU 
isolates. 
 
HP0875 (spot numbers 140-142) 
This protein is a catalase (KatA) and is involved in detoxification.   
 
The KatA can be altered in response to oxidative stress and an iron restricted 
environment.  KatA is an enzyme that is responsible for the dismutation of hydrogen 
peroxide into water and molecular oxygen and protects H. pylori from the potentially 
damaging effects of hydrogen peroxide (Harris et al, 2002).    
 
H. pylori damage of the gastric mucosa is the result of the secretion of the neutrophil 
activating protein and CagA which attract neutrophils and interleukins in response to 
infection.  In activated neutrophils, NADPH oxidase in cell membranes becomes 
activated, and electron transfer takes place from NADPH within the cells to oxygen 
both inside and outside.   The oxygen molecules that receive an electron become 
superoxide radicals that are rapidly converted to hydrogen peroxide (either by 
spontaneous dismutation or enzymatically by the action of superoxide dismutase) 
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and hydroxyl radicals that are formed non-enzymatically in the presence of ferrous 
ions as a secondary reaction (Cadenas, 1989; Farr et al, 1988).   
 
KatA is expressed in high levels in response to oxidative stress in vivo.   However, in 
an iron limited environment KatA expression is reduced, whereas normal iron levels 
promote KatA (Harris et al, 2002).   The Harris et al (2002) study found that H. 
pylori cells with the knockout mutation in the fur gene, or grown on a low-iron 
medium, showed a reduction in catalase activity and were more sensitive to hydrogen 
peroxide.  However, in the present study, all isolates were grown on the same 
medium that was not deficient in iron and none of the proteins that were selected for 
peptide mass fingerprinting were identified as the Fur protein.  This indicates that 
some other mechanism in the DU isolates might be resulting in a down-regulation of 
KatA expression.  However it is possible that Fur might have been one of the other 
differentially regulated proteins that were not identified therefore this protein might 
still be a factor in reduced catalase expression.  Other proteins were identified that 
also respond to iron levels and oxidative stress i.e. CeuE, Pfr and KatA.  Further 
examination and identification of the other unidentified differentially expressed 
proteins would need to be analysed to determine if other proteins such as Fur might 
also have been decreased/increased in conjunction with KatA.   The down-regulation 
of KatA may be due to adaptation to a specific niche and may provide an advantage 
for survival under specific conditions e.g. oxidative stress and iron-starvation.    
 
HP0027 (spot numbers 147 and 148) 
This protein is isocitrate dehydrogenase (Icd).  It is in the tricarboxylic acid (TCA) 
cycle and is involved in energy production and conversion.  
 
The TCA cycle performs a dual role in cell metabolism providing biosynthetic 
starting compounds such as -ketoglutarate, succinyl-CoA and oxaloacetate, which 
act as precursors for a wide spectrum of cell components, as well as a ‘metabolic 
energy’ source through the generation of reduced nucleotides, the reoxidation of 
which may be coupled to ATP synthesis.  Initially it was believed that H. pylori had 
an incomplete TCA cycle (Tomb et al, 1997) but subsequent studies have shown that 
H. pylori has a complete TCA cycle (Pitson et al, 1999; Kather et al, 2000). 
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There are three forms of Icd in eukaryotics; mitochondrial NADP-dependent, 
mitochondrial NAD+-dependent, and cytosolic NADP-dependent (ICDH) (Maeng, 
2004).   H. pylori only has the ICDH form, which is located primarily (96%) in the 
cytosolic fraction and was NADP specific with no detectable activity with NAD+ 
(Pitson, 1999).  The activity of ICDH in H. pylori was found to be inhibited at higher 
concentrations of both NADP+ and isocitrate (Pitson, 1999). 
 
The present study found that the isocitrate dehydrogenase Icd of the GU isolates 
displayed a greater than three-fold increase in spot volume in comparison to the DU 
isolates.  Icd catalyses the oxidative decarboxylation of isocitrate to -ketoglutarate.  
The Icd family of enzymes, either the NAD+-dependent, or NADP-dependent form, 
exists in virtually all species and has a wide variety of functions, including the TCA 
cycle and is responsible for ATP production, and other biosynthesis pathways 
(Holms, 1987).  One study of H. pylori found that in the presence of metronidazole, 
Icd was significantly decreased in activity (Hoffman et al, 1996).  Heat shock may 
increase oxidative stress by increasing the production of reactive oxygen species 
and/or the promotion of cellular oxidation events.  An examination into the effects of 
heat shock induced oxidative stress in E. coli found that ICDH was an important 
antioxidant enzyme protecting against heat shock (Choi et al, 2003).   
 
In eukaryotic organisms, it has been reported that the overexpression of ICDH plays 
an essential role in protecting against oxidative damage by H2O2 (Maeng, 2004).   In 
addition, it was found that it greatly reduced intracellular peroxide levels and cell 
death in response to H2O2.   However, the overexpression of ICDH did not affect the 
expression levels of the other antioxidant enzymes (Maeng, 2004).  In another study 
of the effects of temperature on the development of wild-type Caenorhabditis 
elegans, it was found that Icd was only detected at lower temperatures (Madi et al, 
2003).   
 
To date (December 2005) there are no published studies that have examined the 
effects of oxidative stress on Icd expression in H. pylori.  However, given that other 
anti-oxidative stress proteins (e.g. catalase and non-haeme iron (III) ferritin) were 
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under-expressed in the DU isolates (by a factor greater than three) differences due to 
oxidative stress cannot be ruled out. 
 
4.10.7  DU and NUD Differentially Regulated Proteins 
Five proteins were differentially expressed by isolates from both NUD and DU 
disease groups.  Two proteins had no known function, JHP0052 (spot number 156) 
and HP0453 (spot number 153). The remaining three proteins had a known function 
(Figure 3.12, Table 3.15) in both the NUD and DU disease groups.  
 
When similar quantitative differences are observed for two disease groups the 
possible explanation for these differences might not be the same for both disease 
groups.  Different factors or other proteins of unknown function may determine the 
most likely reason for the up-regulation and/or down-regulation of specific proteins.  
For example non-haeme iron containing ferritin (Pfr) (see page 196), which has been 
extensively studied for H. pylori, is involved in stress, iron and nickel excess and 
iron starvation.  While down-regulation might be caused by oxidative stress in DU 
strains this might not be the case for NUD and there might be possible alternative 
explanation.   Further investigation would be required in these cases to determine the 
most likely cause of the quantitative difference.  See Section 4.9.10 for further 
discussion on possible explanations on the down-regulation of Pfr in DU and NUD 
strains.    
 
JHP0761 (spot number 151) 
This is homoserine dehydrogenase and it was down regulated in both the NUD and 
DU isolates (Hom). Hom belongs to the metabolism category and is involved in 
category amino acid transport. 
 
The enzymes involved in the synthesis of essential amino acids have been 
extensively studied in plants and microorganisms.  Hom is a component of the 
aspartate pathway that catalyses the NADPH-dependent reduction of aspartate to 
produce homoserine (Viola, 2000).  This reaction occurs at a key branch point in the 
pathway, with the substrate, homoserine, serving as the precursor for the biosynthesis 
of lysine which leads to the synthesis of methionine, threonine, and isoleucine 
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(Viola, 2000).  Regulation of the reaction catalysed by homoserine dehydrogenase 
(HDH) is a catalytic domain in a bifunctional enzyme with aspartokinase, and 
allosteric regulation of both activities is mediated through the aspartokinase domain 
(Truffa-Bachi et al, 1974). 
 
Organisms that utilise the aspartate biosynthesis pathway contain several 
aspartokinases that catalyse the initial step in the pathway, the phosphorylation of L-
aspartic acid (Viola, 2000).  In many of these organisms, at least one of these 
enzymes is bifunctional, catalysing both the first, and surprisingly, the third reaction 
in this metabolic sequence (Cohen 1969).  Many bacteria contain several isoforms of 
aspartokinases, some of which are bifunctional.  These bifunctional enzymes are 
subject to differential regulation, both by feedback inhibition by the amino acids 
produced and by repression at the genetic level.  In E. coli, the aspartokinase-HDH II 
enzyme has a feedback mechanism that is inhibited by L-threonine and possibly S-
adenylmethionine levels (Viola, 2000).  The aspartate pathway response to different 
conditions, such as oxidative stress and iron excess/restriction, has not yet been 
reported for H. pylori. 
 
HP0653 (spot number 146) 
This is a non-haeme iron containing ferritin (Pfr) and is down regulated in NUD and 
DU.   It is involved in inorganic ion transport and metabolism.  The protein Pfr is 
known to respond to various stimuli - oxidative stress, iron depletion and nickel 
excess. 
 
While Fe2+ is an essential property required for most life forms, iron can be 
extremely toxic under aerobic conditions.  Bacteria need to maintain a delicate 
balance in order to scavenge sufficient quantities of Fe2+ or Fe3+ without them 
becoming toxic.  Bacteria manage iron balance by utilising five strategies (Andrews 
et al, 2003).  The first involves the utilisation of high-affinity Fe3+ or Fe2+ transport 
proteins in order to scavenge iron, in various forms, from the surroundings (Delany 
et al, 2001b; van Vliet et al, 2001).  Bacteria also control Fe2+ or Fe3+ consumption 
under iron-restricting conditions by down regulating the expression of iron-
containing proteins.  Bacteria also deposit intracellular Fe2+ stores to provide a 
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source of iron that can be drawn upon when external supplies are limited e.g. ferritins 
(Frazier et al, 1993; Evans et al, 1995).  Also they employ redox stress-resistance 
systems such as superoxide dismutase (e.g. degradation of iron-induced reactive 
oxygen species and repair of redox stress-induced damage) to protect the 
microorganism from oxidative stress (Naito and Yoshikawa, 2002).  Finally all 
bacteria utilise an iron-responsive regulatory system that co-ordinates the expression 
of the iron homeostatic machinery according to iron availability (Ernst et al, 2005). 
 
The reduction products of oxygen superoxide and hydrogen peroxide are only mildly 
reactive physiologically.  However, iron interacts with these molecules to generate 
the more damaging hydroxyl radical.  In H. pylori, mechanisms for protecting against 
oxidative stress include the enzymes superoxide dismutase, alkyl hydroxide 
peroxidase and catalase (Naito and Yoshikawa, 2002; Harris et al, 2002).  These 
enzyme systems interact to protect cells from reactive oxygen species.  These 
enzymes are regulated in H. pylori by the protein Fur that responds to stimulants (e.g. 
Fe2+ levels) in the environment by regulating the oxidative-stress proteins and the 
iron storage protein Pfr (Bereswill et al, 1998a Bereswill et al, 1998b; Waidner et al, 
2002). 
 
In the human stomach iron is released from food by peptic degradation, while iron 
restriction can be encountered via the iron-chelating activity of lactoferrin (Nakao et 
al, 1997). Therefore, both iron starvation and iron overload may occur in relatively 
short time intervals. The gastric environment requires the development of regulatory 
systems that allow H. pylori to regulate its iron metabolism.   
 
Pfr functions are essential for gastric adaptation and iron storage is necessary for the 
successful development of H. pylori infection (Waidner et al, 2002). 
 
In H. pylori Pfr has been characterised as the protein involved in the storage of iron 
(Frazier et al, 1993; Evans et al, 1995).  Studies on the function of Pfr indicate that it 
also plays a substantial role in the resistance of H. pylori to metal toxicity (Harrison 
and Arioso, 1996) and oxidative stress.   Fe2+ interacts with superoxide and hydrogen 
peroxide species to generate the highly reactive and extremely damaging hydroxyl 
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radical (Andrews et al, 2003).  The organism at the same time needs to protect itself 
from hydroxyl radicals as a result of the rapid alteration of iron levels in its 
environment.  Ferritins catalyse a function that is the exact opposite to that of iron 
uptake systems, which increase cytoplasmic iron concentration.  In an iron-rich 
environment, Pfr is up regulated and the iron transporter proteins are down regulated 
by Fur (Delany et al 2001a).  It is believed that ferritins may protect the organism 
from other metals (nickel, copper, manganese and zinc) (Contreras et al 2003).  
Evidence of an interaction of ferritin with iron-dependent regulation mechanisms has 
also been obtained (Bereswill et al, 1998a; Bereswill et al, 1998b).   
 
It has also been theorised that there may be other possible roles for ferritin other than 
iron storage, metal toxicity and oxidative stress.  What the other possible functions of 
ferritin might be is still unknown.  However, if there are other roles for ferritin they 
might play a factor in the disease outcome of H. pylori.  See section 4.9.10 for 
further discussion on possible explanations on the down-regulation of Pfr in DU and 
NUD strains 
 
JHP0650 (spot number 150) 
This is the competence protein ComGF which is down regulated in DU and NUD 
isolates.  It belongs to the cellular processes and signalling category and is involved 
in intracellular trafficking and secretion.   
 
The ComG operon in B. subtilis encodes seven proteins (ComGC, GG, GD, GE, GF, 
GB and GA) that are all essential for the binding of transforming DNA to the 
competent cell surface (Chung et al, 1998).   All of the proteins are membrane 
associated.  ComGF behaves as an integral membrane protein while ComGA, a 
putative ATPase, is located on the inner face of the membrane as a peripheral 
membrane protein (Chung et al, 1998).  The ComGF is a small protein with a 
predicted single membrane-spanning segment near its N-terminus (Chung and 
Dubnau, 1998).  It does not appear to possess a processing site, has no known 
orthologue and its role is unknown, although it is required for DNA binding to the 
competent cell surface. 
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Other Proteins 
Other differentially regulated proteins identified were HP0453 (spot number 153) 
and JHP0052 (spot number 156).  JHP0052 has not been categorised, but the NCBI 
record shows that this protein has been inferred to have a biological process involved 
in the regulation of transcription that is DNA dependent.   
 
4.10.8  NUD Differentially Regulated Proteins 
Four proteins with no known function were identified that were differentially 
regulated (Figure 3.12, Table 3.15) for the NUD isolates these are: 
 
 HP0879 (spot number 149). Uncharacterised and with no known function. 
 HP0453 (spot number 153). Function unknown.  It differed in spot intensity 
in the DU isolates. 
 HP1520 (spot number 152).  Function unknown.  
 JHP0052 (spot number 156).  It is related to proteins in transcription activity 
but has no known function.  It also differed in spot intensity in the DU 
isolates. 
 
4.10.9  Unidentified Proteins 
Approximately 50 proteins remain unidentified in this study.  The majority of these 
proteins were small Mr proteins, which would be expected to have only a few 
digestion cleavage sites.  This makes it difficult to identify them as it would generate 
a large number of possible matches in the databases.  A solution that may need to be 
considered in the future is to re-analyse these proteins using a technique such as 
MALDI-TOF Post Source Decay or ESI-MS.  A partial amino acid sequence might 
then be utilised to acquire a more accurate match in the databases.  Other protein 
identification technologies that can be utilised are liquid chromatography/mass 
spectrometry (LC-MS/MS) (Mann and Wilm, 1994; Yates et al., 1995) mass 
spectrometry sequencing (PMF+MS/MS) or Tandem mass spectrometry (MALDI 
TOF-TOF). 
  
Also very little homology may have been found with proteins in the database because 
the unidentified proteins investigated in this study may not actually have been 
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entered into the protein database.  Therefore these proteins would not be identified 
even if another technique was used.  Therefore a peptide mass fingerprint that has a 
“no hit” result needs to be rechecked later when the database has been updated. 
 
4.10.10  Stress response, cell division, cell membrane and other proteins 
Spots selected for identification in this study included proteins 
 
whose expression is altered in response to: 
 Oxidative stress - KatA,  Pfr, Icd, MetK, TrxA/TrxB  
 DNA damage - RecA 
 Iron restricted stress – KatA, Pfr, CeuE, Hsp12 variant C‡ 
 Nickel Excess stress – Pfr and CeuE 
 Temperature – Hsp12 variant C 
that affect: 
 Cell Division – MetK and MinE 
 Cell membrane -  PlsX, Ptc1, ComGF, JHP0140, JHP0896 and SpaA 
that have other roles: 
 Digestion of plant fibre - JHP0295 
 Hom – Aspartate pathway  
 Ribosome binding to RpoN - HP0958  
 Pathogenicity – Cag17/N 
 
Many of the proteins identified in this study have more than one role or alternative 
roles.  For example Pfr (see above), which has been extensively studied for H. pylori, 
is involved in stress, iron and nickel excess and iron starvation.  Whereas another 
protein such as MetK, poorly understood in H. pylori, has been proposed to have 
different roles dependent on the organism studied, oxidative stress (humans) and cell 
division (E. coli).  A comparison of the eleven H. pylori isolates studied identified 
eight proteins that have a role in protection of the organism from stress i.e. oxidative 
stress, iron-restriction, and temperature (KatA, Pfr, MetK, TrxA/TrxB, Hsp12 variant 
C, CeuE and RecA).   Another eight proteins are associated with cell division (MetK 
and MinE) and the cell membrane (PlsX, Ptc1, ComGF, SpaA, JHP0140 and 
JHP0896) but have no apparent connection to stress.  It is possible that stress may 
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indirectly affect these particular aspects of H. pylori’s morphology.   Figure 4.1 
shows a representation of the possible connections between proteins involved in 
these particular aspects. 
 
Oxidative stress 
The induction of an inflammatory response by H. pylori infection leads to an 
increased potential for oxidative damage to the bacterium.  KatA, Pfr, Icd, MetK, 
(involved in metabolism) and TrxA/TrxB (cellular processes and signalling) have 
been associated with protection from oxidative stress.  Additionally other proteins 
unrelated to those involved in protection from oxidative stress may respond to 
damage caused by oxidative stress, e.g. DNA damage (Figure 4.1).  KatA, essential 
for protection against oxidative stress, has been shown to spontaneously mutate and 
cease expression in response to a change in its environment (e.g. in vivo vs in vitro) 
(Manos et al, 1998).  The protein Pfr is known to respond to various stimuli - 
oxidative stress, iron depletion and nickel excess (Waidner et al, 2002; Contreras et 
al, 2003).  However, icd expression has only been found to respond to oxidative 
stress in E. coli (Lee et al, 1999) and humans with no similar event currently (up to 
2005) known to occur in H. pylori.  The TrxA/TrxB redox system is known to 
increase thioredoxin and decrease thioredoxin reductase production in response to 
oxidative stress (Berggren et al, 1996; Reddy et al, 1999).  MetK is believed to be 
important to cell division in E. coli and oxidative stress in eukaryotic organisms (Wei 
and Newman, 2002; Caro and Cederbaum, 2004).  Although no such association has 
been found in H. pylori it is possible that MetK could be linked with the other 
proteins that respond to oxidative stress.  Oxidative stress will cause DNA damage, 
which the organism might respond to by increasing RecA production (Walker, 1984).   
 
A comparison of the isolates revealed that the proteins that are essential in protecting 
the organism from oxidative stress, differed in spot intensities (three-fold or greater 
increase/decrease) for the different disease groups: 
 
 DU isolates – KatA, Pfr, Icd and MetK;  
 NUD isolates – Pfr; and 
 GU isolates – TrxA/TrxB and RecA. 
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Figure 4.1 Proteins involved in stress response, morphology and other aspects of H. pylori  
A diagrammatic representation showing the connection of proteins involved in stress response and morphology of H. pylori  
IP=information processing M=metabolism CPS=cellular process and signalling PC= poorly characterised 
† protein response to stress conditions ‡ proteins that affect physiology of H. pylori *protein response to non-stress related environment
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Compared to the GU isolates the DU isolates produced the greatest number of 
proteins involved in the oxidative-stress response (KatA, Pfr, Icd and MetK).  NUD, 
GI and DU isolates differed from GU isolates in spot intensities for TrxA/TrxB and 
RecA.  While NUD isolates and DU isolates both differed in the spot intensity for Pfr 
in comparison to the GI and GU isolates.   
 
Microorganisms adapt to environmental cues by turning on and off the expression of 
genes for survival within specific environmental niches.  Such adaptations might 
include responses to changes in oxidative stress.  The comparative proteome analysis 
revealed that isolates within a specific disease group displayed similar expression 
patterns for oxidative-stress proteins.  These findings suggest that these proteins may 
play a significant factor in determining the disease outcome of a H. pylori strain.  
 
Haeme and Non-haeme regulation 
In H. pylori both iron acquisition and storage are governed by the ferric uptake 
regulator Fur (Bereswill et al, 1998a; Bereswill et al, 2000;  Fassbinder et al 2000; 
van Vliet et al, 2002).  In response to an increased iron concentration, Fur represses 
transcription of the iron uptake genes fecA2 and frpB1 (Delany et al, 2001a; Delany 
et al, 2001b; Fassbinder et al 2000) while transcription of the ferritin gene pfr 
increases (Bereswill et al, 2000, Delany et al, 2001a). Conversely, under iron-
restricted conditions transcription of the iron uptake genes is stimulated and Pfr-
mediated iron storage is repressed by Fur.   Disruption of the fur gene was found to 
derepress pfr but was not found to be involved in the regulation katA or ceuE. 
 
Expression of Pfr is also repressed by Fur upon increased nickel, copper, zinc, and 
manganese concentrations (Bereswill et al, 2000), leading to a model where 
modulation of Pfr transcription contributes greatly to the maintenance of iron and 
non-haeme metal homeostasis in H. pylori.   
 
This study identified four proteins that might be affected by iron and non-haeme 
metal homeostasis, pH and temperature, these being Pfr, CeuE, KatA and Hsp12 
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variant C.  These proteins have different expression responses to these environmental 
conditions: 
 
 Iron restriction environment 
o Pfr – repressed 
o CeuE – upregulated 
o KatA – upregulated 
o Hsp12 variant C – upregulated 
 Iron excess 
o Pfr – upregulated 
o CeuE – repressed 
 Nickel excess 
o Pfr – repressed 
o CeuE – repressed 
 pH stress 
o Hsp12 variant C – upregulated 
 Temperature stress 
o Hsp12 variant C – upregulated 
 
 
 
This study found that the expression of Pfr was decreased in both NUD and DU 
strains, however why this is the case may not necessarily be the same for both 
disease groups.  One possible explanation is that iron environmental conditions affect 
DU strains and nickel conditions affect NUD strains. 
 
Iron-restriction stress 
Iron has an important role in maintaining basic metabolic functions, such as electron 
transport, and it has a high redox reactivity and toxicity.  Pfr responds to oxidative 
stress, iron restriction and nickel excess.  Under conditions of oxidative stress, Pfr 
expression increases.  When iron-restriction and nickel excess are involved its 
production is reduced.  KatA is expressed at high levels in response to oxidative 
stress in vivo.  However, in an iron limited environment KatA expression is reduced, 
whereas normal iron levels promote KatA.  Iron transport proteins, such as CeuE, are 
increased in response to iron restriction and are restricted in an iron rich 
environment.    Comparative 2-DE analysis between the groups revealed that the DU 
group displayed differences in Pfr and KatA, while NUD displayed differences in 
Pfr, Hsp12 variant C and CeuE.  While iron limitation may be a factor in determining 
the disease outcome of a particular H. pylori strain such as the DU isolates this may 
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not be the case for the NUD isolates.   If iron limitation were a factor in the NUD 
isolates then the observed expression levels of CeuE would have been increased and 
KatA would have been decreased.    
 
This study also identified Hsp12 variant C as a protein specific to the NUD isolates.  
Hsp12 variant C, an induced protein, that is known to respond to more than one type 
of stress, pH, temperature and iron restriction (de Vries et al, 2003).  It is possible 
that Hsp12 was induced by iron restriction.  However, no other corresponding 
variations in the expression of proteins involved in this type of stress, such as the 
CeuE and KatA response to iron restriction, were identified for the NUD isolates.    
Additionally because there are at least six variations of Hsp12 (de Vries et al, 2003) 
that may have different theoretical and observed pIs and Mrs it is uncertain if Hsp12 
was not expressed by the other isolates in this study.  It is also possible that Hsp12 
may have other unidentified factors that alter its expression, for example nickel 
excess.  Further examination would be required to determine other factors that might 
affect Hsp12. 
 
Nickel excess stress 
A constant supply of nickel ions is required for the synthesis and activity of a number 
of metalloenzymes that play a crucial role in prokaryotic and eukaryotic cells 
(Eitinger and Mandrand-Berthelot, 2000). However, when nickel ions accumulate, 
they inhibit growth and exhibit a toxic effect.  Although Pfr and CeuE have been 
associated with nickel excess this stimulus also affects the expression of other 
proteins such as the ferric uptake regulator (Fur), iron-regulated outer membrane 
protein (FrpB), outer-membrane proteins omp11, omp31 and omp32, FlaA, FlaB etc 
(Contreras et al, 2003).  Both DU and NUD isolates displayed differences in the spot 
intensity of Pfr but, NUD isolates were the only ones that differed in the expression 
of CeuE (specifically absent).   The comparative analysis did not reveal any 
significant differences in the spot intensities of the other proteins known to be 
involved in nickel excess response.    Additionally the NUD isolates did not have 
similar spot intensities for FlaA and FlaB.  Also the spot intensity for FlaA and FlaB 
of the NUD3 isolate was at least six-fold greater than nine other isolates (GU1, GU2, 
GU3, GI1, GI2, NUD1, NUD2, DU1 and DU3).   The DU2 was the only other 
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isolate with an abundance of FlaA and FlaB with at least a four-fold increase in spot 
intensity.  This suggests that the expression of any other proteins that are involved in 
the nickel excess response would not be correlated with any disease groups.  Further 
investigation into these proteins that respond to nickel excess is required to 
determine if it might be a factor in the NUD strains. 
 
Cell division and membrane proteins  
Stress conditions such as pH can also affect other essential proteins e.g. membrane 
proteins and cell growth proteins involved in cell division and proliferation.   
 
Two proteins were identified for the DU isolates that have possible roles in cell 
division, MetK and MinE.  As previously mentioned, MetK has possible roles in 
oxidative stress response and cell division (Wei and Newman, 2002; Caro and 
Cederbaum, 2004).  Cell division can also be hampered by the overexpression of 
MinE (de Boer et al, 1992).  A comparison of the groups revealed that the difference 
in the spot intensities of the cell division proteins was a characteristic of DU group.   
Ptc1, found in the GI isolates, plays a possible role in a variety of cellular 
mechanisms, including the control of metabolism, the cell cycle, cell proliferation 
and differentiation (Tatsuya et al, 1993).  However, very little is known about the 
possible function of Ptc1 in H. pylori. 
 
The proteins with possible roles in the cell membrane are PlsX (DU isolates), 
ComGF (DU and NUD), SpaP (DU) and JHP0896 a predicted dynamin GTPase 
(GI).  Very little is known about the possible function of these four proteins.  PlsX is 
possibly involved in cell membrane synthesis (Rock and Cronan, 1982), ComGF is a 
membrane protein for the binding of transforming DNA to the competent cell surface 
(Chung et al, 1998), SpaP may be involved in cell binding (Demuth and Irvine, 2002) 
and JHP0896, a predicted GTPase, has been implicated in vesicle formation and 
traffic (Rothman et al, 1990; Suzuki et al, 2001).  The function of the cell growth and 
membrane proteins has only been predicted, further investigation would be required 
to ascertain if iron limitation and/or oxidative stress might affect these proteins. 
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Other proteins 
The remaining protein differences that were identified had no apparent connection to 
protection from stress or cell division and cell membrane. 
 
Hom, found in the NUD and DU isolates, is an enzyme in the aspartate pathway 
(Viola, 2000).  Currently no study has examined the response of this protein to any 
influences, and no relation to the other conditions mentioned have been noted in 
either eukaryotes or prokaryotes. 
 
Animals such as ruminants are dependent on the presence of microorganisms in the 
fore-stomach and rumen for the digestion of large amounts of plant material (Hespell 
and Whitehead, 1990).  Small amounts of plant fibres are also degraded by the 
microorganisms in humans.  JHP0295, which was identified as a specifically unique 
protein for the DU isolates, is a predicted xylanase that is produced by 
microorganisms to degrade xylan a component of plant material (Bastawde, 1992; 
Kulkarni et al, 1999).  The regulation of xylanase secretion by microorganisms is still 
not completely understood.  It is believed that the xylanase is induced in these 
microorganisms (Bastawde 1992; Kulkarni et al, 1999).   Because xylan cannot enter 
the microorganism, the expression of xylanase is stimulated by low molecular mass 
xylan fragments.   These low molecular mass fragments include xylose, xylobiose, 
xylooligosaccharides, heterodisaccharides of xylose and glucose and play a key role 
in the regulation of xylanase biosynthesis (Kulkarni et al, 1999).  These fragments 
are released from xylan by a small amount of constitutively produced xylanase 
(Bastawde, 1992; Kulkarni et al, 1999).  Cellulose has also been found to be an 
inducer (Hrmova et al 1984).  It is not known if the production of xylanase is 
inducible or constitutive in H. pylori, however it most likely that it is inducible.  
When a protein is induced this would give the appearance of a specifically unique 
protein consequently any alterations in the levels of xylan might result in an increase 
or decrease in the protein spot intensity.  Whereas if the enzyme is constitutive the 
protein spot would still be observable in the proteome map of all isolates.   It is 
possible that xylanase is not a unique protein but might alternatively be a 
differentially expressed protein in DU strains.  Further investigations need to be 
undertaken to understand the implications of this protein in DU strains. 
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HP0958 (also known as JHP0892), in the GU isolates, has recently been identified as 
a potential motility associated protein with strong interactions to RNA polymerase 
sigma-54 factor (RpoN) and FliH (Pereira and Hoover, 2005; Ryan et al, 2005).  It 
has been found that when HP0958 is absent the production of FlaA and FlaB is 
decreased and the production of FlgM is increased.  However, in this study any 
decrease in HP0958 was not found to correspond to alterations in FlaA, FlaB and 
FlgM as observed by Pereira and Hoover (2005).  The expression of FlaA, FlaB and 
FlgM was variable irrespective of HP0958 production levels.   This implies that 
HP0958 may have other possible functions other than motility, or that flagellin 
production is influenced by other factors. 
 
YjgF - little is known about its function.   
 
The proteins AhpC, NapA, GroEL, Rpo7/12, SodB, RpoA and Tsr [see section 4.7.1] 
were found to be positional shifts 
 
Forty eight percent of the identified differences in the proteome were due to 
unknown or poorly characterised proteins.   
 
In summary, the differences in the stress response, cell division and membrane 
proteins of H. pylori isolates could account in part for the different clinical outcomes 
of infection.  These proteome variations between isolates that are associated with a 
specific disease outcome might indicate genes that would influence colonisation of a 
particular niche, such as the duodenum. Variations in protein expression may be in 
response to specific stimuli.   These stimuli in turn can produce other effects that 
may alter the levels of other proteins. For example, oxidative stress alters the 
expression of KatA, Pfr, etc (Figure 4.1).  Additionally, oxidative stress may cause 
DNA damage that alters the production of RecA.   
 
 
4.11  Conclusions 
Proteome analysis has proven to be a useful method for comparing H. pylori isolates 
and disease outcomes.  Through pattern matching of 2-DE spots it was possible to 
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determine how many proteins were common to all isolates and to detect specific 
differences between isolates involved in different disease outcomes.  One hundred 
and seventy three protein spots were identified in this study from the whole cell 
proteins of eleven H. pylori isolates.  Twenty one were basic protein spots that have 
been characterized for the first time in H. pylori, with the remainder having been 
characterized in previous studies.  The proteome analysis highlighted the extensive 
strain variation that H. pylori exhibits with only 471 spots (40.6%) out of ~1168 per 
isolate being located at the same 2-D position.  Furthermore, through the dual 
application of two medium range IPGs and two gel systems this study has 
successfully improved the resolution of basic and low molecular mass proteins and 
provided further information towards the compilation of a master reference map of 
H. pylori.  
 
In contrast to other microorganisms whose proteomes have been studied, basic 
proteins form a large proportion of all the 2-DE patterns of the H. pylori isolates 
investigated.  Because the majority of the proteins in H. pylori have pIs within the 
range of pH 6-11 there is a need to resolve all these basic proteins.  Previous 
comparative studies resolved proteins through the application of IPG with a pH range 
of 6-10 which did not provide efficient and reproducible separation of proteins.  This 
study has shown that IPG 2-D gels in the range pH 6-11 improved the resolution of 
basic proteins within the pH range 8.5–10.5.  However, despite the advances in 
alkaline range IPGs that have improved the reproducibility and quality of separations 
within pH range 6–11 many of the basic proteins still remain unrepresented.  This 
lack at the more alkaline pH may be due to the instability of the gradient, or the 
instability of the proteins themselves, at an extremely alkaline pH.  Additionally 
when H. pylori are removed from their acidic environment many of these basic 
proteins that may have been required for colonisation in a hostile in vivo environment 
may not be expressed in vitro. 
 
This study utilised two gel systems - Tris-glycine and Tris-tricine.  The application 
of tricine as the trailing ion improved the resolution of H. pylori proteins with masses 
between 7-20 kDa, however, no proteins with masses below 7 kDa could be 
visualised.  In addition, the Tricine system also provided excellent resolution of 
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proteins between 20-62 kDa.  However, to obtain efficient separation of proteins 
with high molecular masses between 62-150 kDa glycine was utilised.  
Approximately 38 protein spots migrating in the 7-20 kDa region were identified by 
matrix assisted laser desorption/ionization - mass spectrometry, of which 22 were 
identified for the first time. The digestion of the low mass proteins often produced 
only a few peptides, which were either insufficient for efficient identification by 
mass spectrometry or could not be matched with any proteins in the database. The 
gel system described here may be useful for the efficient separation of low molecular 
mass proteins in future studies to construct proteome maps of H. pylori. 
 
Protein matching analysis of isolates grown in normal culture media indicated that 
the differences are mainly involved in stress responses, cell division and cell 
membrane protein production.  The comparative proteome analysis revealed that 
isolates associated with a specific disease group displayed similar expression patterns 
of these proteins.  Proteins that had known functions were essential to the organism’s 
survival and growth in a hostile environment.  Microorganisms adapt to 
environmental cues by turning on and off the expression of genes for survival within 
specific environmental niches.  Such adaptations might include responses to changes 
in oxidative stress.  These findings suggest that these disease-specific proteins 
identified in this study may play a significant factor in determining  the preferential 
colonisation of particular H. pylori isolates in specific mucosal layer niches and/or 
the disease outcome of a H. pylori strain. 
 
Most significantly this study has found, through the application of protein matching 
and cluster analysis, that protein differences in isolates could be correlated to four 
different clinical outcomes.   While qualitative analysis divided isolates into four 
distinct clusters, quantitative analysis did not display this trend.  However, both the 
qualitative and quantitative cluster analyses showed that isolates formed two major 
clusters, gastric and duodenal.  Interestingly, the isolates in the gastric groups (GU, 
NUD, and GI) clustered closer together than the DU isolates.  This indicates that 
isolates may adapt to particular microhabitats or that certain isolates are better suited 
to a particular microhabitat.   
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The protein differences observed between the disease groups included in this study 
may provide further insight into the physiology of this organism and its proteins.  Of 
course further investigation is needed to determine if other isolates from these 
disease groups also have the same characteristic proteins.  However, the results 
obtained have shown that protein matching and cluster analysis may provide a 
potentially powerful tool for diagnostic, taxonomic and epidemiological 
investigations of H. pylori. 
 
 
4.12  Future Directions 
This study should be expanded in at least four directions.  The first includes 
increasing the number of isolates included in the comparison, particularly in the 
Gastritis group.  Secondly, improving the technique to detect and resolve low 
molecular mass proteins below 7 kDa.  Thirdly, using alternative techniques for the 
analysis of high molecular mass proteins greater than 150 kDa and finally repeating 
the analysis of basic proteins between the pI 10-12.   
 
The gastritis group was represented by two isolates NCTC11638 and 26695, which 
have been cultured in the laboratory a number of years. Therefore, proteins identified 
in the gastritis disease group may not be indicative of disease markers.  Isolates from 
more recent biopsies might provide a more accurate representation and therefore 
more gastritis isolates should be studied.    Because so many proteins of NCTC11638 
(Lock et al, 2001) and 26695 (Jungblut et al, 2000) have been identified and 
referenced these isolates provide valuable information on conserved proteins.   
 
When basic proteins are of interest and need to be displayed in the gel an alternative 
extraction procedure (alkaline) might need to be utilised.  Extraction could be 
performed by two extraction procedures.  The first extraction procedure (for the 
acidic proteins pH 4-7) could use a Tris base up to 40 mmol (Westermeier and 
Naven, 2002) and in the second extraction the basic proteins greater than pH 7 might 
then be precipitated in TCA/acetone (Ohlmeier et al, 2000).  
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Currently techniques to resolve and observe extremely basic proteins are not 
commercially available, while the methods for detection of low molecular mass 
proteins still require further improvements.  However, new methods such as HPLC 
that are currently being utilised for the detection of high and low molecular mass 
proteins show promise.   
 
This study compared the proteome of these isolates under normal in vitro culture 
conditions.  Additionally many of the proteins observed were high abundance 
proteins.  Therefore, in order to obtain a complete proteome map of this organism we 
may require the application of two different approaches.  The first would require 
prefractionation techniques to enrich for low abundance proteins.  The second 
approach would include examination of the organism under different conditions of 
culture.  This would include variables such as starvation of the organism, culturing 
the organism in the presence of antibiotics, and cell culture techniques to observe 
how the organism interacts in the presence of human gastrointestinal cells. 
 
Although the proteome of 26695 has been examined this has not been the case for H. 
pylori strain J99.  The genomes of 26695 and J99 have been compared (Alm and 
Trust, 1999) and found to be largely conserved so it would be of interest to compare 
the proteome of these two isolates to determine how their 2-D maps compare. 
 
Finally, this study should be expanded to involve the large-scale screening of isolates 
associated with specific disease outcomes, in particular GU, NUD, DU and GI.  The 
traditional method used to be 1D Western Blotting of isolates.  However, the new 
method in proteomics using protein microarrays has great potential.  Therefore the 
use of current screening techniques might include the use of protein microarrays for 
the detection of possible disease markers within other isolates.  At least 60 proteins 
present themselves as possible marker proteins of interest for future large-scale 
screening of H. pylori.  In order to ascertain if other isolates from cases of GU, NUD, 
DU and GI contain these marker proteins at least one hundred isolates should be 
screened from each of the four groups.   
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Figure A.1 H. pylori GU1 pH 4-7 
GU1 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine electrode 
buffer. Determination of the molecular mass and pI of protein spots was obtained 
from the use of 2-D protein standards. 
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Figure A.2  H. pylori GU2 pH 4-7 
GU2 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine electrode 
buffer. Determination of the molecular mass and pI of protein spots was obtained 
from the use of 2-D protein standards. 
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Figure A.3  H. pylori GU3 pH 4-7 
GU3 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine electrode 
buffer. Determination of the molecular mass and pI of protein spots was obtained 
from the use of 2-D protein standards. 
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Figure A.4  H. pylori NUD1 pH 4-7 
NUD1 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine 
electrode buffer. Determination of the molecular mass and pI of protein spots was 
obtained from the use of 2-D protein standards. 
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Figure A.5  H. pylori NUD2 pH 4-7 
NUD2 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine 
electrode buffer. Determination of the molecular mass and pI of protein spots was 
obtained from the use of 2-D protein standards. 
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Figure A.6  H. pylori NUD3 pH 4-7 
NUD3 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine 
electrode buffer. Determination of the molecular mass and pI of protein spots was 
obtained from the use of 2-D protein standards. 
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Figure A.7  H. pylori DU1 pH 4-7 
DU1 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine electrode 
buffer. Determination of the molecular mass and pI of protein spots was obtained 
from the use of 2-D protein standards. 
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Figure A.8  H. pylori DU2 pH 4-7 
DU2 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine electrode 
buffer. Determination of the molecular mass and pI of protein spots was obtained 
from the use of 2-D protein standards. 
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Figure A.9  H. pylori DU3 pH 4-7 
DU3 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine electrode 
buffer. Determination of the molecular mass and pI of protein spots was obtained 
from the use of 2-D protein standards. 
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Figure A.10  H. pylori GI1 pH 4-7 
GI1 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine electrode 
buffer.  Determination of the molecular mass and pI of protein spots was obtained 
from the use of 2-D protein standards. 
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Figure A.11  H. pylori GI2 pH 4-7 
GI2 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine electrode 
buffer. Determination of the molecular mass and pI of protein spots was obtained 
from the use of 2-D protein standards 
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Figure A.12  H. pylori GU1 pH 6-11 
GU1 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine electrode 
buffer. Determination of the molecular mass and pI of protein spots was obtained 
from the use of 2-D protein standards. 
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Figure A.13  H. pylori GU2 pH 6-11 
GU2 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine electrode 
buffer. Determination of the molecular mass and pI of protein spots was obtained 
from the use of 2-D protein standards. 
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Figure A.14  H. pylori GU3 pH 6-11 
GU3 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine electrode 
buffer. Determination of the molecular mass and pI of protein spots was obtained 
from the use of 2-D protein standards. 
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Figure A.15  H. pylori NUD1 pH 6-11 
NUD1 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine 
electrode buffer. Determination of the molecular mass and pI of protein spots was 
obtained from the use of 2-D protein standards. 
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Figure A.16  H. pylori NUD2 pH 6-11 
NUD2 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine 
electrode buffer. Determination of the molecular mass and pI of protein spots was 
obtained from the use of 2-D protein standards. 
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Figure A.17  H. pylori NUD3 pH 6-11 
NUD3 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine 
electrode buffer. Determination of the molecular mass and pI of protein spots was 
obtained from the use of 2-D protein standards. 
 
 
 
 
 
 
 
 
  234 
 
    
 
 
 
Figure A.18  H. pylori DU1 pH 6-11 
DU1 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine electrode 
buffer. Determination of the molecular mass and pI of protein spots was obtained 
from the use of 2-D protein standards. 
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Figure A.19  H. pylori DU2 pH 6-11 
DU2 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine electrode 
buffer. Determination of the molecular mass and pI of protein spots was obtained 
from the use of 2-D protein standards. 
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Figure A.20  H. pylori DU3 pH 6-11 
DU3 proteins separated on 8.5% polyacrylamide slab gels by a Tris-tricine electrode 
buffer. Determination of the molecular mass and pI of protein spots was obtained 
from the use of 2-D protein standards. 
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Figure A.21  H. pylori GI1 pH 6-11 
GI1 proteins were separated on 8.5% polyacrylamide slab gels by a Tris-tricine 
electrode buffer. Determination of the molecular mass and pI of protein spots was 
obtained from the use of 2-D protein standards. 
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Figure A.22  H. pylori GI2 pH 6-11 
GI2 proteins were separated on 8.5% polyacrylamide slab gels by a Tris-tricine 
electrode buffer. Determination of the molecular mass and pI of protein spots was 
obtained from the use of 2-D protein standards. 
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Figure A.23  NUD3 Identified Flagellin Spots  
The NUD3 strain is an example of a H. pylori strain which had the highest 
concentration of FlaA, FlaB protein spots.  Determination of the molecular mass and 
pI of protein spots was obtained from the use of 2-D protein standards. 
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Figure A.24  NUD1 Identified Flagellin Spots  
The NUD1 strain is an example of a H. pylori strain which had a medium level 
concentration of FlaA, FlaB protein spots.  Determination of the molecular mass and 
pI of protein spots was obtained from the use of 2-D protein standards. 
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Figure A.25  GI2 Identified Flagellin Spots 
The GI2 strain is an example of a H. pylori strain which displayed no FlaA, FlaB 
protein spots.   Determination of the molecular mass and pI of protein spots was 
obtained from the use of 2-D protein standards. 
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